"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT03574454","Machine Learning in Myeloma Response","MALIMAR","Recruiting","No Results Available","Myeloma","Other: Machine Learning (ML)","Sensitivity of Machine Learning Algorithm to detect Myeloma|Level of Agreement in Assessment of Disease Burden|Level of Agreement to Classify Disease Spread|Quantification of Improvements to Correctly Identify Disease by Site and Reading Time|Difference in Reading Time with and without Machine Learning|Specificity for Identification of Active Disease with and without Machine Learning|Sensitivity to detect Active Disease in non-Experienced Readers with and without Machine Learning|Agreement in Categorisation of Active Disease|Difference in Reading Time for scoring Disease Burden with and without Machine Learning|Agreement in Categorisation of Disease Responders and non-Responders with Reference Standard|Agreement in Categorisation of Disease Responders and non-Responders in non-Experienced Readers|Agreement in Assessment of Disease Burden in non-Experienced Readers|Difference in Costs of Radiology Reading Time with and without Machine Learning","Royal Marsden NHS Foundation Trust|Institute of Cancer Research, United Kingdom|Imperial College London","All","40 Years to 100 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","CCR 4820|233501|16/68/34","July 4, 2018","May 2021","August 2021","July 2, 2018",,"July 17, 2018","Department of Radiology, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom|Institute of Cancer Research, London, London, United Kingdom|Imperial College, London, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03574454"
2,"NCT02943824","Machine-learning Optimization for Prostate Brachytherapy Planning","MOPP","Completed","No Results Available","Prostatic Neoplasms","Other: Machine Learning Planning|Other: Radiation Therapist Planning","post-operative prostate V100%|Pre-operative planning time|Pre-operative dosimetry|Frequency & magnitude of plan modifications","Sunnybrook Health Sciences Centre","Male","Child, Adult, Older Adult","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","1.1.1","August 24, 2017","August 24, 2018","September 4, 2018","October 25, 2016",,"September 6, 2018","Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02943824"
3,"NCT03706664","Small Bowel Deep Learning Algorithm Project",,"Active, not recruiting","No Results Available","Crohn Disease","Other: Machine learning algorithm","Machine learning algorithm's ability to accurately localize the terminal ileum.|Data processing time until a diagnosis reported by algorithm.|Machine learning algorithm's ability to accurately distinguish abnormal and normal terminal ileum.","London North West Healthcare NHS Trust|Imperial College London","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","226","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRAS No:238924","March 1, 2019","November 2020","January 2021","October 16, 2018",,"February 27, 2020","St Mark's Hospital, London, Harrow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03706664"
4,"NCT02330679","Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis",,"Unknown status","No Results Available","Major Depressive Disorder","Drug: Desvenlafaxine|Drug: Placebo","The resting state and emotional task related brain activity pattern at the pretreatment baseline and two weeks post treatment as measured by functional MRI and analyzed by machine learning techniques|The clinical response to antidepressant treatment as measured by Montgomery-Asberg Depression Rating (MADRS) scale.","University of Calgary|University of Alberta","All","20 Years to 55 Years   (Adult)","Phase 4","61","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","REB 14-0194","December 2014","December 2016","December 2016","January 5, 2015",,"January 5, 2015","University of Calgary, TRW Building, Foothills Hospital Campus, Calgary, Alberta, Canada|University of Calgary: Foothills Hospital, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT02330679"
5,"NCT02931500","Machine Learning for Identification of Future Disease Development: A Nationwide Cohort Study (MILESTONE)",,"Unknown status","No Results Available","Cardiovascular Disease|Metabolic Disease",,"Accuracy in prediction of development of cardiovascular and metabolic disease using machine learning algorithm|Accuracy in prediction of development of cardiovascular and metabolic disease using logistic regression analysis|Accuracy in prediction of development of cardiovascular and metabolic disease using Framingham risk score","Yonsei University","All","18 Years and older   (Adult, Older Adult)",,"510000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","4-2016-0383","July 1, 2016","October 30, 2018","December 31, 2018","October 13, 2016",,"January 10, 2018","Yonsei University Severance Hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT02931500"
6,"NCT00330109","Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology",,"Unknown status","No Results Available","Glioma","Procedure: MRS Imaging|Procedure: PET Scanning|Procedure: Diffusion Tensor Imaging","image glioma patients with advanced imaging techniques to help us better characterize gliomas in the future|create an image-based database to allow machine learning analysis of all the clinically available data|through machine learning analysis, develop computer algorithms to allow us to automate tumour segmentation, predict tumour behaviour and predict location of clinically occult glioma cells","AHS Cancer Control Alberta","All","18 Years and older   (Adult, Older Adult)","Not Applicable","113","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CNS-9-0032 / 22151-22523","June 2006","December 2017","December 2017","May 25, 2006",,"January 16, 2017","Cross Cancer Institute, Edmonton, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT00330109"
7,"NCT04448340","A Novel Machine Learning Algorithm to Predict the Lewy Body Dementias","MLDLB","Recruiting","No Results Available","Dementia","Diagnostic Test: machine learning model","MMSE predictive for dlb or PDD|Parkinson's Disease - Cognitive Rating Scale (PD-CRS) predictive for DLB or PDD|Brief Visuospatial Memory Test (BVMT-TR) predictive for DLB or PDD|Symbol digit written predictive for DLB or PDD|Wechsler adult intelligence scale,predictive for DLB or PDD|trail making A and B predictive for DLB or PDD","National and Kapodistrian University of Athens","All","50 Years to 90 Years   (Adult, Older Adult)",,"86","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","251ATHENS HOSPITAL","September 1, 2019","August 1, 2020","March 1, 2021","June 25, 2020",,"June 26, 2020","Anastasia Bougea, Athens, Attiki, Greece",,"https://ClinicalTrials.gov/show/NCT04448340"
8,"NCT02932176","Machine Learning for Handheld Vascular Studies","DopplerZAM","Recruiting","No Results Available","Atherosclerosis|Wounds and Injuries","Device: Non-invasive vascular testing|Device: machine-learning algorithm","Algorithm generated Doppler classification|Presence or absence of pulse|Quality of pulse|Presence or absence of Doppler signal|Quality of Doppler signal","Duke University","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Pro00070090","September 7, 2016","December 14, 2020","December 14, 2020","October 13, 2016",,"March 18, 2020","Duke University Medical Center, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02932176"
9,"NCT04277650","System for High-Intensity Evaluation During Radiotherapy","SHIELD-RT","Completed","No Results Available","Radiation Therapy Complication|Chemotherapeutic Toxicity","Other: Machine learning algorithm","Number of unplanned emergency department visits or hospital admissions|Number of unplanned emergency department visits or hospital admissions up to 15 days post radiation treatment|Number of missed clinical evaluation visits|Number of acute care visits with listed reason as anemia, nutrition (including dehydration), diarrhea, emesis, infectious (including fever, pneumonia, and sepsis), nausea, neutropenia, pain category","Duke University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","311","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","Pro00100647","September 7, 2018","June 30, 2019","June 30, 2019","February 20, 2020",,"February 20, 2020","Duke Cancer Center, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04277650"
10,"NCT03974828","Telemedicine Notifications With Machine Learning for Postoperative Care","ODIN-Report","Not yet recruiting","No Results Available","Surgery--Complications|Perioperative/Postoperative Complications|Acute Kidney Injury|Hospital Mortality","Device: Anesthesia Control Tower Notification","Unplanned ICU admission|Acute Kidney Injury|Hospital length of stay","Washington University School of Medicine","All","18 Years and older   (Adult, Older Adult)","Not Applicable","3375","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other","201905127","September 1, 2020","January 1, 2024","January 1, 2024","June 5, 2019",,"May 7, 2020",,,"https://ClinicalTrials.gov/show/NCT03974828"
11,"NCT03949218","Bipolar Disorder and Oxidative Stress Injury Mechanism - Clinical Big Data Analysis Based on Machine Learning",,"Completed","No Results Available","Bipolar Disorder",,"Early prediction model of bipolar disorder with oxidative stress index as the core","Shanghai Mental Health Center","All","Child, Adult, Older Adult",,"3702","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","CRC2018DSJ01-1","November 20, 2018","November 20, 2018","November 20, 2018","May 14, 2019",,"May 14, 2019","Shanghai Mental Health Center, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03949218"
12,"NCT03847688","Machine Learning to Predict Clinical Response to TMS","LEARN","Enrolling by invitation","No Results Available","Depression, Unipolar","Device: Transcranial Magnetic Stimulation","Changes in functional connectivity maps (i.e., EEG coherence) in patients before and after clinical TMS|Prediction of clinical outcomes based on pre-treatment EEG functional connectivity","Brown University|Providence VA Medical Center","All","18 Years to 65 Years   (Adult, Older Adult)",,"35","Other|U.S. Fed","Observational","Observational Model: Cohort|Time Perspective: Prospective","1805002078","October 22, 2018","September 18, 2020","September 18, 2020","February 20, 2019",,"February 25, 2019","Providence VA Medical Center, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT03847688"
13,"NCT04060706","Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy","Hamlet rt","Not yet recruiting","No Results Available","Cancer","Radiation: Radical Image-Guided Radiotherapy","Machine Learning Modelling|Predictive Modelling|Clinical Toxicity Evaluation","CCTU- Cancer Theme|University of Cambridge|Microsoft Research|Cambridge University Hospitals NHS Foundation Trust","All","18 Years and older   (Adult, Older Adult)",,"310","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","Hamlet.rt","January 1, 2020","January 1, 2023","January 1, 2028","August 19, 2019",,"August 19, 2019","Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04060706"
14,"NCT04219306","Machine Learning Assisted Recognition of Out-of-Hospital Cardiac Arrest During Emergency Calls.",,"Completed","No Results Available","Out-Of-Hospital Cardiac Arrest","Other: Alert on dispatchers screen 'Suspect cardiac arrest'","Dispatcher recognition of cardiac arrest|Time to recognition|Dispatcher assisted telephone CPR|Time to T-CPR","Emergency Medical Services, Capital Region, Denmark","All","Child, Adult, Older Adult","Not Applicable","5242","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Diagnostic","F-35101-01","September 1, 2018","April 1, 2020","April 2, 2020","January 7, 2020",,"April 16, 2020","Emergency Medical Services Copenhagen, Ballerup, Danmark, Denmark","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/06/NCT04219306/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04219306"
15,"NCT03398551","Machine Learning From Fetal Flow Waveforms to Predict Adverse Perinatal Outcomes",,"Unknown status","No Results Available","Perinatal Mortality|Neonatal Morbidities",,"Stillbirth|Early neonatal mortality|IUGR|Prematurity|Birth asphyxia|Neonatal sepsis|Low Birth Weight","Aga Khan University|Universitat Pompeu Fabra","Female","Child, Adult, Older Adult",,"525","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","4872-Ped-ERC-17","February 2018","September 2018","December 2018","January 12, 2018",,"January 12, 2018",,,"https://ClinicalTrials.gov/show/NCT03398551"
16,"NCT04423991","Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning","IDENTIFY","Completed","No Results Available","COVID-19|Coronavirus|Mortality","Device: COViage","Mortality outcome","Dascena","All","Child, Adult, Older Adult","Not Applicable","290","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","060820","March 10, 2020","June 4, 2020","June 4, 2020","June 9, 2020",,"June 9, 2020","Dascena, Oakland, California, United States",,"https://ClinicalTrials.gov/show/NCT04423991"
17,"NCT04337502","Clinical and Radiomic Model of COVID-19",,"Completed","No Results Available","Coronavirus|Machine Learning","Diagnostic Test: Machine learning model","Predictive performance","Maastricht University|The Central Hospital of Wuhan","All","Child, Adult, Older Adult",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","UM_2020_GY_COVID-19","December 23, 2019","January 20, 2020","March 3, 2020","April 7, 2020",,"April 7, 2020","The central hospital of Wuhan, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT04337502"
18,"NCT04282837","Machine Learning for Reclassification of Obesity",,"Completed","No Results Available","Obesity","Diagnostic Test: AI classification of patients with obesity","Metabolic classification of patients with obesity using machine learning|Metabolic features in patients of different subgroups|Risks for noncommunicable disease in patients of different subgroups|Effect of bariatric surgery in patients of different subgroups","Shanghai 10th People's Hospital|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|The Third People's Hospital of Chengdu|Shanghai East Hospital|University of Pittsburgh","All","10 Years to 70 Years   (Child, Adult, Older Adult)",,"2495","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","Obesity Reclassification","March 1, 2020","April 30, 2020","June 20, 2020","February 25, 2020",,"June 25, 2020","Shanghai Tenth People's Hospital, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04282837"
19,"NCT04192175","Identification of Patients Admitted With COPD Exacerbations and Predicting Readmission Risk Using Machine Learning",,"Active, not recruiting","No Results Available","Copd Exacerbation Acute|Readmission|Machine Learning|Natural Language Processing",,"Identification of COPD exacerbation|Readmission risk","University Health Network, Toronto|Canadian Lung Association|Canadian Institutes of Health Research (CIHR)","All","18 Years and older   (Adult, Older Adult)",,"65000","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","19-5124","June 1, 2019","May 31, 2020","December 31, 2020","December 10, 2019",,"March 23, 2020","University Health Network, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04192175"
20,"NCT01448161","A Machine Learning Approach to Continuous Vital Sign Data Analysis",,"Enrolling by invitation","No Results Available","Vital Signs",,"Relevant Clinical Features","University of Colorado, Denver","All","up to 89 Years   (Child, Adult, Older Adult)",,"1200","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","11-0858","December 2011","July 2021","July 2021","October 7, 2011",,"September 30, 2019",,,"https://ClinicalTrials.gov/show/NCT01448161"
21,"NCT04256551","Effects of a Novel Machine Learning Mobile App on Diet Adherence in Individuals Following the Low Fodmap Diet",,"Completed","No Results Available","IBS - Irritable Bowel Syndrome","Other: Heali mobile application + Registered Dietitian|Other: Heali mobile application|Other: Standard Dietary Education","Rome IV|IBS-SSS|Low FODMAP dietary adherence (LFDA)|Low FODMAP dietary knowledge (LFDK)","Arizona State University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","58","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","FODMAP/APP","January 23, 2020","June 1, 2020","June 1, 2020","February 5, 2020",,"July 8, 2020","Arizona State University, Phoenix, Arizona, United States",,"https://ClinicalTrials.gov/show/NCT04256551"
22,"NCT03976297","Artificial Intelligence/Machine Learning Modeling on Time to Palliative Care Review in an Inpatient Hospital Population",,"Recruiting","No Results Available","Palliative Care","Other: Control Tower","Timely identification for need of palliative care|The number of inpatient palliative care consults|Timely identification for need of palliative care per unit|Transition time to hospice-designated bed|Time to hospice designation|Emergency Department visit within 30 days of discharge|Hospitalization or readmission within 30 days of discharge|ICU transfers|Ratio of inpatient hospice death to non-hospice hospital deaths|Rate of discharge to external hospice|Inpatient length of stay","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20000","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","19-002315","August 19, 2019","August 19, 2020","October 2020","June 6, 2019",,"August 28, 2019","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03976297"
23,"NCT03882476","RCT of Sepsis Machine Learning Algorithm",,"Not yet recruiting","No Results Available","Sepsis|Severe Sepsis|Septic Shock","Diagnostic Test: InSight","In-hospital SIRS-based mortality","Dascena|University of California, San Francisco","All","18 Years and older   (Adult, Older Adult)","Phase 2","51645","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic","19-494662","January 1, 2020","February 28, 2021","February 28, 2021","March 20, 2019",,"March 25, 2019",,,"https://ClinicalTrials.gov/show/NCT03882476"
24,"NCT04014010","Machine Learning Modeling of Intraoperative Hemodynamic Predictors of Postoperative Outcomes",,"Completed","No Results Available","Perioperative/Postoperative Complications|Morbidity, Multiple|Surgery|Anesthesia|Death","Other: Blood pressure|Other: Heart rate|Other: Use of hemodynamic medications (i.e. special medications for blood pressure)|Other: Oxygen saturation by pulse oximetry (SpO2)|Other: End-tidal Carbon dioxide (EtCO2)","Mortality|In-hospital Morbidity: Any|In-hospital Morbidity: Cardiac|In-hospital Morbidity: Respiratory|In-hospital Morbidity: Acute Kidney Injury|In-hospital Morbidity: Cerebrovascular|In-hospital Morbidity: Delirium|In-hospital Morbidity: Septic Shock|Postoperative ICU admission|Prolonged Postoperative Length of Stay (LOS)|Hospital readmission|Intraoperative mortality|Days alive and out of hospital at 30 days postoperatively","Janny Xue Chen Ke|Dalhousie University|Harvard University|University of Toronto|University of Ottawa|Nova Scotia Health Authority","All","45 Years and older   (Adult, Older Adult)",,"35000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","1024251","January 1, 2013","December 31, 2017","December 31, 2017","July 10, 2019",,"June 30, 2020",,"""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/10/NCT04014010/Prot_SAP_001.pdf","https://ClinicalTrials.gov/show/NCT04014010"
25,"NCT03724123","Machine Learning-Based Risk Profile Classification of Patients Undergoing Elective Heart Valve Surgery",,"Completed","No Results Available","Heart Valve Diseases|Surgery--Complications",,"Area under the curve for different prediction models","Kepler University Hospital|Institute of Bioinformatics, JKU Linz","All","18 Years and older   (Adult, Older Adult)",,"2229","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","K-82-15","January 1, 2008","December 31, 2014","December 31, 2014","October 30, 2018",,"October 30, 2018",,,"https://ClinicalTrials.gov/show/NCT03724123"
26,"NCT02934971","Optimized Multi-modality Machine Learning Approach During Cardio-toxic Chemotherapy to Predict Arising Heart Failure","MERMAID","Unknown status","No Results Available","Toxicity Due to Chemotherapy",,"Change in LVEF from baseline to one year, as determined by MRI as gold standard according to random study group allocation","RWTH Aachen University|Technion, Israel Institute of Technology","Female","18 Years to 100 Years   (Adult, Older Adult)",,"470","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","16-079","January 2017","January 2019","January 2019","October 17, 2016",,"October 17, 2016","Department of Cardiology, RWTH Aachen University Hospital, Aachen, Germany",,"https://ClinicalTrials.gov/show/NCT02934971"
27,"NCT02805621","Machine leArning Based CT angiograpHy derIved FFR: a Multi-ceNtEr, Registry","Machine","Completed","No Results Available","Coronary Heart Disease|Coronary Artery Disease",,"Diagnostic accuracy of local reduced order CFD and machine learning based CT angiography derived FFR, both validated against invasive FFR. Measured at both vessel and patient level.|Influence of calcium on diagnostic accuracy of CT angiography derived FFR.|Confidence intervals of CT angiography derived FFR|Direct vessel based comparison between CT angiography derived FFR and QCT stenosis measurements|Analysis of anatomically mild stenosis (<50% lumen diameter reduction) but functionally significant (invasive FFR ≤ 0.80)|Long term clinical outcome of CT angiography derived FFR","Erasmus Medical Center|Asan Medical Center|University Hospital, Linkoeping|Institute of Cardiology, Warsaw, Poland|Medical University of South Carolina|Siemens Healthcare Diagnostics Inc","All","18 Years and older   (Adult, Older Adult)",,"352","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","Machine","April 2016","January 2017","January 2017","June 20, 2016",,"January 4, 2017","ErasmusMC, Rotterdam, Zuid Holland, Netherlands",,"https://ClinicalTrials.gov/show/NCT02805621"
28,"NCT04074772","Leveraging Machine Learning to Effortlessly Track Patient Movement in the Clinic.",,"Not yet recruiting","No Results Available","Movement Disorders",,"Successful Tracking Achieved in Clinic|Identification of Diseases by Movement Tracking","University of Colorado, Denver","All","18 Years to 70 Years   (Adult, Older Adult)",,"190","Other","Observational","Observational Model: Other|Time Perspective: Other","19-1250","April 2020","October 2021","October 2021","August 30, 2019",,"March 19, 2020",,,"https://ClinicalTrials.gov/show/NCT04074772"
29,"NCT04193475","Machine Learning in Quantitative Stress Echocardiography","MLQSE","Recruiting","No Results Available","Cardiovascular Diseases|Ischaemic Heart Disease","Other: Analysis","Inducible myocardial ischaemia|Workload|Velocity|Strain rate|Strain","Hull University Teaching Hospitals NHS Trust|Barts & The London NHS Trust|Cardiff and Vale University Health Board","All","20 Years to 89 Years   (Adult, Older Adult)",,"1250","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","R2458","November 22, 2019","May 2021","June 2023","December 10, 2019",,"February 5, 2020","Castle Hill Hospital, Cottingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04193475"
30,"NCT03927066","Physiological Validation of Current Machine Learning Models for Hemodynamic Instability in Humans",,"Not yet recruiting","No Results Available","Hypotension and Shock","Other: Assigned Interventions","Blood Pressure|Heart rate","Mayo Clinic","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","19-002893","September 1, 2020","October 10, 2023","October 10, 2023","April 25, 2019",,"June 11, 2020","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03927066"
31,"NCT04189029","PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study",,"Recruiting","No Results Available","Heart Failure|Heart Failure With Preserved Ejection Fraction","Other: Extensive phenotyping","Machine learning algorithm to identify distinct phenotypic subgroups among HFpEF patients|Prognosis|Myocardial stiffness|Sarcopenia and muscular capacity|Exercise tolerance|Cardiac fibrosis|Arterial Stiffness|Right heart and pulmonary circulation|Ventricular-arterial coupling|Omics signature|Quality of life evaluation|Telemonitoring of weight|Telemonitoring of cardiac rythm|Telemonitoring of ECG|Telemonitoring of physical activity|Telemonitoring of blood pressure|Telemonitoring of pulmonary function|Telemonitoring of oxygen saturation|Telemonitoring of pulmonary congestion|Digitalized ECG|Cardiac echography|Cardiac calcium scoring|Cardiac MRI|Left atria","Assistance Publique - Hôpitaux de Paris|BPIfrance|Sanofi|Institut de Recherches Internationales Servier|Institut National de la Santé Et de la Recherche Médicale, France|BioSerenity|Casis|Firalis SA|Fealinx|Centre National de la Recherche Scientifique, France|ESPCI Paris|University of Paris 5 - Rene Descartes|Sorbonne University","All","18 Years to 90 Years   (Adult, Older Adult)",,"2620","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","APHP190558|2019-A01795-52","December 9, 2019","December 2021","June 2024","December 6, 2019",,"January 21, 2020","AP - HP, Hôpital Européen Georges-Pompidou, Paris, France",,"https://ClinicalTrials.gov/show/NCT04189029"
32,"NCT04390516","Respiratory Decompensation and Model for the Triage of COVID-19 Patients","READY","Completed","No Results Available","COVID-19|Coronavirus|Mortality|Mechanical Ventilation","Device: COViage","Mechanically ventilated patient outcome|Mortality or mechanically ventilated patient outcome","Dascena","All","18 Years and older   (Adult, Older Adult)","Not Applicable","197","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","051420","March 24, 2020","May 4, 2020","May 30, 2020","May 15, 2020",,"June 12, 2020","Dascena, Oakland, California, United States",,"https://ClinicalTrials.gov/show/NCT04390516"
33,"NCT04442425","A Feasibility Study Investigating the Use of Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer Pain",,"Not yet recruiting","No Results Available","Cancer|Neoplasms|Solid Tumors",,"Feasibility of using facial recognition technology to classify pain","National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)","All","12 Years and older   (Child, Adult, Older Adult)",,"120","NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","200130|20-C-0130","July 14, 2020","March 1, 2022","March 1, 2022","June 22, 2020",,"July 9, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04442425"
34,"NCT03490149","Prediction of the Cognitive Effects of Electroconvulsive Therapy Via Machine Learning and Neuroimaging","CoEffECT","Recruiting","No Results Available","ECT|Depression|Cognitive Impairment|Memory Impairment","Device: Electroconvulsive Therapy|Drug: Medication - Treatment as usual","Change in auditory verbal learning performance|Change in autobiographical memory performance|Change in subjective memory impairment|Occurence of retrograde amnesia|Change in depression severity as measured by the Hamilton Depression Rating Scale (HDRS 28).|Change in depression severity as measured by the Montgomery-Åsberg Depression Rating Scale (MADRS)","University Hospital, Bonn|Maximilian Kiebs, M.Sc. - University Hospital Bonn (Department of Medical Psychology)","All","18 Years to 85 Years   (Adult, Older Adult)",,"180","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","CoEffECT - Study","January 2, 2018","December 1, 2020","March 1, 2021","April 6, 2018",,"September 25, 2019","Klinik und Poliklinik für Psychiatrie und Psychotherapie, Bonn, Nordrhein-Westfalen, Germany",,"https://ClinicalTrials.gov/show/NCT03490149"
35,"NCT03895606","Prediction of Kidney Injury After Hyperthermic Intraperitoneal Chemotherapy (HIPEC)* With Machine Learning","HIPEC","Recruiting","No Results Available","Acute Kidney Injury|Chemotherapy","Other: Data collection","number of patients with postoperative acute kidney injury staged by Kidney Disease: Improving Global Outcomes (KDIGO)","Gangnam Severance Hospital","All","19 Years and older   (Adult, Older Adult)",,"80","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","3-2019-0016","March 29, 2019","March 18, 2020","March 30, 2020","March 29, 2019",,"July 31, 2019","Gangnam Severeance Hospital, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03895606"
36,"NCT04269304","Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE","PINNACLE","Recruiting","No Results Available","Age-related Macular Degeneration",,"Sensitivity / specificity of OCT and autofluorescence parameters.|Sensitivity / specificity of novel imaging characteristics","University of Southampton|University College, London|Imperial College London|University of Basel|Medical University of Vienna|University of Michigan","All","55 Years to 90 Years   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRAS - 256931|47270|210572/Z/18/Z","October 28, 2019","December 2023","December 2024","February 13, 2020",,"February 13, 2020","Medical University of Vienna, Vienna, Austria|University Hospital Basel, Basel, Switzerland|The Princess Alexandra Hospital Nhs Foundation Trust, Harlow, Essex, United Kingdom|Portsmouth Hospitals Nhs Trust, Portsmouth, Hampshire, United Kingdom|University Hospital Southampton, Southampton, Hampshire, United Kingdom|Frimley Health Nhs Foundation Trust, Frimley, Surrey, United Kingdom|Salisbury Nhs Foundation Trust, Salisbury, Wiltshire, United Kingdom|University Hospitals Bristol Nhs Foundation Trust, Bristol, United Kingdom|Moorfields Eye Hospital, London, United Kingdom|Royal Free London Nhs Foundation Trust, London, United Kingdom|Guy'S and St Thomas' Nhs Ft, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04269304"
37,"NCT01369290","Electroencephalography (EEG) Signal Processing","EEG-SP","Unknown status","No Results Available","Major Depressive Disorder","Drug: Venlafaxine|Drug: bupropion|Drug: escitalopram|Other: Psychotherapy|Drug: Duloxetine","Machine learning","St. Joseph's Healthcare Hamilton","All","18 Years to 70 Years   (Adult, Older Adult)",,"150","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","ESP-3152|EEG Signal Processing","October 2009","October 2012","October 2013","June 8, 2011",,"November 30, 2011","St. Joseph's Healthcare, Centre for Mountain Health Services, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01369290"
38,"NCT04407585","Testing the Accuracy of a Digital Test to Diagnose Covid-19",,"Recruiting","No Results Available","Covid-19","Diagnostic Test: Covid-19 swab PCR test","SARS-CoV-2 infection","King's College London|Zoe Global Limited|Department of Health, United Kingdom","All","18 Years and older   (Adult, Older Adult)",,"1000000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Covid-19 Validation Study","June 1, 2020","May 10, 2021","May 10, 2021","May 29, 2020",,"June 24, 2020","King's College London, London, United Kingdom","""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/85/NCT04407585/SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04407585"
39,"NCT03644940","Subpopulation-Specific Sepsis Identification Using Machine Learning",,"Not yet recruiting","No Results Available","Sepsis|Severe Sepsis|Septic Shock","Diagnostic Test: CustomSight","In-hospital SIRS-based mortality|In-hospital severe sepsis/shock-coded mortality|SIRS-based hospital length of stay|Severe sepsis/shock-coded hospital length of stay","Dascena|University of California, San Francisco","All","18 Years and older   (Adult, Older Adult)","Phase 2","51645","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic","18-347718","December 2020","July 2021","July 2021","August 23, 2018",,"December 27, 2018",,,"https://ClinicalTrials.gov/show/NCT03644940"
40,"NCT03711656","Prediction and Prevention of Nocturnal Hypoglycemia in Persons With Type 1 Diabetes Using Machine Learning Techniques",,"Completed","No Results Available","Type1diabetes|Hypoglycemia","Device: isCGM (intermittently scanned Continuous Glucose Monitoring)|Device: Physical exercise tracker","Sensitivity (SE) and specificity (SP) to predict Level 1 hypoglycemia|Sensitivity (SE) and specificity (SP) to predict Level 2 hypoglycemia|Predicted HbA1c from the sensor data|standard deviation (SD)|Mean glucose|Level 3 hypoglycaemia|Percentage of time in hypoglycemic ranges|Percentage of time in target range|Percentage of time in hyperglycemic range >180|Percentage of time in hyperglycemic range >250|Glucose variability LBGI|Glucose variability HBGI|Number of Level 3: severe hypoglycemia","Hospital Clinic of Barcelona|Universitat de Girona","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","Nocturnal Hypoglycemia","October 10, 2018","March 1, 2019","April 30, 2019","October 18, 2018",,"August 7, 2019","Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain",,"https://ClinicalTrials.gov/show/NCT03711656"
41,"NCT03752489","Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment",,"Not yet recruiting","No Results Available","Sepsis|Severe Sepsis|Septic Shock","Diagnostic Test: Treatment-specific InSight|Diagnostic Test: InSight","In-hospital SIRS-based mortality","Dascena","All","18 Years and older   (Adult, Older Adult)","Phase 2","51645","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic","19-426246","July 1, 2020","February 28, 2021","June 30, 2021","November 26, 2018",,"November 26, 2018",,,"https://ClinicalTrials.gov/show/NCT03752489"
42,"NCT03734484","Gram Type Infection-Specific Sepsis Identification Using Machine Learning",,"Not yet recruiting","No Results Available","Sepsis|Severe Sepsis|Septic Shock","Diagnostic Test: InSight","Change in time to antibiotic administration|Change in administration of unnecessary antibiotics","Dascena","All","18 Years and older   (Adult, Older Adult)","Phase 2","51645","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic","01072019","May 1, 2022","November 30, 2022","March 1, 2023","November 8, 2018",,"November 8, 2018",,,"https://ClinicalTrials.gov/show/NCT03734484"
43,"NCT04287712","Detection of Lung Cancer by Plasma Lipids","ELAID","Completed","No Results Available","Early-Stage Lung Cancer","Diagnostic Test: Plasma lipids","Plasma Lipids","Peking University People's Hospital|Beijing Haidian Hospital|Jiangsu Cancer Institute & Hospital|Peking University Health Science Center","All","18 Years and older   (Adult, Older Adult)",,"558","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2018PHB233-01","December 13, 2018","October 31, 2019","May 20, 2020","February 27, 2020",,"June 4, 2020","Peking University People's Hospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04287712"
44,"NCT04399811","Near-infrared Vision for Microcirculatory Status","NVIM","Not yet recruiting","No Results Available","Near-infrared Vision|Machine Learning|Microcirculatory Status","Diagnostic Test: Near-infrared Vision Photograph","Hospital mortality|Lacteta clearance rate|Capillary refill time (CRT)","Shanghai Zhongshan Hospital","All","18 Years and older   (Adult, Older Adult)",,"2000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","B2020-057R","May 17, 2020","December 31, 2023","December 31, 2023","May 22, 2020",,"May 22, 2020",,,"https://ClinicalTrials.gov/show/NCT04399811"
45,"NCT01766869","Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS","GCC 1261","Withdrawn","No Results Available","Prostate Cancer",,"Primary Objective: distinguishing high-grade tumors vs. low-grade tumors and normal prostate|Secondary Objective: non-invasive and quantitative test to accurately identify the tumor grade and location.","University of Maryland, Baltimore","Male","18 Years and older   (Adult, Older Adult)",,"0","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","HP-00054431","April 2015","April 2015","April 2015","January 11, 2013",,"March 18, 2020","Ummc Msgcc, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT01766869"
46,"NCT04130789","Personalized Swiss Sepsis Study","PSSS_digital","Recruiting","No Results Available","Sepsis","Other: compare data patterns by data-driven algorithms to determine sepsis|Other: compare data patterns by data-driven algorithms to predict sepsis-related mortality","sepsis-related mortality (sensitivity)|sepsis-related mortality (specificity)|Determination of sepsis","University Hospital, Basel, Switzerland|Swiss Personalized Health Network (SPHN)|Personalized Health and Related Technologies (PHRT) initiative of ETH Zürich","All","18 Years and older   (Adult, Older Adult)",,"17500","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2018-01088; qu18Egli2","November 15, 2019","June 2022","June 2023","October 17, 2019",,"July 8, 2020","Clinical Microbiology, University Hospital Basel, Basel, Switzerland|Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland|Medical Intensive Care Unit; University Hospital Basel, Basel, Switzerland|Surgical Intensive Care Unit, University Hospital Basel, Basel, Switzerland|Institute for Infectious Diseases, University of Bern, Bern, Switzerland|Division Infectious Diseases, University Hospital Bern, Bern, Switzerland|Intensive Care Medicine, University Hospital Bern, Bern, Switzerland|Division Bacteriology Laboratory, University Hospital Geneva, Geneva, Switzerland|Division Infectious Diseases, University Hospital Geneva, Geneva, Switzerland|Intensive Care Medicine, University Hospital Geneva, Geneva, Switzerland|Division Intensive Care Medicine, University Hospital Lausanne, Lausanne, Switzerland|Institute of Microbiology, University Hospital Lausanne, Lausanne, Switzerland|Service Infectious Diseases, University Hospital Lausanne, Lausanne, Switzerland|Institute for Medical Microbiology, University Hospital Zurich, Zürich, Switzerland|Division Infectious Diseases, University Hospital Zurich, Zürich, Switzerland|Institute for Intensive Medicine, University Hospital Zurich, Zürich, Switzerland",,"https://ClinicalTrials.gov/show/NCT04130789"
47,"NCT04408976","Implementation Study With Decision Support Based on Data",,"Completed","No Results Available","Urinary Tract Infections",,"Non-recurrent UTI","Leiden University Medical Center|Pacmed BV|Zorgverzekeraar CZ|Zorgverzekeraar Zilveren Kruis|Zorgverzekeraar Menzis|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Netherlands Instititute for Health Services Research","All","12 Years and older   (Child, Adult, Older Adult)",,"16824","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","P1746","November 13, 2017","May 16, 2018","May 16, 2018","June 1, 2020",,"June 1, 2020","Netherlands Institute for Health Services Research, Utrecht, Netherlands",,"https://ClinicalTrials.gov/show/NCT04408976"
48,"NCT03246490","A Machine Learning Approach for Inferring Alcohol Intoxication Levels From Gait Data","Alcogait","Completed","No Results Available","Alcohol Drinking","Other: All Participants","Phone App","Butler Hospital","All","21 Years to 75 Years   (Adult, Older Adult)","Not Applicable","141","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","AA025193","December 12, 2017","July 31, 2019","July 31, 2019","August 11, 2017",,"April 7, 2020","Butler Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT03246490"
49,"NCT04461990","Clinical Study of Imaging Genomics Based on Machine Learning for BCIG",,"Not yet recruiting","No Results Available","Breast Cancer|Molecular Typing|Pathology|Image, Body","Procedure: Multidisciplinary cooperative comprehensive treatment","Image prediction model of different molecular typing","Fudan University|RenJi Hospital|International Peace Maternity and Child Health Hospital","Female","Child, Adult, Older Adult",,"1500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","BCIG","December 1, 2020","December 30, 2022","December 30, 2023","July 8, 2020",,"July 8, 2020","Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04461990"
50,"NCT04005001","HindSight Phase II",,"Not yet recruiting","No Results Available","Sepsis|Severe Sepsis|Septic Shock","Diagnostic Test: HindSight|Diagnostic Test: InSight","False alert reduction","Dascena|University of California, San Francisco|Cape Regional Medical Center|Oroville Hospital","All","18 Years and older   (Adult, Older Adult)","Phase 2","51645","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic","19-569185","January 1, 2020","December 31, 2021","December 31, 2021","July 2, 2019",,"July 2, 2019",,,"https://ClinicalTrials.gov/show/NCT04005001"
51,"NCT03053518","Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes",,"Recruiting","No Results Available","Type2 Diabetes","Device: iPro2 CGM with Enlite sensors|Behavioral: LifeStyle","Observed incremental area under the curve (iAUCobs)","NYU Langone Health","All","21 Years to 70 Years   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","16-01059","June 30, 2017","December 2019","December 2019","February 15, 2017",,"November 8, 2019","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03053518"
52,"NCT04270799","Lung Nodule Imaging Biobank for Radiomics and AI Research","LIBRA","Not yet recruiting","No Results Available","Lung Cancer|Pulmonary Nodule, Multiple|Pulmonary Nodule, Solitary|Lung Neoplasms","Diagnostic Test: Machine Learning Classification","Development of an imaging biobank|Discovery of a CT-thorax based radiomics profile to predict cancer risk.","Royal Marsden NHS Foundation Trust|Royal Marsden Partners|The Royal Brompton and Harefield NHS Foundation Trust|University College London Hospitals|Guys and St Thomas' NHS Foundation Trust|Imperial College NHS Foundation Trust|Lewisham and Greenwich NHS Trust|King's College Hospital NHS Trust|Epsom and St Helier University Hospitals NHS Trust|The Institute of Cancer Research, London|Biomedical Research Centre, London","All","18 Years and older   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","CCR5215","April 2020","August 2021","August 2021","February 17, 2020",,"February 17, 2020",,,"https://ClinicalTrials.gov/show/NCT04270799"
53,"NCT04092933","Perioperative Risk Calculator","PROTECT","Active, not recruiting","No Results Available","Perioperative/Postoperative Complications",,"postoperative complications|in-hospital mortality","Technische Universität München|Health Information Management, Belgium","All","Child, Adult, Older Adult",,"109000","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","253/19","May 1, 2014","June 30, 2019","February 28, 2022","September 17, 2019",,"January 14, 2020",,,"https://ClinicalTrials.gov/show/NCT04092933"
54,"NCT03198975","Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma",,"Unknown status","No Results Available","Hepatocellular Carcinoma","Diagnostic Test: Magnetic resonance image","Presence of microvascular invasion","Ming Kuang|Sun Yat-sen University","All","18 Years to 80 Years   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","HCC10","June 23, 2017","July 31, 2017","July 31, 2017","June 26, 2017",,"June 26, 2017","The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03198975"
55,"NCT04323137","Encouraging Flu Vaccination Among High-Risk Patients Identified by ML",,"Not yet recruiting","No Results Available","Influenza|Vaccination|Health Promotion|Health Behavior|Risk Reduction","Behavioral: Risk reduction|Behavioral: Medical records-based recommendation|Behavioral: Algorithm-based recommendation","Flu vaccination rate|Flu diagnosis rate|Flu-like symptoms rate|Flu complications rate|Change in ER visits from pre- to post-intervention|Change in hospitalizations from pre- to post-intervention|Flu vaccination among relatives|Flu diagnosis among relatives|Flu-like symptoms among relatives|Flu complications among relatives","Geisinger Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","16500","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention","2020-0290","September 2020","May 2021","May 2021","March 26, 2020",,"March 26, 2020",,,"https://ClinicalTrials.gov/show/NCT04323137"
56,"NCT04293471","Prediction of Outcome by Echocardiography in Left Bundle Branch Block","EchoLBBB","Recruiting","No Results Available","Left Bundle-Branch Block",,"Cardiovascular death|Death of any cause|Hospital admission due to heart-failure","University Hospital of North Norway|Oslo University Hospital|University of Bergen|Norwegian University of Science and Technology|University of Tromso|KU Leuven","All","18 Years to 100 Years   (Adult, Older Adult)",,"2000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","REK2019/134","November 1, 2019","December 31, 2023","August 31, 2034","March 3, 2020",,"March 23, 2020","University Hospital North Norway, Tromsø, Troms, Norway",,"https://ClinicalTrials.gov/show/NCT04293471"
57,"NCT04331015","Artificial Intelligence in Diagnosis of DFNA9","DFNA9","Completed","No Results Available","DFNA9|Sensorineural Hearing Loss","Diagnostic Test: Pure tone audiometry","hearing threshold|age|prediction gene locus","Jessa Hospital","All","18 Years and older   (Adult, Older Adult)",,"111","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","JessaH-5-ORL","February 1, 2020","March 28, 2020","March 28, 2020","April 2, 2020",,"April 3, 2020","Jessa Hospital, Hasselt, Limburg, Belgium|University of Antwerp, Antwerpen, Belgium",,"https://ClinicalTrials.gov/show/NCT04331015"
58,"NCT02960386","An Engagement Engine for Fitness Trackers","iTrackFitnes","Active, not recruiting","No Results Available","Overweight|Obese","Other: Machine Learning Algorithm","Engagement level with the tracker|Change in Physical Activity|Change in Self-efficacy scale for Physical Activity|Change in Barriers to Being Active Questionnaire","Massachusetts General Hospital|Robert Wood Johnson Foundation","All","18 Years to 95 Years   (Adult, Older Adult)","Not Applicable","138","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","2016P001506","January 2016","April 2018","December 2018","November 9, 2016",,"August 15, 2018","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02960386"
59,"NCT03635710","Smartphone Enabled Detection of Nocturnal Cough Rate and Sleep Quality as a Prognostic Marker for Asthma Control",,"Completed","No Results Available","Asthma|Cough","Device: The patient will undergo no intervention","Coughs per night assessed by smartphone audio recording|Detection rates of two machine learning algorithms|Sleep quality (Pittsburgh sleep quality index)","Cantonal Hospital of St. Gallen|University of Zurich|University of St.Gallen","All","18 Years and older   (Adult, Older Adult)",,"94","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","EKOS 17/164","January 1, 2018","December 31, 2019","December 31, 2019","August 17, 2018",,"January 27, 2020","Cantonal Hospital St. Gallen, St. Gallen, SG, Switzerland|University of Zürich, Zürich, ZH, Switzerland|Cantonal Hospital St. Gallen, St. Gallen, Switzerland",,"https://ClinicalTrials.gov/show/NCT03635710"
60,"NCT03458806","Phono- and Electrocardiogram Assisted Detection of Valvular Disease","PEA-Valve","Active, not recruiting","No Results Available","Aortic Valve Stenosis|Mitral Regurgitation|Heart Murmurs|Valvular Heart Disease","Diagnostic Test: AS Algorithm 1|Diagnostic Test: AS Algorithm 2|Diagnostic Test: MR Algorithm 1|Diagnostic Test: MR Algorithm 2","Differentiation of clinically significant aortic stenosis from structurally normal hearts|Differentiation of clinically significant mitral stenosis from structurally normal hearts|Differentiation of clinically significant aortic stenosis from the absence of clinically significant aortic stenosis|Differentiation of clinically significant mitral regurgitation from the absence of clinically significant mitral regurgitation","University of California, San Francisco|Eko Devices, Inc.","All","18 Years and older   (Adult, Older Adult)",,"900","Other|Industry","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","17-21881","February 22, 2018","December 31, 2020","December 31, 2020","March 8, 2018",,"May 15, 2020","University of California San Francisco, San Francisco, California, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/06/NCT03458806/Prot_SAP_000.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/06/NCT03458806/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT03458806"
61,"NCT04415736","Artificial Intelligence in Subarachnoid Hemorrhage",,"Completed","No Results Available","Subarachnoid Hemorrhage, Aneurysmal","Other: No intervention, observational study","HRV data analysed by artificial intelligence for detection of DCI","Göteborg University","All","16 Years to 100 Years   (Child, Adult, Older Adult)",,"64","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","AISAH","May 2015","October 2016","May 2020","June 4, 2020",,"June 4, 2020","Sahlgrenska University Hospital, Gothenburg, Sweden",,"https://ClinicalTrials.gov/show/NCT04415736"
62,"NCT03235193","Predictive algoRithm for EValuation and Intervention in SEpsis","PREVISE","Unknown status","No Results Available","Sepsis|Septic Shock|Severe Sepsis","Other: Severe Sepsis Prediction|Other: Severe Sepsis Detection","In-hospital mortality|Hospital length of stay","Dascena|Cabell Huntington Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1241","Industry|Other","Interventional","Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","1097090-1","August 1, 2017","October 2017","October 2017","August 1, 2017",,"August 3, 2017","Cabell Huntington Hospital, Huntington, West Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03235193"
63,"NCT04092543","Validation of DRAGON Versus a Simplified DRAGON/Machine Learning",,"Recruiting","No Results Available","Stroke, Acute",,"Modified Rankin Scale at day 90|Modified Rankin Scale at 7 days after discharge|PROMIS 10 questionnaire at 7 days after discharge|PROMIS 10 questionnaire at 90 days after the onset of stroke|NIHSS at 90 days after the onset of stroke|Analysis of the hospitalization cost after the onset of stroke","Ziekenhuis Oost-Limburg|University Hospital, Ghent","All","Child, Adult, Older Adult",,"700","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","DRAGON","March 1, 2019","August 1, 2021","November 1, 2021","September 17, 2019",,"September 17, 2019","Ziekenhuis Oost-Limburg, Genk, Belgium",,"https://ClinicalTrials.gov/show/NCT04092543"
64,"NCT03898076","Predictive A1c Based on CGM Data Using CGM Data","A1c","Not yet recruiting","No Results Available","Diabetes Mellitus, Type 1","Device: Flash Glucose Monitoring|Other: A1c|Other: Predictive A1c","The difference of Predictive A1c level from CGM data with Real A1c level from EMR","Sidra Medical and Research Center","All","2 Years to 18 Years   (Child, Adult)",,"120","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2019003271","December 1, 2019","January 30, 2020","March 30, 2020","April 1, 2019",,"October 24, 2019","Sidra Medicine, Doha, Qa, Qatar",,"https://ClinicalTrials.gov/show/NCT03898076"
65,"NCT03631069","Detecting Dementia in the Retina Using Optical Coherence Tomography",,"Not yet recruiting","No Results Available","Dementia Alzheimers|Dementia|Dementia, Vascular|Dementia Senile",,"Retinal nerve fiber layer thickness|Ganglion cell layer thickness|Macular volume","Moorfields Eye Hospital NHS Foundation Trust","All","40 Years and older   (Adult, Older Adult)",,"200000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","KEAP1004","September 2019","August 2022","August 2022","August 15, 2018",,"August 16, 2019","Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03631069"
66,"NCT03330496","Assessment of Pain in Newborns and Older Infants (Infant Pain Assessment Study =","iPAS)","Suspended","No Results Available","Pain, Acute","Other: Pain Measurement","Pain Measurement (all infants)|Pain Measurement|Pain Measurement (newborns 0-30 days)|Pain Measurement (infants 1-6 months)","Stanford University|Autonomous Healthcare, Inc.","All","up to 6 Months   (Child)",,"120","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB-39076","October 30, 2017","November 2025","December 2026","November 6, 2017",,"March 18, 2020","Lucile Packard Children's Hospital Stanford, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT03330496"
67,"NCT02945514","Providing Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response.",,"Completed","No Results Available","Healthy Volunteers","Other: DayTwo machine learning algorithm","Postprandial blood sugar level","Mayo Clinic|DayTwo","All","18 Years and older   (Adult, Older Adult)",,"327","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","16-005208","September 2016","February 27, 2018","February 28, 2018","October 26, 2016",,"February 28, 2018","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02945514"
68,"NCT03582501","Measurement of Hemodynamic Responses to Lower Body Negative Pressure","LBNP","Completed","No Results Available","Hypotension and Shock","Other: Lower body negative pressure","Blood pressure|Heart rate","Mayo Clinic","All","18 Years to 55 Years   (Adult)","Not Applicable","24","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","18-002695","January 8, 2019","May 23, 2019","May 23, 2019","July 11, 2018",,"June 12, 2019","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03582501"
69,"NCT02828475","CALYPSO Pilot Study: Machine Learning Based Predictions of Surgical Complications","CALYPSO","Completed","No Results Available","Complication of Surgical Procedure|Postoperative Infection","Other: CALYPSO|Behavioral: Standard Care","Thirty Day Overall Complications|Thirty Day Mortality|Wound Complications|Cardiac Complications|Respiratory Complications|Thrombotic complications|Renal Complications|urinary tract infections|Neurologic complications|Septic complications|Unplanned reoperation|unplanned readmission|bleeding complications","Duke University","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Pro00072563","June 2016","January 2017","February 2017","July 11, 2016",,"July 3, 2018","Duke University Medical Center, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02828475"
70,"NCT03633825","Brief Online Help-seeking Barrier Reduction Intervention",,"Completed","Has Results","Crisis Intervention|Suicide and Depression","Behavioral: Brief help-seeking barrier reduction intervention","Number of Participants Reporting Use of Crisis-referrals|Number of Participants in the Treatment Versus Control Conditions Reporting Their Experience Using Koko Was ""Good""","Harvard University","All","Child, Adult, Older Adult","Not Applicable","39450","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","IRB17-1303","August 10, 2017","September 20, 2017","September 20, 2017","August 16, 2018","April 17, 2019","August 12, 2019","Harvard University, Cambridge, Massachusetts, United States","""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/25/NCT03633825/SAP_000.pdf|""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/25/NCT03633825/Prot_001.pdf","https://ClinicalTrials.gov/show/NCT03633825"
71,"NCT03033615","PixelShine vs. Iterative Reconstruction (IR) Processing of CT Images",,"Unknown status","No Results Available","Cancer, Lung|Cancer Liver|X-rays; Effects","Device: PixelShine|Device: Conventional processing","Visual Image Quality as Assessed by Image Noise Reduction|Image Resolution as Assessed by Size of Detected Lesions","AlgoMedica, Inc.|Cedars-Sinai Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Industry|Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","ALG-002","August 2017","October 2017","December 2017","January 27, 2017",,"June 28, 2017",,,"https://ClinicalTrials.gov/show/NCT03033615"
72,"NCT04441775","Artificial Intelligence for Prostate Cancer Treatment Planning",,"Not yet recruiting","No Results Available","Prostate Cancer|Artificial Intelligence|Radiotherapy","Other: AI-assisted RT modelling","Change (trend) in AI System performance over time","Dartmouth-Hitchcock Medical Center|Oregon Health and Science University|University of Massachusetts, Worcester|Nicolalde R&D, LLC|National Cancer Institute (NCI)|NRG Oncology","Male","21 Years to 90 Years   (Adult, Older Adult)",,"195","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Other","D20003|75N91019C00054-0-9999-1","June 22, 2020","June 2023","June 2023","June 22, 2020",,"June 22, 2020",,,"https://ClinicalTrials.gov/show/NCT04441775"
73,"NCT04215211","MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence",,"Recruiting","No Results Available","Glioma","Diagnostic Test: Survival prediction for glioma patients","AUC of survival prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 90 Years   (Child, Adult, Older Adult)",,"2500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","GliomaAI-2","January 1, 2017","January 1, 2027","June 1, 2027","January 2, 2020",,"January 3, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04215211"
74,"NCT04217044","Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence",,"Recruiting","No Results Available","Glioma","Diagnostic Test: Histopathology images based prediction of molecular pathology","AUC of prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 95 Years   (Child, Adult, Older Adult)",,"3000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","GliomaAI-3","January 1, 2017","January 1, 2027","June 1, 2027","January 3, 2020",,"January 6, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04217044"
75,"NCT04217018","MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence",,"Recruiting","No Results Available","Glioma","Diagnostic Test: Prediction of molecular pathology","AUC of prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 95 Years   (Child, Adult, Older Adult)",,"3000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","GliomaAI-1","January 1, 2017","January 1, 2027","June 1, 2027","January 3, 2020",,"January 7, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04217018"
76,"NCT04215224","Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence",,"Recruiting","No Results Available","Glioma","Diagnostic Test: Histopathology images based survival prediction for glioma patients","AUC of survival prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 90 Years   (Child, Adult, Older Adult)",,"3500","Other","Observational","Observational Model: Cohort|Time Perspective: Other","GliomaAI-4","January 1, 2017","January 1, 2027","June 1, 2027","January 2, 2020",,"January 3, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04215224"
77,"NCT04280354","Molecular Biomarkers for Sepsis",,"Not yet recruiting","No Results Available","Sepsis|Severe Community-acquired Pneumonia (sCAP)|Infection, Bacterial","Other: compare data patterns by data-driven algorithms to determine sepsis|Other: compare data patterns by data-driven algorithms to predict sepsis-related mortality","Detection of sepsis|Sepsis related mortality|Time to sepsis detection (minutes after Intensive Care Unit (ICU) admission)","University Hospital, Basel, Switzerland|Swiss Personalized Health Network (SPHN)|Personalized Health and Related Technologies (PHRT) initiative of ETH Zürich","All","18 Years and older   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2020-00297;qu18Egli3","August 2020","March 2021","March 2021","February 21, 2020",,"June 11, 2020","Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland|Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland|Intensive Care Unit; University Hospital Basel, Basel, Switzerland|Institute for Infectious Diseases, University of Bern, Bern, Switzerland|Infectious Diseases and Hospital Epidemiology, University Hospital Bern, Bern, Switzerland|Intensive Care Unit, University Hospital Bern, Bern, Switzerland|Infectious Diseases and Hospital Epidemiology, University Hospital Geneva, Geneva,, Switzerland|Clinical Bacteriology, University Hospital Geneva, Geneva, Switzerland|Intensive Care Unit, University Hospital Geneva, Geneva, Switzerland|Clinical Microbiology, University Hospital Lausanne, Lausanne, Switzerland|Infectious Diseases and Hospital Epidemiology , University Hospital Lausanne, Lausanne, Switzerland|Intensive Care Unit, University Hospital Lausanne, Lausanne, Switzerland|Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zürich, Switzerland|Institute for Medical Microbiology, University Hospital Zurich, Zürich, Switzerland|Intensive Care Unit, University Hospital Zurich, Zürich, Switzerland",,"https://ClinicalTrials.gov/show/NCT04280354"
78,"NCT01608438","Motor Learning in a Customized Body-Machine Interface","BMI","Active, not recruiting","No Results Available","Spinal Cord Injury","Device: Customizing the Body-Machine Interface","Change in Time to task completion from Baseline at 8 months|Change in Movement Smoothness from Baseline at 8 months|Change in Strength|Change in Mental State","Shirley Ryan AbilityLab|National Institutes of Health (NIH)","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","157","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","STU00057856","February 2013","September 2022","September 2022","May 31, 2012",,"November 15, 2019","Shirley Ryan AbilityLab, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT01608438"
79,"NCT04093908","Prediction of STN DBS Motor Response in PD","DBS-PREDICT","Enrolling by invitation","No Results Available","Parkinson Disease","Other: Prediction of motor outcome after STN DBS based on preoperative variables","area under the curve of the receiver operator curve|predictive accuracy|true positive prediction rate|false positive prediction rate","Maastricht University Medical Center","All","18 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2019-0739-A9","August 1, 2019","December 17, 2019","May 2020","September 18, 2019",,"February 21, 2020","MaastrichtUMC, Maastricht, Limburg, Netherlands",,"https://ClinicalTrials.gov/show/NCT04093908"
80,"NCT04060537","Identification of Novel Biomarkers of Response to Systemic Treatments in Renal Cell Cancer","ARTIST_RCC","Not yet recruiting","No Results Available","Carcinoma, Renal Cell","Other: Laboratory analysis of samples|Other: Application of machine learning","Biological identification of biomarkers of response to systemic treatment in Renal Cell Cancer.|Radiological identification of biomarkers of response to systemic treatment in Renal Cell Cancer.","CCTU- Cancer Theme|Cambridge University Hospitals NHS Foundation Trust","All","18 Years and older   (Adult, Older Adult)",,"12","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","ARTIST RCC","January 2020","January 2022","January 2022","August 19, 2019",,"August 19, 2019",,,"https://ClinicalTrials.gov/show/NCT04060537"
81,"NCT03655626","Implementation and Evaluations of Sepsis Watch",,"Completed","No Results Available","Sepsis|Severe Sepsis|Septic Shock","Other: Sepsis Watch","Rate of Centers for Medicare and Medicaid Services (CMS) bundle completion for patients with sepsis|Mean time from ED arrival to sepsis for patients with sepsis|Average number of patients who develop sepsis per day and month|Average number of patients who develop sepsis and are not treated per day and month|Mean ED length of stay for patients with sepsis|Mean Hospital length of stay for patients with sepsis|Mean Inpatient mortality for patients with sepsis|Mean ICU requirement rate for patients with sepsis|Mean time from sepsis onset to blood culture|Mean time from sepsis onset to antibiotics|Mean time from sepsis onset to IV fluids|Mean time from sepsis onset to lactate|Mean time from sepsis onset to CMS bundle completion|Rate of lactate complete for patients with sepsis|Number of sepsis diagnosis codes across Duke University Hospital patients per month","Duke University|Data & Society Research Institute|Duke Clinical Research Institute","All","18 Years and older   (Adult, Older Adult)","Not Applicable","32003","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Pro00093721","November 5, 2018","July 5, 2019","July 5, 2019","August 31, 2018",,"August 1, 2019","Duke University Hospital, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03655626"
82,"NCT04140565","Positron Emission Tomography (PET) Images Using Deep Neural Networks",,"Not yet recruiting","No Results Available","PET Images and Deep Neural Networks Algorithms",,"Production of diagnostic PET images using deep neural networks algorithms","Sheba Medical Center|Computational Imaging Lab , Dr. Arnaldo Mayer","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SHEBA-19-6267-LD-CTIL","November 1, 2019","November 1, 2021","November 1, 2021","October 28, 2019",,"October 30, 2019","Sheba Medical Center Hospital- Tel Hashomer, Ramat Gan, Israel",,"https://ClinicalTrials.gov/show/NCT04140565"
83,"NCT03969056","AI Activity Study in Patients With Elevated Blood Pressure",,"Not yet recruiting","No Results Available","Hypertension","Behavioral: Artificial Intelligence (AI) Activity|Behavioral: 10,000 steps","Changes in weekly daily average steps|Duration (minutes) of moderate to vigorous intensity physical activity (MVPA) per day|Changes in Systolic blood pressure (SBP)|Changes in diastolic blood pressure (DBP)|aortic stiffness|sodium intake|Changes in weight|Changes in Body Mass Index (BMI)","University of California, San Francisco","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18-26452","October 10, 2020","March 2021","June 30, 2021","May 31, 2019",,"September 11, 2019","University of California San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT03969056"
84,"NCT04358510","COVID-19 Mortality Prediction Model",,"Completed","No Results Available","COVID-19|Pneumonia|Mechanical Ventilation","Device: COViage","Mortality outcome in COVID-19 ICU patients|Mortality outcome in mechanically ventilated ICU patients|Mortality outcome in pneumonia ICU patients","Dascena","All","18 Years and older   (Adult, Older Adult)",,"114","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","04202001","April 1, 2020","April 17, 2020","April 17, 2020","April 24, 2020",,"April 24, 2020","Dascena, Oakland, California, United States",,"https://ClinicalTrials.gov/show/NCT04358510"
85,"NCT04395482","Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury","TAC-COVID19","Recruiting","No Results Available","covid19","Other: Lung CT scan analysis in COVID-19 patients","A qualitative analysis of parenchymal lung damage induced by COVID-19|A quantitative analysis of parenchymal lung damage induced by COVID-19|The potential impact of parenchymal morphological CT scans in patients with severe moderate respiratory failure.|Automated segmentation of lung scans of patients with COVID-19 and ARDS.|Knowledge of chest CT features in COVID-19 patients and their detail through the use of machine learning and other quantitative techniques.|The ability within which the analysis of artificial intelligence that uses deep learning models can be used to predict clinical outcomes","University of Milano Bicocca","All","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","TAC-COVID19","April 15, 2020","June 15, 2020","October 15, 2020","May 20, 2020",,"May 26, 2020","Ospedale Papa Giovanni XXIII, Bergamo, Italy|Policlinico San Marco-San Donato group, Bergamo, Italy|Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy|ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy|ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy|ASST Monza, Monza, Italy|AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy|Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino, San Marino",,"https://ClinicalTrials.gov/show/NCT04395482"
86,"NCT03833804","Data-driven Identification for Substance Misuse",,"Not yet recruiting","No Results Available","Substance Use|Substance Abuse|Substance-Related Disorders","Other: Processing of clinical notes in the EHR data collected during routine care","Proportion of patients that had a universal screen positive and received SBIRT (screening, brief intervention, or referral to treatment)|All-cause re-hospitalizations following 6-months from the Index hospital encounter","Loyola University|Rush University Medical Center","All","18 Years to 89 Years   (Adult, Older Adult)",,"34800","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","211165","September 2021","September 2023","November 2023","February 7, 2019",,"September 9, 2019",,,"https://ClinicalTrials.gov/show/NCT03833804"
87,"NCT04350437","Induction Of Labor: Predictors of Outcomes","IOL-ID","Not yet recruiting","No Results Available","Induction of Labor Affected Fetus / Newborn","Drug: induction of labor","Cesarean section rate|Suspected intraamniotic infection|Postpartum hemorrhage|Low neonatal APGAR Score|Admission to neonatal intensive care unit","Assiut University|Aswan University|Middle East OBGYN graduate education Foundation","Female","18 Years to 40 Years   (Adult)","Not Applicable","3000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IOL-ID","July 1, 2020","June 30, 2021","July 30, 2021","April 17, 2020",,"April 17, 2020",,,"https://ClinicalTrials.gov/show/NCT04350437"
88,"NCT03848897","Contribution of Virtual Reality and Modelling in Falling Risk Assessment in Elderly and Parkinson's Disease Patients","PrévSim","Not yet recruiting","No Results Available","Aging Disorder|Parkinson Disease","Other: Metrology of motor behavior","Timed Up & Go in virtual reality (VR)|Timed Up & Go (non VR condition)|Validation of the TUG in VR condition|Correlation between TUG and TUG VR times and fall follow-up|Kinematics analysis|Kinetics analysis|Physiological analysis 1|Physiological analysis 2|Physiological analysis 3|Visual attention analysis|Psychology analysis 1|Psychology analysis 2|Psychology analysis 3|Automated learning and falling risk estimation","Central Hospital, Nancy, France|OHS - Office d'Hygiène Sociale|ONPA - Office Nancéien des Personnes Agées|University of Lorraine","All","65 Years to 80 Years   (Older Adult)","Not Applicable","116","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2018-A02637-48","April 30, 2019","June 30, 2020","June 30, 2022","February 21, 2019",,"April 16, 2019","University Hospital of Nancy, Vandœuvre-lès-Nancy, France",,"https://ClinicalTrials.gov/show/NCT03848897"
89,"NCT03874702","Automated Diagnosis of Stroke in Computed Tomography With the Use of Artificial Intelligence",,"Enrolling by invitation","No Results Available","Stroke|Ischemic Stroke",,"Alberta Stroke Program Early Computed Tomography Score","University of Guadalajara","All","18 Years and older   (Adult, Older Adult)",,"350","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","UGuadalajara","August 15, 2019","June 1, 2022","June 1, 2022","March 14, 2019",,"September 25, 2019","Departamento de neurociencias, Guadalajara, Jalisco, Mexico",,"https://ClinicalTrials.gov/show/NCT03874702"
90,"NCT02694159","Physician Judgment and Machine Predictions",,"Active, not recruiting","No Results Available","Sepsis",,"Patients developing sepsis|Under- and over-diagnosis of sepsis|Treatment decisions among patients in the emergency department","University of Pennsylvania|Harvard University","All","18 Years to 90 Years   (Adult, Older Adult)",,"50000","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","823464","February 2016","December 30, 2020","December 30, 2020","February 29, 2016",,"June 25, 2020",,,"https://ClinicalTrials.gov/show/NCT02694159"
91,"NCT03946319","Personalized, Transdiagnostic Approach to Preventative Mental Health",,"Recruiting","No Results Available","Mental Health|Mental Disorders|Delivery of Health Care|Self-Assessment|Diagnosis, Psychiatric","Diagnostic Test: Introspect Health","Self-Report Adherence Rate|Completed Assessments Scored|Assessment Questions Scored|Time per Assessment Question|Response Time|Assessment Completion Rate","Introspect Health","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","IH-001","May 2019","August 2019","August 2019","May 10, 2019",,"May 14, 2019","California Institute of Integral Studies, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT03946319"
92,"NCT02651493","Digital Dysmorphology Project",,"Recruiting","No Results Available","Down Syndrome","Device: photographs","Number of participants with Down syndrome accurately assessed by computer-aided detection (CADe) tool|Number of participants with other dysmorphic syndromes accurately assessed by computer-aided detection (CADe) tool","Kevin Cleary|Children's National Research Institute|George Washington University|Chiang Mai University","All","up to 18 Years   (Child, Adult)","Not Applicable","750","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","Pro00003506.","February 2013","December 2023","December 2023","January 11, 2016",,"January 4, 2019","Children's National, Washington, District of Columbia, United States",,"https://ClinicalTrials.gov/show/NCT02651493"
93,"NCT04200950","Trial for the Early Identification of Acute Kidney Injury",,"Not yet recruiting","No Results Available","Acute Kidney Injury","Device: Previse","Incidence of adverse kidney events as assessed by Major Adverse Kidney Event within 30 days (MAKE30) criteria","Dascena","All","18 Years and older   (Adult, Older Adult)","Phase 2","8574","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","07012020","July 2020","June 2021","June 2021","December 16, 2019",,"December 16, 2019",,,"https://ClinicalTrials.gov/show/NCT04200950"
94,"NCT03680014","Remote Monitoring and Analysis of Gait and Falls Within an Elderly Population","4279","Not yet recruiting","No Results Available","Accidental Fall|Fall|Fall Injury|Hip Fractures","Diagnostic Test: CUSH","Validation of gait analysis algorithm by use of Inertial Measurement Unit (IMU)","CUSH Health Ltd.","All","65 Years and older   (Older Adult)",,"40","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CUSH DHTC 4279","September 12, 2018","October 31, 2018","September 30, 2019","September 21, 2018",,"September 21, 2018",,,"https://ClinicalTrials.gov/show/NCT03680014"
95,"NCT04359745","Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression",,"Recruiting","No Results Available","Glioblastoma",,"Accuracy of the artificial intelligence model|Failure rate of the artificial intelligence model","Guy's and St Thomas' NHS Foundation Trust|King's College London","All","18 Years to 80 Years   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","3.0 04/09/18","March 21, 2019","May 26, 2023","May 26, 2023","April 24, 2020",,"April 27, 2020","Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King's College Hospital NHS Trust, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04359745"
96,"NCT04415541","Psychodynamic Psychotherapy for Psychosis",,"Not yet recruiting","No Results Available","Psychotic Disorders","Behavioral: Psychodynamic Psychotherapy|Behavioral: Usual Care","Overall Symptom Severity|Overall Functioning - Social|Overall Functioning - Role|Symptom Severity (Positive Symptoms)|Symptom Severity (Negative Symptoms)","Yale University|University of Southern California","All","16 Years to 35 Years   (Child, Adult)","Not Applicable","10","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Gallagher01","September 2020","August 2021","August 2021","June 4, 2020",,"June 4, 2020",,,"https://ClinicalTrials.gov/show/NCT04415541"
97,"NCT04045639","A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.","PULsE AI","Recruiting","No Results Available","Atrial Fibrillation",,"Percentage of participants with diagnosed Atrial Fibrillation during the research window in control and intervention arms|Expected healthcare resource utilisation (Annual maintenance costs related to health states (informed by the primary endpoint), and daily treatment costs (including monitoring))|Quality-adjusted life years (QALYs)|Life years (LYs)","Bristol-Myers Squibb","All","30 Years and older   (Adult, Older Adult)",,"18000","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CV185-703","May 31, 2019","April 30, 2020","April 30, 2020","August 5, 2019",,"November 13, 2019","Local Institution, Leamington Spa, United Kingdom|Local Institution, Ludlow, United Kingdom|Local Institution, Shropshire, United Kingdom|Local Institution, Warkwickshire, United Kingdom|Local Institution, Wolverhampton, United Kingdom|Local Institution, Worcester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04045639"
98,"NCT04026555","Realtime Streaming Clinical Use Engine for Medical Escalation","ReSCUE-ME","Completed","No Results Available","Clinical Deterioration|Hospital Medicine|Monitoring, Physiologic","Other: MEWS++ Monitoring|Other: Predictor Score","Overall rate of care escalation|Number of participants requiring blood pressure support|Number of participants requiring respiratory support|Number of cardiac arrest episode|Mortality Rate|Notification Frequency|Number of calls|Sensitivity and Specificity of the RRT alert","Icahn School of Medicine at Mount Sinai","All","18 Years and older   (Adult, Older Adult)","Not Applicable","2915","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","GCO 19-0729","June 18, 2019","March 19, 2020","March 19, 2020","July 19, 2019",,"June 25, 2020","Mount Sinai Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04026555"
99,"NCT04184791","Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's Disease",,"Recruiting","No Results Available","Parkinson Disease","Device: Deep Brain Stimulation","Change in Gait and Balance using Wearable Sensors|Accuracy of Predicting Gait Response to 60hz with Machine Learning|Accuracy of Predicting Best Stimulation Frequency (60hz vs. High Frequency) with Machine Learning|Change in Hand Tremor Severity|Change in Speed of Limb Movements","Northwell Health|National Institute of Neurological Disorders and Stroke (NINDS)|The University of Tennessee, Knoxville","All","21 Years to 80 Years   (Adult, Older Adult)","Not Applicable","30","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","19-0217|R21NS111301","January 15, 2020","December 2021","December 2021","December 4, 2019",,"May 1, 2020","Northwell Health, Great Neck, New York, United States",,"https://ClinicalTrials.gov/show/NCT04184791"
100,"NCT03533205","Prediction of Hemodynamic Instability in Patients Undergoing Surgery",,"Completed","No Results Available","Blood Pressure|Prediction Models|Machine Learning|Hemodynamic Instability","Diagnostic Test: Hypotension Probability Indicator","Sensitivity of the HPI algorithm|Specifity of the HPI algorithm|Predictive positive value of the HPI algorithm|Negative predictive value of the HPI algorithm|Time from HPI alarm to hypotensive event during surgery","Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","All","18 Years and older   (Adult, Older Adult)",,"507","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","W15_080","April 1, 2015","December 1, 2016","April 26, 2018","May 23, 2018",,"May 23, 2018",,,"https://ClinicalTrials.gov/show/NCT03533205"
101,"NCT04455646","Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)",,"Recruiting","No Results Available","Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment","Behavioral: CBT-based, mobile-delivered, intervention platform","Patient Patient Health Questionnaire (PHQ) Patient Health Questionnaire (PHQ) Patient Health Questionnaire (PHQ) Health Questionnaire (PHQ)|Patient Patient Health Questionnaire (PHQ)","Brainsway","All","22 Years to 68 Years   (Adult, Older Adult)",,"540","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","101","August 26, 2019","August 26, 2021","August 26, 2021","July 2, 2020",,"July 9, 2020","Kadima Neuropsychiatry, San Diego, California, United States|Advanced Mental Health Care Inc. - Juno Beach, Juno Beach, Florida, United States|Advanced Mental Health Care Inc. - Palm Beach, Palm Beach, Florida, United States|Advanced Mental Health Care Inc. - Royal Palm Beach, Royal Palm Beach, Florida, United States|Greenbrook - Annapolis, Annapolis, Maryland, United States|Greenbrook - Columbia, Columbia, Maryland, United States|Greenbrook - Frederick, Frederick, Maryland, United States|Greenbrook - Glen Burnie, Glen Burnie, Maryland, United States|Greenbrook - Greenbelt, Greenbelt, Maryland, United States|Greenbrook - Kensington, Kensington, Maryland, United States|Greenbrook - Olney, Olney, Maryland, United States|Greenbrook - Rockville, Rockville, Maryland, United States|Greenbrook - O'Fallon, O'Fallon, Missouri, United States|Greenbrook - Tesson Ferry, Saint Louis, Missouri, United States|Greenbrook - Creve Coeur, Saint Louis, Missouri, United States|Greenbrook - Chapel Hill, Chapel Hill, North Carolina, United States|Greenbrook - Greensboro, Greensboro, North Carolina, United States|Greenbrook - Matthews, Matthews, North Carolina, United States|Greenbrook - Raleigh, Raleigh, North Carolina, United States|Greenbrook - Glen Allen, Glen Allen, Virginia, United States|Greenbrook TMS NeuroHealth Centers, McLean, Virginia, United States|Greenbook - Newport News, Newport News, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT04455646"
102,"NCT04060160","Acne Detection Software (AcneDect)","AcneDect","Not yet recruiting","No Results Available","Acne Lesions|Acne Vulgaris","Other: Self- learning software that can detect acne lesions|Other: Patient reported outcomes","Pictures to train the AcneDect software|AcneDect questionnaire regarding acne burden (Visual Analogue Scale (VAS) scale ranging from ""Not bad at all"" to ""Very bad"")","University Hospital, Basel, Switzerland","All","10 Years to 35 Years   (Child, Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2018-00702; sp19Navarini","July 2020","December 2020","December 2020","August 16, 2019",,"April 3, 2020","Department of Dermatology, University Hospital Basel, Basel, Switzerland",,"https://ClinicalTrials.gov/show/NCT04060160"
103,"NCT03982654","Investigating the Physiology of Labour and Labour Onset Through Longitudinal Measurements Performed With a Wearable Sensor",,"Completed","No Results Available","Labour Onset","Device: Bloomlife","Accuracy|Labour probability","Bloom Technologies","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","145","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","WISH01","March 30, 2018","November 26, 2018","March 5, 2019","June 11, 2019",,"June 11, 2019","Ziekenhuis Oost-Limburg, Genk, Belgium|CHR de la Citadelle, Liège, Belgium",,"https://ClinicalTrials.gov/show/NCT03982654"
104,"NCT04035993","The HEADWIND-Study","HEADWIND","Recruiting","No Results Available","Diabetes|Diabetes Mellitus, Type 1","Other: Controlled hypoglycaemic state while driving with a driving simulator","Accuracy of the HEADWIND-model: Diagnostic accuracy of the hypoglycaemia warning system (HEADWIND) to detect hypoglycaemia (blood glucose < 3.9 mmol/l) quantified as the area under the receiver operator characteristics curve (AUC ROC > 0.85).|Change of time driving over midline|Change of swerving|Change of spinning|Defining the glycemic level when driving performance is decreased|Driving performance before and after hypoglycemia|Change of heart-rate|Change of heart-rate variability|Change of electrodermal activity (EDA)|Change of skin temperature|CGM accuracy during hypoglycaemic state|CGM time-delay during hypoglycaemic state|Change of glucagon|Change of growth hormone (GH)|Change of catecholamines|Change of cortisol|Glycemic level at time point of hypoglycemia detection by the HEADWIND-model|Comparison CGM and HEADWIND-model regarding time-point of hypoglycemia detection|Comparison CGM and HEADWIND-model regarding glycemia|Accuracy-comparison of HEADWIND-model and HEADWINDplus-model|Self-estimation of glucose and hypoglycemia|Self-estimation of driving performance|Time point of need-to-treat|Self-perception of hypoglycemia symptoms compared to baseline hypoglycemia awareness|Incidence of Adverse Events (AEs)|Incidence of Serious Adverse Events (SAEs)|Perceived ease of use of the early hypoglycaemia warning system (EWS)|Perceived usefulness of the EWS|Perceived enjoyment during EWS usage|Intention to adopt the EWS|Intention to continuously use the EWS|Reception of recommendations of the EWS|Processing of recommendations of the EWS|Perceived understandability of the recommendations of the EWS|Perceived familiarity of the recommendations of the EWS|Cognitive and emotional trust in the recommendations of the EWS","University Hospital Inselspital, Berne|University of Zurich|University of St.Gallen","All","21 Years to 50 Years   (Adult)","Not Applicable","25","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","HEADWIND","October 7, 2019","July 31, 2020","July 31, 2020","July 29, 2019",,"December 2, 2019","University Department of Endocirnology, Diabetology, Clinical Nutrition and Metabolism, Bern, Switzerland",,"https://ClinicalTrials.gov/show/NCT04035993"
105,"NCT04139889","Diagnosis of Laryngeal Lesions Using the Probe-based Confocal Laser Endomicroscopy",,"Recruiting","No Results Available","Laryngeal Leiomyoma|Probe-based Confocal Laser Endomicroscopy","Diagnostic Test: Confocal Laser Endomicroscopy","pCLE diagnostic classification|the image analysis by machine learning","Eye & ENT Hospital of Fudan University","All","18 Years to 85 Years   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","20170601","June 1, 2017","November 30, 2019","December 21, 2020","October 25, 2019",,"January 7, 2020","Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04139889"
106,"NCT03739073","Can we Predict COronary Resistance By EYE Examination ? (COREYE)","COREYE","Recruiting","No Results Available","Coronary Artery Disease","Other: OCTA (angiography by tomography in optical coherence)","Coronary microvascular resistance results (Combowire)|Coronary microvascular resistance results (OCTA)|angiographical stenosis|Fractional Flow Reserve (FFR)|coronary microvascular resistance (CFR)|microvascular resistance values|total area of flow signal void on the choriocapillaris layer","Hospices Civils de Lyon","All","18 Years and older   (Adult, Older Adult)","Not Applicable","210","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","69HCL18_0301|2018-A01181-54","October 4, 2018","April 5, 2020","April 5, 2021","November 13, 2018",,"December 31, 2018","Hospices Civils de Lyon - Hopital de la Croix Rousse, Lyon, France",,"https://ClinicalTrials.gov/show/NCT03739073"
107,"NCT04152031","Activity-Aware Prompting to Improve Medication Adherence in Heart Failure Patients",,"Completed","No Results Available","Heart Failure|Cardiovascular Diseases","Other: Prompting","Medication adherence rate","Washington State University|University of California, Irvine","All","21 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","16243-001","October 20, 2016","August 5, 2019","August 5, 2019","November 5, 2019",,"November 5, 2019",,,"https://ClinicalTrials.gov/show/NCT04152031"
108,"NCT03696420","Probabilistic Targeting of the VIM","PROBA-VIM","Recruiting","No Results Available","Essential Tremor|Deep Brain Stimulation","Other: Coordinates of active plots and VIM landmarks calculation","Euclidian distance between the predicted target and the center of the active contact of the DBS lead","University Hospital, Bordeaux|Institut National de Recherche en Informatique et en Automatique","All","18 Years and older   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","CHUBX 2018/26","November 30, 2018","November 2020","November 2020","October 4, 2018",,"January 14, 2019","Bordeaux University Hospital, Bordeaux, France",,"https://ClinicalTrials.gov/show/NCT03696420"
109,"NCT00241046","Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment",,"Terminated","No Results Available","Metastatic Breast Cancer","Drug: Letrozole","Comparison of the the individual pretherapeutic predictions from the computer or doctor with the patient data obtained in a first- or second-line treatment of metastatic breast cancer after progression of the disease|Determination of the individual response at 3 monthly assessments","Novartis Pharmaceuticals|Novartis","Female","18 Years and older   (Adult, Older Adult)","Phase 4","13","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CFEM345ADE02","April 2002","March 2005",,"October 18, 2005",,"April 19, 2012",,,"https://ClinicalTrials.gov/show/NCT00241046"
110,"NCT03804606","Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure",,"Enrolling by invitation","No Results Available","Heart Failure","Other: Referral to MTM Pharmacist","All-cause mortality|Hospital admission|Healthcare utilization - Total cost of care|Incidence of flu vaccine care gap closure; relationship to mortality|Incidence of evidence-based beta blocker care gap closure; relationship to mortality|Incidence of ACE inhibitor/ARB care gap closure; relationship to mortality|Incidence of diabetic a1C ""in goal"" care gap closure; relationship to mortality","Geisinger Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research","2018-0735","February 28, 2019","June 2020","June 2020","January 15, 2019",,"April 9, 2019","Geisinger Health System, Danville, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03804606"
111,"NCT03984773","Machine-Generated Mortality Estimates and Nudges to Promote Advance Care Planning Discussion Among Cancer Patients",,"Completed","No Results Available","Oncology","Behavioral: Nudge","Change in the proportion of patients with a documented serious illness conversation (SIC)|Change in the proportion of patients with a documented SIC among those identified as high-risk by the algorithm|Change in the proportion of patients with a documented advanced care planning|Change in the proportion of patients with a documented serious illness conversation (SIC) including follow-up|Change in the proportion of patients with a documented SIC among those identified as high-risk by the algorithm including follow-up|Change in the proportion of patients with a documented advanced care planning including follow-up","University of Pennsylvania","All","18 Years and older   (Adult, Older Adult)","Not Applicable","78","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","833178","July 15, 2019","November 1, 2019","April 19, 2020","June 13, 2019",,"April 24, 2020","Penn Medicine, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03984773"
112,"NCT02265354","Developing Smokers for Smoker (S4S): A Collective Intelligence Tailoring System","S4S","Active, not recruiting","No Results Available","Tobacco Smoking","Behavioral: Collective-Intelligence computer tailored health communication|Behavioral: Rule-based computer tailored health communication","Repeated Use of website measure|30-day point prevalent smoking cessation at six months","University of Massachusetts, Worcester|University of Massachusetts, Amherst|National Cancer Institute (NCI)","All","19 Years and older   (Adult, Older Adult)","Not Applicable","260","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","H00002005|K07CA172677","January 11, 2017","December 28, 2017","June 28, 2020","October 15, 2014",,"December 12, 2019","UMass Medical School, Worcester, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02265354"
113,"NCT03547219","Biomarkers of Antidepressant Response and Suicidal Events in Depressed Youth",,"Completed","No Results Available","Depression|Adolescent","Drug: Escitalopram","the change from baseline in CDRS-R at week 8 or upon termination|CGI-I at 8 weeks or upon termination","Seoul National University|National Research Foundation of Korea","All","12 Years to 17 Years   (Child)","Not Applicable","152","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015R1A2A2A01004501","August 5, 2015","August 2, 2018","August 2, 2018","June 6, 2018",,"April 4, 2019","Seoul National University Hospital, Seoul, N/A = Not Applicable, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03547219"
114,"NCT04208789","Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis",,"Recruiting","No Results Available","MDR Tuberculosis|Resistance to Tuberculostatic Drugs","Diagnostic Test: Rapid Molecular Drug-Resistant Tuberculosis Test|Other: Artificial Intelligent Model|Diagnostic Test: Drug Susceptibility Test","Accuracy of Artificial Intelligent Model to Drug Susceptibility Test Results|Accuracy of Rapid Molecular Drug Resistant Tuberculosis test to Drug Susceptibility Test Results","Hasanuddin University|Chulalongkorn University","All","Child, Adult, Older Adult",,"528","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","0111190912","June 15, 2020","September 30, 2020","December 30, 2020","December 23, 2019",,"June 25, 2020","Kanudjoso Djatiwibowo General Hospital, Balikpapan, East Kalimantan, Indonesia|Tarakan General Hospital, Tarakan, North Kalimantan, Indonesia|Labuang Baji General Hospital, Makasar, South Sulawesi, Indonesia|Balai Besar Kesehatan Paru Masyarakat, Makasar, South Sulawesi, Indonesia|Wahidin Sudirohusodo General Hospital, Makassar, South Sulawesi, Indonesia",,"https://ClinicalTrials.gov/show/NCT04208789"
115,"NCT02416375","Home Monitoring to Predict Exacerbation in Cystic Fibrosis","SmartCare","Unknown status","No Results Available","Cystic Fibrosis",,"Home monitoring possible in adult Cystic Fibrosis patients|Whether daily monitoring can provide early warning of a new chest infection|Development of a web-based machine learning tool","Papworth Hospital NHS Foundation Trust|Cystic Fibrosis Trust|King's College Hospital NHS Trust|Royal Brompton & Harefield|The Leeds Teaching Hospitals NHS Trust|University Hospital Southampton NHS Foundation Trust|Microsoft Research|Frimley Park Hospital NHS Trust|University Hospitals Bristol NHS Foundation Trust","All","18 Years and older   (Adult, Older Adult)",,"200","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","PO1955","May 2015","May 2016","November 2016","April 15, 2015",,"February 17, 2016","Papworth Hospital NHS Trust, Cambridge, Cambridgeshire, United Kingdom|Papworth Hospital NHS Trust, Cambridge, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02416375"
116,"NCT03607435","A Clinical Study to Collect Calibration & Performance Data of the KBS Systems 1.0 Non-Invasive Glucose Monitoring Device",,"Recruiting","No Results Available","Diabetes","Device: Spectroscopy for Analyte Quantification","Calibration of the KBS-1 Test Article using the POC Control data for comparison.|Research Subject Assessment|Calibration of the RBA-1 Test Article using the hospital lab test Control data and POC blood glucose monitor Control data for comparison.","Florida Hospital Tampa Bay Division|Kaligia Biosciences, LLC","All","21 Years and older   (Adult, Older Adult)","Not Applicable","300","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","KBS002","August 2, 2018","June 2019","July 2019","July 31, 2018",,"August 6, 2018","Florida Hospital Tampa, Tampa, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03607435"
117,"NCT03879291","Assessment of Utility of accelerateIQ in the Care of Patients Participating in a Pulmonary Rehabilitation Program","GASSP","Terminated","No Results Available","COPD|Pulmonary Rehabilitation","Other: pinpointIQ","Clinical Utility","Karen Larimer|Sunovian|physIQ, Inc.","All","40 Years and older   (Adult, Older Adult)",,"5","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CTP-010","January 9, 2019","December 30, 2019","December 30, 2019","March 18, 2019",,"March 16, 2020","NorthShore University Health System, Evanston, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT03879291"
118,"NCT04057690","Automatic PredICtion of Edema After Stroke","APICES","Recruiting","No Results Available","Stroke, Acute|Brain Edema",,"Number of patients with stroke-related malignant edema after recanalization treatment detected by deep learning algorithms|Number of correctly identified specific imaging findings for early detection of malignant edema","University Hospital Tuebingen","All","Child, Adult, Older Adult",,"1500","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","APICES","April 1, 2019","March 31, 2020","March 31, 2022","August 15, 2019",,"August 15, 2019","University Hospital Tuebingen, Tuebingen, Germany",,"https://ClinicalTrials.gov/show/NCT04057690"
119,"NCT01962181","Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment",,"Unknown status","No Results Available","""Attention Deficit Hyperactivity Disorder""","Drug: Ritalin|Drug: Placebo","Resting oscillation activity and Event-related-Potentials in Attention Deficit / Hyperactivity Disorder (ADHD) and healthy subjects.","Hadassah Medical Organization","All","18 Years to 50 Years   (Adult)","Not Applicable","40","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","RE0379-HMO-STILL","October 2013","December 2015","December 2015","October 14, 2013",,"October 14, 2013","Hadassah Medical Center, Jerusalem, Israel",,"https://ClinicalTrials.gov/show/NCT01962181"
120,"NCT03662802","Development of a Novel Convolution Neural Network for Arrhythmia Classification","AI-ECG","Not yet recruiting","No Results Available","Arrhythmias, Cardiac|Cardiac Arrest|Cardiac Arrythmias","Other: Neural Network Classifier","Diagnostic Accuracy","Scripps Clinic|Scripps Health","All","Child, Adult, Older Adult",,"2000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","027527","October 2018","October 2019","October 2019","September 7, 2018",,"September 7, 2018","Scripps Clinic, San Diego, California, United States",,"https://ClinicalTrials.gov/show/NCT03662802"
121,"NCT03605810","Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data",,"Completed","No Results Available","Renal Function","Other: No Intervention","Performance of classification to predict eGFR","Bayer","All","18 Years and older   (Adult, Older Adult)",,"5132200","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","20325","July 15, 2018","December 31, 2018","December 31, 2018","July 30, 2018",,"December 10, 2019","US OPTUM CDM database, Whippany, New Jersey, United States",,"https://ClinicalTrials.gov/show/NCT03605810"
122,"NCT03627923","Personalizing Mediterranean Diet in Children.",,"Not yet recruiting","No Results Available","Personalized Nutrition In Children|Glucose, High Blood|Diet Habit",,"Postprandial glycemic response|Microbiome composition and function","Weizmann Institute of Science|Schneider Children's Medical Center, Israel|University of Naples","All","6 Years to 9 Years   (Child)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","0694-17-RMC","November 2018","August 2020","August 1, 2021","August 14, 2018",,"October 3, 2018",,,"https://ClinicalTrials.gov/show/NCT03627923"
123,"NCT04404452","Heart Failure Monitoring With Eko Electronic Stethoscopes","HOME0","Not yet recruiting","No Results Available","Heart Failure|Crackles|Heart Failure With Preserved Ejection Fraction","Device: Use of Eko CORE and Eko DUO electronic stethoscopes","Feasibility of use of Eko DUO by protocol compliance|Feasibility of use of Eko CORE|Intra-Subject Reproducibility of Normalized EMAT|Intra-Subject Reproducibility of HRV|Intra-Subject Reproducibility of S3 Heart Sound|Algorithm Model Development of Hemodynamic Status based on time since invasive right heart catheter insertion","Eko Devices, Inc.","All","18 Years and older   (Adult, Older Adult)",,"50","Industry","Observational","Observational Model: Case-Only|Time Perspective: Prospective","2020.2","June 2020","January 2021","January 2021","May 27, 2020",,"May 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04404452"
124,"NCT03474315","Interactive Patient's Assistant - LUCY",,"Unknown status","No Results Available","Chronic Heart Failure","Diagnostic Test: Multivariate assessment","Ambulatory visit qualified as meaningful due to change in pharmacotherapy or ICD parameters related to tachycardia detection or treatment.|Ambulatory visit qualified as meaningful due to alarming condition related to ICD.","Medical University of Warsaw","All","18 Years to 90 Years   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","LUCY","April 2018","February 2019","February 2019","March 22, 2018",,"March 22, 2018","Department of Medical Informatics and Telemedicine, Warsaw, Mazowieckie, Poland",,"https://ClinicalTrials.gov/show/NCT03474315"
125,"NCT02734875","Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology","IQ-MATCH","Completed","No Results Available","Atrial Fibrillation","Other: Intervention","Anticoagulation therapy","Brigham and Women's Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","432","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other","2015P000893/BWH","May 2016","August 2017","August 2017","April 12, 2016",,"January 16, 2019",,,"https://ClinicalTrials.gov/show/NCT02734875"
126,"NCT03857373","Renal Cancer Detection Using Convolutional Neural Networks","RCCCNN","Recruiting","No Results Available","Kidney Cancer",,"Predicting recurrences","Zealand University Hospital","All","Child, Adult, Older Adult",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Zealand_UCRU","February 1, 2019","January 1, 2023","January 1, 2023","February 28, 2019",,"March 11, 2019","Zealand University Hospital, Roskilde, Denmark",,"https://ClinicalTrials.gov/show/NCT03857373"
127,"NCT04400513","Development of an Algorithm to Differentiate Heart Murmurs Using Electronic Stethoscopes",,"Recruiting","No Results Available","Murmur, Heart|Aortic Valve Stenosis|Tricuspid Regurgitation|Mitral Regurgitation|Innocent Murmurs|Heart Murmurs","Device: Use of Eko CORE and Eko DUO electronic stethoscopes","Murmur Timing|Systolic Murmur Type Classification|Systolic Murmur Severity Classification","Eko Devices, Inc.","All","18 Years and older   (Adult, Older Adult)",,"1145","Industry","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","2020.3","June 25, 2020","September 2021","September 2021","May 22, 2020",,"June 29, 2020","CoxHealth, Springfield, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT04400513"
128,"NCT04400435","Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence","DAVID1","Not yet recruiting","No Results Available","Left Ventricular Dysfunction","Device: Use of Eko DUO electronic stethoscope","Single-lead ECG based algorithm development","Eko Devices, Inc.","All","18 Years and older   (Adult, Older Adult)",,"600","Industry","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","2020.4","July 2020","March 2021","March 2021","May 22, 2020",,"May 22, 2020",,,"https://ClinicalTrials.gov/show/NCT04400435"
129,"NCT02910921","Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit","Migraine Alert","Completed","No Results Available","Migraine Disorders|Headache Disorders, Primary|Headache Disorders|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases",,"AUC of individual prediction models using cross validation data on environmental and physiological variables.|AUC of individual prediction models using post prediction data on environmental and physiological variables.","Second Opinion Health|Mayo Clinic|University of Southern California|Allergan","All","18 Years and older   (Adult, Older Adult)",,"19","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","16-005803","November 2016","July 2018","July 31, 2018","September 22, 2016",,"August 6, 2018","Mayo Clinic Arizona, Scottsdale, Arizona, United States|University of Southern California, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT02910921"
130,"NCT03734380","Lower Knee Joint Loading by Real-time Biofeedback Stair Walking Rehabilitation for Patients With MCKOA",,"Not yet recruiting","No Results Available","Knee Osteoarthritis","Behavioral: Laboratory-based gait retraining (LGR)|Behavioral: Sensor-based gait retraining (SGR)|Behavioral: Walking exercise control (Ctrl)","Change in knee adduction moment (KAM)|Change in Chinese Knee Injury and Osteoarthritis Outcome Score (KOOS)|Chnage in validated visual analogue scale (VAS)","The Hong Kong Polytechnic University|City University of Hong Kong|Chinese University of Hong Kong|Bern University of Applied Sciences","All","45 Years to 80 Years   (Adult, Older Adult)","Not Applicable","57","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","HSEARS20181031005","January 1, 2021","December 30, 2022","December 30, 2023","November 8, 2018",,"February 11, 2020","The Hong Kong Polytechnic University, Hong Kong, China",,"https://ClinicalTrials.gov/show/NCT03734380"
131,"NCT03570086","Multiparametric Diagnostic Model of Thick-section Clinical-quality MRI Data in Detecting Migraine Without Aura",,"Unknown status","No Results Available","Migraine Without Aura","Diagnostic Test: diagnostic","accuracy|sensitivity|specificity","Xidian University","All","21 Years to 55 Years   (Adult)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","20170908010418","July 1, 2018","December 30, 2018","December 30, 2019","June 26, 2018",,"June 26, 2018","Xijing Hospital, Xi'an, Shaanxi, China",,"https://ClinicalTrials.gov/show/NCT03570086"
132,"NCT02176226","IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)",,"Completed","Has Results","Major Depressive Disorder|Anxiety Disorders","Behavioral: IntelliCare","Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module|GAD-7 (Generalized Anxiety Disorder Scale-7)|Mean Number of Treatment App Use Sessions by Study Week","Northwestern University","All","19 Years and older   (Adult, Older Adult)","Not Applicable","105","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01MH100482-01FTIC","March 2015","June 2016","June 2016","June 27, 2014","October 29, 2018","October 29, 2018","Northwestern University, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT02176226"
133,"NCT04100486","Non-Invasive Bioelectronic Analytics","NIBA","Recruiting","No Results Available","Autonomic Dysfunction|Autonomic Imbalance|Autonomic Nervous System Diseases|Vagus Nerve Autonomic Disorder","Other: Standing-Squatting-Standing Test|Other: Deep Breathing Test|Other: Cold Pressor Test|Other: Cold Face Test|Other: Valsalva Maneuver|Device: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)","Changes in Heart Rate (Electrocardiography) related to Autonomic Nervous System Perturbations|Changes in Brain Activity (Electroencephalography) related to Autonomic Nervous System Perturbations|Changes in Respiratory Rate related to Autonomic Nervous System Perturbations|Changes in Sweat Gland Activity (Galvanic Skin Response) related to Autonomic Nervous System Perturbations|Changes in Blood Pressure related to Autonomic Nervous System Perturbations|Changes in Skin Temperature related to Autonomic Nervous System Perturbations|Changes in Pupil Size related to Autonomic Nervous System Perturbations|Changes in Heart Rate (Electrocardiography) due to taVNS|Changes in Brain Activity (Electroencephalography) due to taVNS|Changes in Respiratory Rate due to taVNS|Changes in Sweat Gland Activity (Galvanic Skin Response) due to taVNS|Changes in Blood Pressure due to taVNS|Changes in Skin Temperature due to taVNS|Changes in Pupil Size due to taVNS","Northwell Health","All","18 Years to 60 Years   (Adult)",,"48","Other","Observational","Observational Model: Other|Time Perspective: Prospective","19-0461","August 29, 2019","May 2020","September 2020","September 24, 2019",,"March 4, 2020","The Feinstein Institutes for Medical Research, Manhasset, New York, United States",,"https://ClinicalTrials.gov/show/NCT04100486"
134,"NCT03877614","Artificial Intelligence With Deep Learning and Genes on Cardiovascular Disease",,"Recruiting","No Results Available","Cardiovascular Diseases","Other: ASCVD risk score","Major cardiovascular events|Heart function changes|Lipid profiles|Arrhythmia events|Recurrent acute coronary events","National Cheng-Kung University Hospital","All","18 Years and older   (Adult, Older Adult)",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","A-ER-107-149","August 28, 2018","December 2021","June 2022","March 15, 2019",,"March 15, 2019","Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan",,"https://ClinicalTrials.gov/show/NCT03877614"
135,"NCT04430491","To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease",,"Completed","No Results Available","Interstitial Lung Disease|Idiopathic Pulmonary Fibrosis|Usual Interstitial Pneumonia","Diagnostic Test: radiomics","IPF classifier","Maastricht University|Université Libre de Bruxelles","All","18 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","RESPIRE_2019","January 1, 2005","January 1, 2017","July 1, 2017","June 12, 2020",,"June 12, 2020","Maastricht University, Maastricht, Limburg, Netherlands",,"https://ClinicalTrials.gov/show/NCT04430491"
136,"NCT03637712","Deep-Learning for Automatic Polyp Detection During Colonoscopy",,"Completed","No Results Available","Screening Colonoscopy","Device: Computer Algorithm","Adenoma Detection Rate","NYU Langone Health","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","18-00746","September 1, 2018","July 7, 2019","July 7, 2019","August 20, 2018",,"May 15, 2020","NYU Langone Health, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03637712"
137,"NCT02801877","IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression","AIM","Completed","Has Results","Depression|Anxiety","Behavioral: IntelliCare|Behavioral: Hub App with the Recommender System|Behavioral: Coaching","Adherence to the Mobile Application Intervention|Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity|GAD-7 (Generalized Anxiety Disorder Scale-7) - Anxiety Severity","Northwestern University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","301","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01MH100482-01-RCTIC|R01MH100482-01","July 2016","January 2018","January 2018","June 16, 2016","May 31, 2019","March 2, 2020","Northwestern University, Chicago, Illinois, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/77/NCT02801877/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02801877"
138,"NCT03960203","Effect of a Sepsis Prediction Algorithm on Clinical Outcomes",,"Completed","No Results Available","Severe Sepsis","Diagnostic Test: InSight","In-hospital mortality|Hospital length of stay|30-day readmissions","Dascena","All","18 Years and older   (Adult, Older Adult)","Not Applicable","75147","Industry","Interventional","Masking: None (Open Label)|Primary Purpose: Diagnostic","05172019","January 2017","June 2018","June 2018","May 22, 2019",,"May 24, 2019",,,"https://ClinicalTrials.gov/show/NCT03960203"
139,"NCT04040179","A Volunteer Study to Collect Imaging Data for the Development of the ntelligentUltrasound Anatomy Guide",,"Completed","No Results Available","Ultrasound Imaging of Anatomical Structures",,"Model development","Medaphor Limited|IntelligentUltrasound Limited","All","18 Years and older   (Adult, Older Adult)",,"30","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","IU2019_AG_03","August 5, 2019","September 30, 2019","September 30, 2019","July 31, 2019",,"October 10, 2019","Medicentre, Cardiff, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04040179"
140,"NCT03654300","A Volunteer Study to Collect Imaging Data for the Development of the Medaphor Anatomy Guide.",,"Completed","No Results Available","Ultrasound Imaging of Anatomical Structures",,"Model development","Medaphor Limited","All","18 Years and older   (Adult, Older Adult)",,"103","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","ML2018_AG_01","September 14, 2018","October 30, 2018","October 30, 2018","August 31, 2018",,"July 25, 2019","Medicentre, Cardiff, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03654300"
141,"NCT02902328","Accuracy Evaluation for SIS Software-based Visualization of Anatomical Brain Structures",,"Completed","No Results Available","Software Evaluation for Visualizing Anatomical Structures That Are Not Typically Identified on Clinical MR Images",,"Validation of the accurate visualization of brain structures based on SIS algorithms","Surgical Information Sciences Inc.","All","18 Years and older   (Adult, Older Adult)",,"30","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","SurgicalIS","March 2016","September 2016","September 2016","September 15, 2016",,"September 15, 2016",,,"https://ClinicalTrials.gov/show/NCT02902328"
142,"NCT01909947","Prediction of Extubation Readiness in Extreme Preterm Infants by the Automated Analysis of CardioRespiratory Behavior",,"Completed","No Results Available","Prediction of Extubation Readiness","Other: Cardiorespiratory signal acquisition","Extubation Failure|The need for reintubation within 72h of the first planned extubation|The need for reintubation","McGill University Health Centre/Research Institute of the McGill University Health Centre|Canadian Institutes of Health Research (CIHR)|Wayne State University|Brown University","All","Child, Adult, Older Adult",,"266","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","APEX 01|288299|12-387-PED","September 2013","October 2018","December 2018","July 29, 2013",,"April 1, 2019","Wayne State University, Detroit, Michigan, United States|Women and Infants Hospital of Rhode Island, Providence, Rhode Island, United States|Royal Victoria Hospital, Montreal, Quebec, Canada|Montreal Children's Hospital, Montreal, Quebec, Canada|Jewish General Hospital, Montreal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT01909947"
143,"NCT03930199","Personalized Mobility Interventions Using Smart Sensor Resources for Lower-Limb Prosthesis Users",,"Active, not recruiting","No Results Available","Amputation","Other: Needs-based intervention (physical, psychological, or both)","Pre-intervention:10 Meter Walk Test (10MWT)|Pre-intervention: 6 Minute Walk Test (6MWT)|Pre-intervention: Berg Balance Scale Test|Post-intervention:10 Meter Walk Test (10MWT)|Post-intervention: 6 Minute Walk Test (6MWT)|Post-intervention: Berg Balance Scale Test|Delayed post-intervention:10 Meter Walk Test (10MWT)|Delayed post-intervention: 6 Minute Walk Test (6MWT)|Delayed post-intervention: Berg Balance Scale Test|Pre-intervention: Amputee Mobility Predictor (AMP)|Pre-intervention: Modified Falls Efficacy Scale (mFES)|Post-intervention: Amputee Mobility Predictor (AMP)|Post-intervention: Modified Falls Efficacy Scale (mFES)|Delayed post-intervention: Amputee Mobility Predictor (AMP)|Delayed post-intervention: Modified Falls Efficacy Scale (mFES)","Shirley Ryan AbilityLab|Walter Reed National Military Medical Center|Minneapolis Veterans Affairs Medical Center","All","18 Years to 89 Years   (Adult, Older Adult)","Not Applicable","125","Other|U.S. Fed","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","STU00208186","May 1, 2020","September 30, 2022","September 30, 2023","April 29, 2019",,"May 6, 2020","Shirley Ryan AbilityLab, Chicago, Illinois, United States|Walter Reed National Military Medical Center, Center for Rehabilitation Sciences Research, Bethesda, Maryland, United States|Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/99/NCT03930199/Prot_SAP_000.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/99/NCT03930199/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT03930199"
144,"NCT04213183","Association of Eye With Hepatobiliary Disorders :Qualitative Analysis Via Deep Learning",,"Recruiting","No Results Available","Ophthalmology|Artificial Intelligence|Hepatobiliary Disease","Diagnostic Test: Hepatobiliary Disorders","area under the receiver operating characteristic curve of the deep learning system|sensitivity and specificity of the deep learning system","Sun Yat-sen University|Third Affiliated Hospital, Sun Yat-Sen University|Huadu District People's Hospital of Guangzhou|iKang Medical International","All","Child, Adult, Older Adult",,"1788","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","AEHD-2019","December 1, 2018","December 25, 2019","December 31, 2020","December 30, 2019",,"March 26, 2020","Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04213183"
145,"NCT04301102","Intraoperative Hemodynamic Optimization Using HPI: Relationship With Microcirculation: Detection of Acute Kidney Damage",,"Not yet recruiting","No Results Available","Intraoperative Hypotension","Device: Hemosphere platform® together with the FloTrac Acumen IQ® sensor|Device: Hemosphere platform® together with the FloTrac® sensor","Arterial Hypotension|Accumulated Hypotension Time|Area Under the Curve (AUC) of the Average Arterial Pressure|Total fluid therapy during surgery|Accumulated dose of Fentanyl, remifentanyl and/or morphine.|Accumulated dose during the intraoperative period of vasoactive|Accumulated dose during the intraoperative period of ionotopic drug|Need and accumulated dose of drugs not included in previous groups|Total intraoperative diuresis.|Transfusion of total blood products during surgery|Lactate|pH|Excess base|Hemoglobin|Urea|Creatinine|Microcirculation monitoring, StO2|Kidney damage variables: TIMP2-IGFBP7:|Postoperative variables|Postoperative complications|Postoperative hyperglycemia|Length of hospital stay|Mortality|Time spent in the Post-Anaesthesia Recovery Unit/ICU after surgery (until discharge to a conventional hospital ward)|Surgery time.","Fundación Pública Andaluza Progreso y Salud|Edwards Lifesciences|Andalusian Network for Design and Translation of Advanced Therapies","All","65 Years and older   (Older Adult)","Not Applicable","80","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","FPS-HPI-2019-02","June 1, 2020","June 1, 2021","May 1, 2022","March 10, 2020",,"March 10, 2020","Hospital Universitario de Jerez de la Frontera, Jerez De La Frontera, Cádiz, Spain|Hospital Universitario de Badajoz, Badajoz, Spain|Hospital Universitario Juan Ramón Jiménez, Huelva, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain",,"https://ClinicalTrials.gov/show/NCT04301102"
146,"NCT03788915","Weight Loss and Reversing T2D Through eHealth Coaching","LIVA","Recruiting","No Results Available","Obesity","Behavioral: Online dietetic lifestyle counseling|Behavioral: Usual care","Weight change|HbA1C change","University of Southern Denmark|Odense University Hospital","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","340","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","LIVA USouthernDenmark","April 16, 2018","April 2019","March 2021","December 28, 2018",,"December 28, 2018","Research Unit for General Practice, Department for Public Health, University of Southern Denmark, Odense, Region Of Southern Denmark, Denmark|Lægehuset i Stenstrup, Stenstrup, Denmark",,"https://ClinicalTrials.gov/show/NCT03788915"
147,"NCT03920995","Multi-center Database Registry to Study Thalamus Changes Using AI in MS",,"Not yet recruiting","No Results Available","Multiple Sclerosis",,"Multi-center registry of MRI scans","University at Buffalo|Celgene","All","18 Years to 85 Years   (Adult, Older Adult)",,"1000","Other|Industry","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","N/A-NI-MS-PI-13632","April 2019","September 30, 2020","March 31, 2021","April 19, 2019",,"April 22, 2019",,,"https://ClinicalTrials.gov/show/NCT03920995"
148,"NCT02499094","Modeling and Predicting Real World Behavior Using Mobile Sensor Data on Patients With Major Depressive Disorder",,"Completed","No Results Available","Depressive Disorder","Other: Behavioral-data driven support","Change in depression symptom severity|Change in patient activation","Ginger.io","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","1004","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","GIO-001","December 2014","July 2015",,"July 15, 2015",,"July 15, 2015",,,"https://ClinicalTrials.gov/show/NCT02499094"
149,"NCT01594502","Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies",,"Active, not recruiting","No Results Available","Prostate Cancer","Drug: Dutasteride|Drug: Placebo","Effects of dutasteride (vs. placebo) using multi-feature scores derived from digital image analysis on both nuclear and architectural features in benign prostate tissue.|Multivariable treatment-response score between subjects who develop PCa while on dutasteride and those who do not.|Magnitude of association between nuclear phenotype in benign biopsies, and subsequent risk of PCa in untreated men at elevated risk.","University of Illinois at Chicago|National Cancer Institute (NCI)","Male","50 Years to 75 Years   (Adult, Older Adult)",,"300","Other|NIH","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","2010-0670|R01CA155301","September 2011","November 2019","July 2021","May 9, 2012",,"April 19, 2019","University of Illinois at Chicago, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT01594502"
150,"NCT04288011","Validation of the BeCare Multiple Sclerosis Assessment App",,"Enrolling by invitation","No Results Available","Multiple Sclerosis",,"Clinical EDSS score vs MLA EDSS score comparison|Disease Progression Measured by Change in EDSS score|Development of a novel application to measure change in MS","BeCare Link LLC|Yale University","All","18 Years to 75 Years   (Adult, Older Adult)",,"30","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2000023992","February 26, 2020","August 26, 2021","December 26, 2021","February 27, 2020",,"July 9, 2020","Yale University School of Medicine, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT04288011"
151,"NCT03962426","Efficacy of Social Cognitive Training (SCT) in Recent-onset Psychosis",,"Recruiting","No Results Available","Psychosis","Device: SocialVille Social Cognitive Training","Global cognition|Neural effects- Blood Oxygenation Level Dependent (BOLD) images|Decision scores of the ROP-HC classifier|Global functioning - Social (GF-S) and Role (GF-R)|Global Assessment of Functioning (GAF)|Positive and Negative Syndrome Scale (PANSS)|Cognitive Domain - Social Cognition (SC)|Cognitive Domain - Speed of Processing (SoP)|Cognitive Domain - Working Memory (WM)|Cognitive Domain - Verbal Learning (VL)|Cognitive Domain - Attention (Attn)|Cognitive Domain - Executive Functioning (EF)","Ludwig-Maximilians - University of Munich|Posit Science Corporation","All","15 Years to 40 Years   (Child, Adult)","Not Applicable","66","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","972_961_PNKT_LKI","May 2016","February 29, 2020","February 29, 2020","May 24, 2019",,"January 10, 2020","LudwigMaximilians, München, Deutschland, Germany",,"https://ClinicalTrials.gov/show/NCT03962426"
152,"NCT04261062","Validity Test of Wearable Continuous Blood Pressure Measuring System",,"Not yet recruiting","No Results Available","Patients in Surgical Intensive Care",,"Title quality of pulsewave|User Comfortability","Yonsei University","All","18 Years and older   (Adult, Older Adult)",,"220","Other","Observational","Observational Model: Other|Time Perspective: Other","1-2019-0080","March 2020","January 2022","January 2022","February 7, 2020",,"February 7, 2020","Yonsei University College of Medicine, Department of Anesthesiology and Pain Medicine, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04261062"
153,"NCT03998007","Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain",,"Completed","No Results Available","Chronic Pain","Device: IRIS System","Pearsons Correlation between IRIS derived pain biomarker and patient reported Numeric Rating Scale (0-10)","PainQx, Inc|National Institute on Drug Abuse (NIDA)","All","18 Years to 85 Years   (Adult, Older Adult)",,"50","Industry|NIH","Observational","Observational Model: Case-Only|Time Perspective: Prospective","00001","October 2, 2018","January 22, 2019","January 22, 2019","June 25, 2019",,"June 27, 2019","Boston Pain Care Center, Waltham, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03998007"
154,"NCT03965026","Activity Modeling in Birth Room",,"Completed","No Results Available","Delivery",,"Anticipate deliveries number 48 hours in advance","Groupe Hospitalier Paris Saint Joseph","Female","18 Years and older   (Adult, Older Adult)",,"5100","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","MODELSAN","June 22, 2018","September 30, 2018","December 22, 2018","May 28, 2019",,"May 28, 2019","Groupe Hospitalier Paris Saint Joseph, Paris, France",,"https://ClinicalTrials.gov/show/NCT03965026"
155,"NCT02787200","Identification of Time-invariant EEG Signals for Brain-Computer Interface",,"Unknown status","No Results Available","EEG Data Analysis|Healthy Subjects",,"Time invariant components of EEG signals","National Taiwan University Hospital","All","20 Years to 40 Years   (Adult)",,"50","Other","Observational","Time Perspective: Cross-Sectional","201604024RIND","May 2016","May 2017","May 2017","June 1, 2016",,"June 8, 2016","National Taiwan University Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT02787200"
156,"NCT04034537","Repository of Phase Signals for Algorithm Development and Testing in CAD in CHINA","CADChina","Not yet recruiting","No Results Available","Coronary Artery Disease","Diagnostic Test: cPSTA","positive coronary artery disease|positive cardiac Phase Space Tomography Analysis","Shanghai Zhongshan Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","500","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CADC-CIP-001","August 2019","June 2020","July 2020","July 26, 2019",,"July 26, 2019",,,"https://ClinicalTrials.gov/show/NCT04034537"
157,"NCT03688906","AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test",,"Completed","No Results Available","Colo-rectal Cancer|Cancer Colon|Cancer, Rectum|Neoplasms,Colorectal|Polyps|Polyp of Colon|Adenoma|Adenoma Colon",,"Diagnosis of colorectal cancer or advanced adenomas in patients undergoing routine screening colonoscopy, or post-colonoscopy","Freenome, Inc.","All","18 Years and older   (Adult, Older Adult)",,"3275","Industry","Observational","Observational Model: Other|Time Perspective: Prospective","AI-EMERGE/FRE-001","January 12, 2018","November 25, 2019","November 25, 2019","September 28, 2018",,"May 1, 2020","Clinical Research Associates, Huntsville, Alabama, United States|Del Sol Research Management, Chandler, Arizona, United States|Del Sol Research Management,, Tucson, Arizona, United States|Del Sol Research Management, Tucson, Arizona, United States|Preferred Research Partners, Little Rock, Arkansas, United States|Precision Research Institute, Chula Vista, California, United States|Diverse Research Solutions, Oxnard, California, United States|Precision Research Institute, San Diego, California, United States|Gastroenterology Associates of Fairfield County, Bridgeport, Connecticut, United States|Palmetto Research, Hialeah, Florida, United States|Clinical Research of Homestead, Homestead, Florida, United States|Advanced Gastroenterology Associates, LLC, Palm Harbor, Florida, United States|Rockford Gastroenterology, Rockford, Illinois, United States|Delta Research Partners, Bastrop, Louisiana, United States|New Orleans Research Institute, Metairie, Louisiana, United States|Louisiana Research Center, Shreveport, Louisiana, United States|Commonwealth Clinical Studies, Brockton, Massachusetts, United States|Quality Clinical Research, Omaha, Nebraska, United States|Asheville Gastroenterology Associates, Asheville, North Carolina, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Cumberland Research Associates, Fayetteville, North Carolina, United States|Wake Research Associates, Raleigh, North Carolina, United States|Trial Management Associates, Wilmington, North Carolina, United States|The Jackson Clinic, Jackson, Tennessee, United States|Advanced Research Institute, Ogden, Utah, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|Verity Research Inc, Fairfax, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Washington Gastroenterology, Bellevue, Washington, United States|Forzani and MacPhail Colon Cancer Screening Centre, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT03688906"
158,"NCT04416425","Hemodynamic Change of Coronary Atherosclerotic Plaque After Evolocumab Treatment",,"Not yet recruiting","No Results Available","Atherosclerosis",,"the change of lesion-specific CT-FFR","Zibo Central Hospital","All","18 Years to 85 Years   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ZiboCH","June 10, 2020","December 31, 2021","February 27, 2022","June 4, 2020",,"June 5, 2020",,,"https://ClinicalTrials.gov/show/NCT04416425"
159,"NCT04306172","Validation of EPIC's Readmission Risk Model, the LACE+ Index and SQLape as Predictors of Unplanned Hospital Readmissions",,"Recruiting","No Results Available","Hospital Readmission","Other: An US Readmission Risk Prediction Model|Other: LACE+ score|Other: SQLAPE model","Discrimination at 18 days|Discrimination at 30 days|Calibration at 18 days|Calibration at 30 days|Overall Performance at 18 days|Overall Performance at 30 days|Clinical usefulness (NRI) at 18 days|Clinical usefulness (NRI) at 30 days|Clinical usefulness (NB) at 18 days|Clinical usefulness (NB) at 30 days","Luzerner Kantonsspital|University of Lucerne","All","1 Year to 100 Years   (Child, Adult, Older Adult)",,"40000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","LUKS_RRM_2019","March 10, 2020","April 30, 2020","June 30, 2020","March 12, 2020",,"April 9, 2020","Cantonal Hospital of Lucerne, Lucerne, Canton Lucerne, Switzerland","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/72/NCT04306172/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04306172"
160,"NCT04321200","PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability",,"Not yet recruiting","No Results Available","Pediatric ALL|Infant Development|Neurodevelopmental Disorders","Diagnostic Test: PANDA Gym|Other: Mobile App","Prechtl's General Movements Assessment (GMA)|The Test of Infant Motor Performance (TIMP)|Alberta Infant Motor Scale (AIMS)|Hammersmith Infant Neurological Examination (HINE)","University of Pennsylvania|Children's Hospital of Philadelphia","All","up to 6 Months   (Child)",,"1700","Other","Observational","Observational Model: Other|Time Perspective: Prospective","833180","August 1, 2020","August 1, 2023","July 1, 2024","March 25, 2020",,"March 25, 2020",,,"https://ClinicalTrials.gov/show/NCT04321200"
161,"NCT03175302","PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing","PRECEDE","Recruiting","No Results Available","Cognitive Dysfunction","Behavioral: digital cognitive testing","Control and pre-surgery differences between digital behaviors|Predictive validity of digital behaviors on outcome|Change over time in digital behavior between groups","University of Florida|National Institute on Aging (NIA)","All","65 Years and older   (Older Adult)",,"25240","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Other","IRB201700747-N|R01AG055337|OCR18881","June 28, 2018","August 1, 2021","May 2022","June 5, 2017",,"July 25, 2019","UF Health, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03175302"
162,"NCT04354623","Developing a Falls Prediction Tool Using Both Accelerometer and Video Gait Analysis Data in Older Adults","APDM system","Not yet recruiting","No Results Available","Fall Injury Prevention","Other: A 6-minute walk test","Classification of accuracy of the algorithm on the validation dataset","University of British Columbia","All","65 Years and older   (Older Adult)",,"100","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","H19-03094","June 1, 2020","May 31, 2021","August 1, 2021","April 21, 2020",,"April 21, 2020","Vancouver Coastal Health Research Institute, VGH Research Pavilion Room 186, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT04354623"
163,"NCT01699243","Continuous Noninvasive Method for Estimating and Predicting Maternal and Fetal Hemodynamic Changes During Regional Anesthesia",,"Enrolling by invitation","No Results Available","Pregnancy|Anesthesia",,"effective intravascular volume loss during maternal regional anesthesia","University of Colorado, Denver","Female","14 Years to 44 Years   (Child, Adult)",,"19","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","12-0990","September 2012","June 2020","June 2020","October 3, 2012",,"October 8, 2019","Children's Hospital Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT01699243"
164,"NCT01700465","Estimating and Predicting Hemodynamic Changes During Hemodialysis",,"Completed","No Results Available","Hemodialysis",,"Acute intravascular volume loss during hemodialysis","University of Colorado, Denver","All","2 Years to 89 Years   (Child, Adult, Older Adult)",,"241","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","11-1437","September 2012","December 2016","December 2016","October 4, 2012",,"December 5, 2016","Fresenius Medical Center East Denver, Aurora, Colorado, United States|Children's Hospital Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Fresenius Medical Center Central, Denver, Colorado, United States|Fresenius Medical Center Rocky Mountain, Denver, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT01700465"
165,"NCT03037710","Link-HF, Phase II: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation","LINK-HF","Completed","No Results Available","Cardiac Failure","Device: HealthPatch","Detection of Heart Failure Exacerbation Event","Josef Stehlik|University of Utah","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","81833","June 2015","January 26, 2017","January 26, 2017","January 31, 2017",,"January 9, 2018","Palo Alto VA Health Care System, Palo Alto, California, United States|Malcom Randall VA Medical Center, Gainesville, Florida, United States|Michael E. DeBakey VA Medical Center, Houston, Texas, United States|George E Wahlen Medical Center, Salt Lake City, Utah, United States",,"https://ClinicalTrials.gov/show/NCT03037710"
166,"NCT03659526","Quantitative Stress Echocardiography to Diagnose Myocardial Ischaemia","DEVISE","Recruiting","No Results Available","Ischemia, Myocardial","Diagnostic Test: Deformation imaging","Diagnostic accuracy of quantitative measures of dobutamine stress echocardiography|Lowest dose of dobutamine to provoke measurable marker of inducible myocardial ischaemia|Diagnostic accuracy of using machine learning to interpret multiparametric and multidimensional datasets to diagnose myocardial ischaemia","University Hospital of Wales|Leuven University|Universitat Pompeu Fabra|Hull University Teaching Hospitals NHS Trust|Danderyd Hospital","All","20 Years to 89 Years   (Adult, Older Adult)",,"390","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRAS Project ID 136434","January 21, 2016","October 31, 2020","October 31, 2021","September 6, 2018",,"September 6, 2018","UZ Leuven, Leuven, Belgium|Danderyd Hospital, Stockholm, Sweden|University Hospital Wales, Cardiff, United Kingdom|Castle Hill Hospital, Cottingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03659526"
167,"NCT03452774","SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry",,"Recruiting","No Results Available","Cancer, Metastatic|Cancer|Cancer of Pancreas|Cancer of Liver|Cancer of Stomach|Cancer Liver|Cancer of Rectum|Cancer of Kidney|Cancer of Esophagus|Cancer of Cervix|Cancer of Colon|Cancer of Larynx|Cancer, Lung|Cancer, Breast|Cancer, Advanced|Cancer Prostate|Cancer of Neck|Cancer of Skin|Neuroendocrine Tumors|Carcinoma|Mismatch Repair Deficiency|BRCA Gene Rearrangement|Non Hodgkin Lymphoma|Leukemia|Non Small Cell Lung Cancer|Cholangiocarcinoma|Glioblastoma|Central Nervous System Tumor|Melanoma|Urothelial Carcinoma|Bladder Cancer|Ovarian Cancer|Endometrial Cancer|Testicular Cancer|Breast Cancer|COVID","Other: Clinical Trial Matching","Proportion of patients Eligible for CTE versus Actual CTE|Impact of CTE on Overall Survival (OS), estimated by Kaplan-Meier and Cox multivariable survival analysis|Impact of CTE on Progression-Free Survival (PFS), estimated by Kaplan-Meier and Cox multivariable survival analysis|Identification of Barriers to CTE|Real World Data Analytics|Virtual Tumor Board Utilization|Time from Intervention to Actual CTE (months)","Massive Bio, Inc.","All","Child, Adult, Older Adult",,"1500","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","SYNERGY-AI","January 1, 2018","December 2021","December 2022","March 2, 2018",,"April 28, 2020","Massive Bio, Inc, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03452774"
168,"NCT04074577","Computer Aided Detection, Tandem Colonoscopy Study",,"Not yet recruiting","No Results Available","Colonic Diseases","Diagnostic Test: Standard technique First|Diagnostic Test: combination technique First","Number of adenomas detected in combination technique compared to adenomas detected in standard technique Measured by Adenoma Miss Rate (AMR)","NYU Langone Health","All","22 Years and older   (Adult, Older Adult)","Not Applicable","196","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","19-00801","September 2019","September 2020","September 2020","August 30, 2019",,"August 30, 2019","NYU Langone Health, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04074577"
169,"NCT03788811","ERG Components in Schizophrenia and Bipolar Disorder Type I",,"Recruiting","No Results Available","Schizophrenia|Bipolar I Disorder","Device: ERG assessment (RSPA)","Differences in ERG components vs control ERG with full-field ERG stimulation conditions.|Differences in ERG components vs control ERG with Photopic Negative Response (PhNR) ERG stimulation conditions.|Differences in ERG components vs control ERG with On-Off ERG stimulation conditions.","diaMentis Inc.","All","18 Years to 50 Years   (Adult)",,"300","Industry","Observational","Observational Model: Case-Control|Time Perspective: Prospective","dM/CL-01","July 5, 2018","December 31, 2020","December 31, 2020","December 28, 2018",,"March 6, 2020","McLean Hospital, Belmont, Massachusetts, United States|Rutgers University Behavioral HealthCare, Piscataway, New Jersey, United States|Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada|Institut Universitaire en Santé Mentale de Montréal, Montréal, Quebec, Canada|Douglas Mental Health University Institute, Montréal, Quebec, Canada|Douglas Mental Health University Institute, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT03788811"
170,"NCT03946618","Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy",,"Recruiting","No Results Available","Epilepsy","Device: Medtronic Summit System, Olympus","Adverse events (AE) experienced with the RC+S system|24/7 continuous iEEG monitoring|Change in mood|Change in anxiety|Tracking cognition","Mayo Clinic|National Institute of Neurological Disorders and Stroke (NINDS)|Medtronic","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1","10","Other|NIH|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18-005483|UH2NS095495-03","July 10, 2019","April 30, 2022","December 31, 2022","May 10, 2019",,"December 18, 2019","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03946618"
171,"NCT03845699","Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose",,"Recruiting","No Results Available","Drug Overdose|Opioid-Related Disorders","Device: Diagnostic algorithms that detects/predicts hypoventilation","Percent Sensitivity and Specificity of Detecting/Predicting the Onset of Mild Hypoventilation due to an Opioid Overdose|Percent Sensitivity and Specificity of Detecting/Predicting the Onset of Moderate Hypoventilation due to an Opioid Overdose|Percent Sensitivity and Specificity of Detecting/Predicting the Onset of Severe Hypoventilation due to an Opioid Overdose|Absolute Difference Between Trachea Sound Sensor's Measurements and Reference Sensor Measurements","RTM Vital Signs, LLC|Thomas Jefferson University","All","18 Years to 40 Years   (Adult)",,"20","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","20183438,18C.7","May 15, 2019","May 14, 2020","May 14, 2020","February 19, 2019",,"May 9, 2019","Thomas Jefferson University, Philadelphia, Pennsylvania, United States","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/99/NCT03845699/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT03845699"
172,"NCT04255615","Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes","AI in ART","Suspended","No Results Available","Infertility|in Vitro Fertilization (IVF)|ART","Other: AI to analyze 3 D ultrasound","Number of baseline antral follicle count|Number of retrieved oocytes|Number of mature oocytes|Number of multiple gestation|Number of clinical intrauterine pregnancies IVF|Number of clinical intrauterine pregnancies OI","Weill Medical College of Cornell University","All","18 Years to 48 Years   (Adult)","Not Applicable","2000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","19-06020306","February 12, 2020","January 31, 2022","January 31, 2023","February 5, 2020",,"April 2, 2020","Weill Cornell Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04255615"
173,"NCT01448694","Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss",,"Completed","No Results Available","Hemorrhage","Other: No treatment","Algorithm","University of Colorado, Denver|United States Department of Defense","All","18 Years to 89 Years   (Adult, Older Adult)",,"320","Other|U.S. Fed","Observational","Observational Model: Case-Only|Time Perspective: Prospective","10-1421","November 2011","October 2013","September 2014","October 7, 2011",,"December 3, 2014","Children's Hospital Colorado, Aurora, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT01448694"
174,"NCT03305380","Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth",,"Recruiting","No Results Available","Stage IV Non-small Cell Lung Cancer","Other: No interventions","Cause of pneumonitis|Predictive accuracy of radiomics for determining the cause of pneumonitis","Maastricht Radiation Oncology|Maastricht University Medical Center|Zuyderland Medical Centre","All","18 Years and older   (Adult, Older Adult)",,"380","Other","Observational","Observational Model: Other|Time Perspective: Other","BMS Radiomics","September 1, 2017","December 1, 2020","December 1, 2020","October 10, 2017",,"January 18, 2020","Zuyderland Medical Center, Heerlen, Netherlands|MUMC+, Maastricht, Netherlands",,"https://ClinicalTrials.gov/show/NCT03305380"
175,"NCT03352648","CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry (DERIVATE)","DERIVATE","Enrolling by invitation","No Results Available","Heart Failure|Left Ventricular Systolic Dysfunction",,"all-cause mortality|sudden cardiac death (SCD)|aborted sudden cardiac death (SCD)|heart failure (HF) death|sustained ventricular tachycardia (VT)|major adverse cardiac events (MACE)","Gianluca Pontone, MD, PhD|University of Lausanne Hospitals|Centro Cardiologico Monzino","All","Child, Adult, Older Adult",,"4000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","R659/17-CCM698","January 2007","August 2019","December 2020","November 24, 2017",,"June 6, 2019","Loyola University of Chicago,, Chicago, Illinois, United States|Medical University of South Carolina, Charleston, South Carolina, United States|KU Leuven-University of Leuven, Leuven, Belgium|St.Luke's Hospital Thessaloniki, Thessaloníki, Greece|Ospedale Medico-Chirurgico Accreditato Villa dei Fiori, Acerra, Italy|University Hospital Policlinico Consorziale, Bari, Italy|Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy|A.O. Desio e Vimercate - P.O. Desio, Desio, Italy|Ospedali Riuniti University Hospital, Foggia, Italy|University of Messina, Messina, Italy|IRCCS Policlinico San Donato,, Milano, Italy|Vita-Salute San Raffaele University, Milano, Italy|Centro Cardiologico Monzino, IRCCS, Milano, Italy|IRCCS Istituto Auxologico Italiano, Milano, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy|University of Padua, Padua, Italy|Azienda Ospedaliero-Universitaria di Parma, Parma, Italy|Policlinico San Matteo Pavia Fondazione IRCCS, Pavia, Italy|Fondazione G. Monasterio CNR, Regione Toscana, Pisa, Italy|Azienda Unità Sanitaria Locale di Rimini - Regione Emilia Romagna, Rimini, Italy|Casilino Polyclinic, Roma, Italy|Vannini Hospital Rome, Roma, Italy|Sapienza University of Rome, Rome, Italy|Humanitas Research Hospital, Hospital Care and Research Institution, IRCCS,, Rozzano, Italy|University of Siena, Siena, Italy|Lausanne University Hospital-CHUV, Lausanne, Switzerland|Bristol Heart Institute, Bristol, United Kingdom|King's College London, London, United Kingdom|The Heart Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03352648"
176,"NCT03857438","Correlation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania",,"Completed","No Results Available","Bipolar Disorder, Manic|Artificial Intelligence|Neurocognition|Treatment Resistant Disorders|Affective Computing|Multi- Modal Analysis","Drug: Ongoing treatment for bipolar mania|Diagnostic Test: Audiovisual recording during guided presentation","Treatment response|Changes in visual features|Changes in audio features|in Stop Signal Test|Changes in Rapid Visual Processing|in Cambridge Gambling Task|Changes in Emotion Recognition Test","Istanbul Saglik Bilimleri University|Namik Kemal University|Bosphorus University","All","18 Years to 65 Years   (Adult, Older Adult)",,"89","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","BipolarAI","September 30, 2016","February 20, 2017","July 8, 2017","February 28, 2019",,"February 28, 2019","SBU Erenkoy Mental State Hospital, Istanbul, Turkey","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/38/NCT03857438/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/38/NCT03857438/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT03857438"
177,"NCT03916562","Optimization Principles in Hemiparetic Gait",,"Recruiting","No Results Available","Stroke","Behavioral: Manipulation of spatiotemporal coordination during walking","Oxygen consumption (VO2)|Correlation between oxygen consumption (VO2) and step length asymmetry|Angular momentum during walking|Correlation between angular momentum and step length asymmetry during walking","University of Southern California|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","21 Years and older   (Adult, Older Adult)","Not Applicable","108","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HS-18-00533|R01HD091184","November 13, 2018","May 31, 2022","May 31, 2022","April 16, 2019",,"April 16, 2019","University of Southern California, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT03916562"
178,"NCT03286491","Clinical Decision Support System to Define 30 Day Adverse Clinical Events for Emergency Department Acute Coronary Syndromes",,"Unknown status","No Results Available","Acute Coronary Syndrome|Clinical Decision Support System","Diagnostic Test: Further cardiac imaging","Non fatal myocardial infarction, cardiac related death or coronary intervention in 30 days","Turkish Ministry of Health Izmir Teaching Hospital","All","18 Years and older   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","TurkishMOHITH","August 12, 2017","December 12, 2017","February 1, 2018","September 18, 2017",,"September 18, 2017","Izmir Bozyaka Training and Research Hospital, Izmir, Turkey",,"https://ClinicalTrials.gov/show/NCT03286491"
179,"NCT03647618","Anatomy Guidance for Regional Anaesthesia",,"Recruiting","No Results Available","Ultrasound Imaging","Other: Ultrasound","Phase 1 Outcome Measures: - Training/Verification •|Phase II Validation Outcome Measures - Validation","Medaphor Limited","All","18 Years and older   (Adult, Older Adult)",,"200","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","ML2018_AG_02","December 20, 2018","April 1, 2020","April 1, 2020","August 27, 2018",,"January 14, 2020","St Woolos Hospital, Newport, Wales, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03647618"
180,"NCT03837327","Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy","VOCAL","Recruiting","No Results Available","Adnexal Mass|Ovarian Cancer|Pelvic Mass",,"To determine the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the VOCAL test|To evaluate the association of protein and glycoprotein (GP) biomarkers with histological subtypes, stage, treatments and disease free survival (DFS) among woman with ovarian cancer","Venn Biosciences Corporation","Female","18 Years and older   (Adult, Older Adult)",,"1200","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","OVACA-001","April 16, 2019","April 2021","April 2021","February 12, 2019",,"November 22, 2019","Palo Alto Medical Foundation, Sunnyvale, California, United States|Mayo Clinic, Jacksonville, Florida, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Dr. Sudarshan K. Sharma, Ltd. - Gynecologic Oncology, Hinsdale, Illinois, United States|Hospital Sultan Ismail, Johor Bahru, Johor, Malaysia|Hospital Seberang Jaya, Seberang Jaya, Penang, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia|Hospital Wanita Dan Kanak-kanak Sabah, Kota Kinabalu, Sabah, Malaysia|The Medical City, Pasig City, Metro Manila, Philippines",,"https://ClinicalTrials.gov/show/NCT03837327"
181,"NCT03956004","The Impact of a Technology-enabled Decision Aid, for Patients With Hip and Knee Osteoarthritis on Decision Quality, Level of Shared Decision-making, Patient Satisfaction and Magnitude of Limitations",,"Recruiting","No Results Available","Osteoarthritis, Knee","Other: OM1 Dell Shared Decision Making Tool|Other: Education material from OM1 Dell Shared Decision Making Tool","Knee Osteoarthritis Decision Quality Instrument|CollaboRATE|Numeric rating scale-satisfaction|Knee injury and osteoarthritis outcome score, joint replacement (KOOS JR)|Undergoing joint replacement surgery or not|Average time of patient visit and average time spent with provider","University of Texas at Austin","All","45 Years to 89 Years   (Adult, Older Adult)","Not Applicable","250","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","2018-11-0042","March 28, 2019","June 2020","June 2020","May 20, 2019",,"May 20, 2019","UT Health Austin, Austin, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03956004"
182,"NCT03905668","Intelligent ICU of the Future",,"Recruiting","No Results Available","Pain|Delirium","Other: Video Monitoring|Other: Accelerometer Monitoring|Other: Electromyographic Monitoring|Other: Noise Level Monitoring|Other: Light Level Monitoring","Defense Veterans Pain Reporting Scale (DVPRS)","University of Florida|National Institute for Biomedical Imaging and Bioengineering (NIBIB)|U.S. National Science Foundation","All","18 Years to 100 Years   (Adult, Older Adult)",,"1000","Other|NIH|U.S. Fed","Observational","Observational Model: Case-Only|Time Perspective: Prospective","IRB201900354 -N|1R21EB027344-01|1750192|OCR20330","November 25, 2019","March 2022","March 2022","April 5, 2019",,"December 5, 2019","UF Health Shands Hospital, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03905668"
183,"NCT03923699","Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety","TECTONICS","Recruiting","No Results Available","Surgery|Surgery--Complications|Perioperative/Postoperative Complications","Device: Anesthesia Control Tower monitoring","Number of Participants with clinically relevant adverse perioperative outcomes.|Thirty-day postoperative mortality|Postoperative delirium|Postoperative respiratory failure|Postoperative acute kidney injury","Washington University School of Medicine|National Institute of Nursing Research (NINR)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40000","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","201903026|R01NR017916","July 1, 2019","July 2024","July 2024","April 23, 2019",,"June 23, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT03923699"
184,"NCT03253432","IN-TANDEM Familial Hypercholesterolemia Pilot Study",,"Completed","No Results Available","Familial Hypercholesterolemia","Other: Genetic testing","Likelihood of having FH-causing mutation","University of Pennsylvania|The Familial Hypercholesterolemia Foundation|Lancaster General Hospital","All","18 Years and older   (Adult, Older Adult)",,"378","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","826438","July 20, 2017","November 7, 2018","November 7, 2018","August 17, 2017",,"February 28, 2019","Lancaster General Hospital, Lancaster, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03253432"
185,"NCT01668979","Assessment of a New System to Detect, Quantify and Treat Near Falls in Older Adults",,"Unknown status","No Results Available","Idiopathic Fallers","Device: new system to detect Near Falls","usability of the system to detect Near Falls|Near Fall severity","Tel-Aviv Sourasky Medical Center","All","60 Years to 85 Years   (Adult, Older Adult)",,"20","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","TASMC-12-NG-0363-CTIL","September 2012","September 2013","September 2013","August 20, 2012",,"August 20, 2012","Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT01668979"
186,"NCT03414853","Free Text Prediction Algorithm for Appendicitis",,"Active, not recruiting","No Results Available","Acute Appendicitis|Abdominal Pain","Diagnostic Test: Free text prediction algorithm for appendicitis","Accuracy of predictive algorithm for acute appendicitis","National University Hospital, Singapore","All","21 Years to 99 Years   (Adult, Older Adult)",,"689","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","N-171-000-456-001","December 4, 2017","July 1, 2019","July 1, 2020","January 30, 2018",,"March 13, 2020","National University Hospital, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT03414853"
187,"NCT03406455","Telemedicine in Total Knee Arthroplasty Using Wearable Technology",,"Completed","No Results Available","Knee Arthritis",,"Acceptability|Step Count in steps per day|Maximum knee range of motion in degrees|Patient Reported Outcome Measures (linear numeric scale from 0 to 28)|Home Exercise Plan compliance","The Cleveland Clinic","All","60 Years to 80 Years   (Adult, Older Adult)",,"25","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ClevelandCF02","July 2, 2018","May 15, 2019","May 15, 2019","January 23, 2018",,"July 24, 2019","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03406455"
188,"NCT03858699","Brain Vital Signs M-Score: Point-of-care Monitoring for Motor Recovery After Stroke",,"Recruiting","No Results Available","Stroke","Other: Recording of electroencephalographic (EEG) data","Resting state EEG measures|Motor task EEG measures|Imagery task EEG measures|Wolf Motor Function Test|Fugl-Meyer Assessment|Box-and-Block Test|Nine-Hole Peg Test","HealthTech Connex Inc.","All","19 Years to 80 Years   (Adult, Older Adult)",,"60","Industry","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","HTC_MScore_001","April 15, 2019","January 31, 2020","January 31, 2020","March 1, 2019",,"August 9, 2019","HealthTech Connex Centre for Neurology Studies, Surrey, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT03858699"
189,"NCT03845660","Risk EValuation And Its Impact on ClinicAL Decision Making and Outcomes in Heart Failure","REVeAL-HF","Recruiting","No Results Available","Heart Failure","Behavioral: Electronic Alert","All-Cause Mortality|Heart failure Re-hospitalization|Length of stay|Discharge doses of heart failure therapies|Palliative care referral|Advanced therapies referral|Electrophysiology referral|Weight Change","Yale University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","4000","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other","2000025000","January 1, 2020","December 30, 2022","December 30, 2024","February 19, 2019",,"January 21, 2020","Yale New Haven Hospital, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT03845660"
190,"NCT04221100","xrAI - Improving Quality and Efficiency in Chest Radiograph Interpretation by Radiologists",,"Not yet recruiting","No Results Available","Pulmonary Disease","Device: Radiograph interpretation for pulmonary abnormalities","Number of abnormalities identified divided by number of total of images analyzed (accuracy)|Number of true abnormalities identified divided by the total of abnormalities identified (precision)|Number of true abnormalities identified divided by the sum of true abnormalities identified and abnormalities missed (recall)|Mean of radiologist accuracy (as defined in outcome 1)|Mean of radiologist precision (as defined in outcome 2)|Mean of radiologist recall (as defined in outcome 3)","1QB Information Technologies Inc.","All","Child, Adult, Older Adult","Not Applicable","12","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","xrAI ClinicalEvaluation Rads","March 2020","May 2020","May 2020","January 9, 2020",,"January 9, 2020",,,"https://ClinicalTrials.gov/show/NCT04221100"
191,"NCT02009150","Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment in Women at High Risk for Breast Cancer.",,"Active, not recruiting","No Results Available","Breast Cancer",,"Diagnostic accuracy of 3D MIRA as a breast imaging aid in women with a high risk of breast cancer|To test whether repetitive screening with 3D MIRA technology can provide information on the likelihood of developing breast cancer.","Real Imaging Ltd.","Female","20 Years and older   (Adult, Older Adult)",,"236","Industry","Observational","Observational Model: Case-Only|Time Perspective: Prospective","960-CSP-ISR_HighRiskMC_ILS1","April 2014","July 2017","October 2018","December 11, 2013",,"September 5, 2018","The Chaim Sheba Medical Center at Tel-Hashomer, Ramat-Gan, Israel",,"https://ClinicalTrials.gov/show/NCT02009150"
192,"NCT02155075","Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System",,"Unknown status","No Results Available","Breast Cancer","Device: MIRA device imaging","Sufficient number of cancer case and controls have been imaged","Real Imaging Ltd.","Female","30 Years and older   (Adult, Older Adult)","Not Applicable","730","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","960-CSP-ISR_ImplantsMC_ILS3","January 2015","October 2019","October 2019","June 4, 2014",,"June 19, 2018","The Chaim Sheba Medical Center at Tel Hashomer, Ramat-Gan, Israel",,"https://ClinicalTrials.gov/show/NCT02155075"
193,"NCT04153045","xrAI - Improving Quality and Efficiency in Chest Radiograph Interpretation",,"Not yet recruiting","No Results Available","Pulmonary Disease","Device: Radiograph interpretation for pulmonary abnormalities","Number of abnormalities identified divided by number of total of images analyzed (accuracy)|Number of true abnormalities identified divided by the total of abnormalities identified (precision)|Number of true abnormalities identified divided by the sum of true abnormalities identified and abnormalities missed (recall)|Mean of physician accuracy (as defined in outcome 1)|Mean of physician precision (as defined in outcome 2)|Mean of physician recall (as defined in outcome 3)","1QB Information Technologies Inc.|Saskatchewan Health Authority - Regina Area","All","Child, Adult, Older Adult","Not Applicable","36","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","xrAI ClinicalEvaluation Stage1","February 1, 2020","March 1, 2020","March 1, 2020","November 6, 2019",,"January 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04153045"
194,"NCT02910193","Alcohol Addiction: A Systems-oriented Approach","eMedAlcohol","Completed","No Results Available","Alcoholism",,"Functional brain imaging assessed using a Siemens Magnetom TimTrio, 3 Tesla|Structural brain imaging assessed using a Siemens Magnetom TimTrio, 3 Tesla|Assessment of genetic candidate markers and epigenetic markers of alcohol use disorders","Charite University, Berlin, Germany|Central Institute of Mental Health, Mannheim","All","18 Years to 75 Years   (Adult, Older Adult)",,"159","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","01ZX1311E","May 17, 2016","May 27, 2019","May 27, 2019","September 21, 2016",,"July 31, 2019","Charite - Universitätsmedizin Berlin, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT02910193"
195,"NCT04425941","Polyp Artificial Intelligence Study",,"Completed","No Results Available","Software Analysis on Polyp Histology Prediction","Other: artificial intelligence diagnosis","Software accuracy of polyp histology prediction","Petz Aladar County Teaching Hospital","All","18 Years to 90 Years   (Adult, Older Adult)",,"373","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PetzACTHospital","January 5, 2014","May 31, 2020","May 31, 2020","June 11, 2020",,"June 11, 2020",,,"https://ClinicalTrials.gov/show/NCT04425941"
196,"NCT03957343","The Parkwood Pacing and Planning™ App",,"Not yet recruiting","No Results Available","Acquired Brain Injury","Device: Pacing and Planning App","Symptom changes|Changes in general well-being|Change in daily activities and symptoms","Lawson Health Research Institute|St. Joseph's Health Care (SJHC) Foundation|Cowan Foundation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","113428","January 1, 2020","December 2022","December 2022","May 21, 2019",,"October 30, 2019",,,"https://ClinicalTrials.gov/show/NCT03957343"
197,"NCT04397380","COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study","COVID3T","Not yet recruiting","No Results Available","Pyrexia|COVID","Device: Thermography|Device: Tympanic Temperature","Temperature","NHS Greater Clyde and Glasgow","All","16 Years and older   (Child, Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","INGC20AE209","May 20, 2020","June 3, 2020","July 1, 2020","May 21, 2020",,"May 22, 2020","Queen Elizabeth University Hospital, Glasgow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04397380"
198,"NCT03495180","Quantitative SSEP and EEG as Objective Pain Biomarker",,"Active, not recruiting","No Results Available","Pain","Other: Standard EEG or SSEP","Correlation of (electrical) pain intensity (X) and amplitude of SSEP (Y).","University of Alabama at Birmingham","All","19 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","67890123","May 22, 2018","November 14, 2019","November 1, 2020","April 11, 2018",,"December 4, 2019","University of Alabama at Birmingham, Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT03495180"
199,"NCT03991637","Non-Invasive Blood Test Cross-Validation Study",,"Completed","No Results Available","Reproducibility of Results|Safety Issues","Device: Non-Invasive Comprehensive Metabolic Panel","Performance of Non-Invasive Comprehensive Metabolic Panel","Joseph Allen Jr.|University of North Dakota|Concord Medical Technology Corporation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","IRB-201807-004","July 18, 2018","September 11, 2018","March 1, 2019","June 19, 2019",,"June 24, 2019","Altru Health System, Grand Forks, North Dakota, United States",,"https://ClinicalTrials.gov/show/NCT03991637"
200,"NCT04309851","A Deep Learning Approach to Submerged Teeth Classification and Detection",,"Completed","No Results Available","Artificial Intelligence|Submerging Tooth","Diagnostic Test: deep learning","Submerged Tooth Detection","Eskisehir Osmangazi University","All","5 Years to 12 Years   (Child)",,"74","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","E86412-49","January 1, 2019","January 1, 2020","March 1, 2020","March 16, 2020",,"March 16, 2020","Seçil Çalışkan, Eskisehir, Turkey",,"https://ClinicalTrials.gov/show/NCT04309851"
201,"NCT04287166","Early Remote At-risk Diagnosis for Cerebral Palsy in Follow-up Clinics for High-risk Infants",,"Not yet recruiting","No Results Available","Cerebral Palsy",,"Scorable video for remote GMA|Correlation of computer software data between standard video set-up and handheld smartphone video.|Predictability of GMA and computer-based assessment for development of CP","St. Olavs Hospital|Alesund Hospital|Levanger Hospital","All","up to 2 Months   (Child)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","REK 62240","August 1, 2020","January 2025","January 2025","February 27, 2020",,"February 27, 2020","Department of Pediatrics, Nord-Trøndelag Hospital Trust, Levanger, Norway|Department of Pediatrics, St. Olav's Hospital Trust, Trondheim, Norway|Department of Pediatrics, Møre and Romsdal Hospital Trust, Ålesund, Norway",,"https://ClinicalTrials.gov/show/NCT04287166"
202,"NCT04409340","Viscoelasticity Imaging to Assess Liver Cancer","VisCan","Not yet recruiting","No Results Available","Liver Cancer","Device: Magnetic Resonance Viscoelastography|Device: QUS","Liver viscoelastography determined by MRI|Liver viscoelastography determined by QUS|Detection of focal HCC lesions","Centre hospitalier de l'Université de Montréal (CHUM)|Siemens Corporation, Corporate Technology|Fonds de recherche du Québec - Santé (FRQS)|Onco-Tech|Centre de Recherche du Centre Hospitalier de l'Université de Montréal","All","18 Years to 90 Years   (Adult, Older Adult)",,"200","Other|Industry","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","2020-8561","July 2020","July 2021","September 2022","June 1, 2020",,"June 5, 2020","Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT04409340"
203,"NCT02505698","A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment",,"Withdrawn","No Results Available","Breast Cancer",,"Sufficient number of cancer case and controls have been imaged","Real Imaging Ltd.","Female","30 Years to 80 Years   (Adult, Older Adult)",,"0","Industry","Observational","Observational Model: Case-Control|Time Perspective: Prospective","960-CLP-ISR-IR8","October 2015","October 2015","October 2015","July 22, 2015",,"April 11, 2018","The Breast Iamging Unit, Tel aviv, Israel",,"https://ClinicalTrials.gov/show/NCT02505698"
204,"NCT04464863","Kinematic Analysis in Stroke Patients Using Microsoft Kinect and Akira Software: Kinect-Akira Movement Study","KAM","Recruiting","No Results Available","Stroke","Other: Kinematic metrics","Kinematic metrics: join angles|Kinematic metrics: movement acceleration|Kinematic metrics: movement pattern|Relationship of kinematic measures with the degree of disability after stroke.","Instituto de Investigación Hospital Universitario La Paz","All","18 Years and older   (Adult, Older Adult)",,"140","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","KAM-Study (PI-3787)","January 29, 2020","January 29, 2021","June 29, 2021","July 9, 2020",,"July 9, 2020","La Paz University Hospital, IdiPAZ, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT04464863"
205,"NCT04136470","BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics",,"Recruiting","No Results Available","Non Small Cell Lung Cancer|Microbiome|Metagenome|Immunotherapy|Melanoma","Biological: Collection of stool, blood (PBMC) and biopsy (FFPE)","Microbial diversity in stool samples|Number of Responders and Non-responders on immunotherapy (evaluated using RECIST 1.1 criteria)","Ardigen|The National Centre for Research and Development","All","18 Years and older   (Adult, Older Adult)",,"130","Industry|Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","BioForte|POIR.01.01.01-00-0347/17","April 1, 2019","September 30, 2020","March 31, 2021","October 23, 2019",,"June 9, 2020","University Clinical Centre in Gdansk, Gdańsk, Poland|The John Paul II Hospital in Krakow, Kraków, Poland|The Maria Sklodowska-Curie National Research Institute of Oncology Krakow Branch, Kraków, Poland|Poznań University Hospital of Lord's Transfiguration, Poznań, Poland|Provincial Hospital St. Father Pio in Przemyśl, Przemyśl, Poland|Mountains Center of Pulmonology and Chemotherapy ""Izer-Med"", Szklarska Poręba, Poland|The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw, Poland|Masovian Oncology Hospital in Wieliszew, Wieliszew, Poland|Lower Silesian Oncology Center & Łukasiewicz Research Network - PORT Polish Center For Technology Development, Wrocław, Poland",,"https://ClinicalTrials.gov/show/NCT04136470"
206,"NCT03832192","Care.Coach Avatars for Improvement of Outcomes in Hospitalized Elders, Including Mitigation of Falls and Delirium: a Multi-Site Clinical Study","AvatarHELP","Recruiting","No Results Available","Delirium|Fall Injury","Behavioral: care.coach Avatar (HELP-Protocolized)","Incident Delirium|Falls|Delirium Resolution|Change in Delirium Severity|Patient Sitter Utilization|Change in Cognitive Function|Falls with Injury","Victor Wang|National Institute of Nursing Research (NINR)|Pace University|care.coach corporation","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","2400","Industry|NIH|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","1R44NR017842-02","January 8, 2019","January 7, 2021","January 7, 2021","February 6, 2019",,"November 25, 2019","Jamaica Hospital Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03832192"
207,"NCT02747940","Neurologic Signatures of Chronic Pain Disorders",,"Unknown status","No Results Available","Chronic Pain|Chronic Migraine|Fibromyalgia","Drug: flunarizine and/or pregabalin","clinical improvement after treatment (1) headache/pain intensity [NRS, numeric rating scale]|clinical improvement after treatment (2) headache/pain frequency [attacks per month]|clinical improvement after treatment (3) headache/pain duration [hours per day]|EEG change after treatment|sensory and pain threshold change after treatment|Autonomic function change after treatment","Taipei Veterans General Hospital, Taiwan|Ministry of Science and Technology, R.O.C.","All","20 Years to 70 Years   (Adult, Older Adult)","Phase 4","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015-10-001BC2015-11-001AC002B","December 2015","December 2019",,"April 22, 2016",,"April 22, 2016","Headache Center, Teipei Veterans General Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT02747940"
208,"NCT03955614","Intelligent Operating Room","inOr","Recruiting","No Results Available","Surgery","Other: pedal-controlled GoSurgeryTM|Other: ML-controlled GoSurgeryTM|Other: NoGo","Does GosurgeryTM affect teamwork?|Does GoSurgeryTM affect surgical training overtime?|Does GoSurgeryTM affect delays in the operating theatre?|Does GoSUrgeryTM affect mental demand overtime when operating?|Does GoSurgeryTM affect operative timings?|Does GoSurgeryTM affect patient outcomes (the presence of complications )?|Does GoSurgeryTM affect patient outcomes (duration of hospital stay)?|How does GosurgeryTM affect team performance?|Evaluation of the Machine Learning algorithm to correctly detect operative steps of the procedures.|Does GoSurgeryTM influence cost of wasted equipment?","Imperial College London","All","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","19SM4984","October 4, 2019","October 2020","October 2020","May 20, 2019",,"October 10, 2019","Imperial College Hospitals NHS Trust, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03955614"
209,"NCT04298866","White Matter Hyperintensities Subtypes in Cerebral Small Vessel Disease : 7 Tesla Ultra-high Resolution Imaging MRI","SV7","Not yet recruiting","No Results Available","Cerebral Small Vessel Diseases","Other: Experimental Arm","Percentage of patients with a different form of white matter hyperintensities (WMH)|Frequency of different WMH subtypes in different types of small cerebral vessel disease|Frequency of large tract involvement|Global cognitive function|Language|Spatial exploration|Spatial memory|Visual memory|Episodic verbal memory|Working memory|Executive function|Attentional Performances status|Depression and Anxiety status|Apathy status|Pulse wave Velocity count","Assistance Publique - Hôpitaux de Paris","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","APHP180445","March 4, 2020","June 4, 2023","June 4, 2023","March 6, 2020",,"March 6, 2020",,,"https://ClinicalTrials.gov/show/NCT04298866"
210,"NCT04357834","WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories","WAVE","Not yet recruiting","No Results Available","COVID|COVID 19|SARS-CoV 2","Other: Equipment with smartwatch throughout hospital stay on the general ward","Diagnostic accuracy of smartwatch data in predicting ICU requirement in COVID-19 contracted inpatients quantified as the area under the receiver operator characteristics curve (AUC ROC > 0.85).|Diagnostic accuracy of routine physiological data in predicting ICU requirement in COVID-19 contracted in-patients quantified as the area under the receiver operator characteristics curve (AUC ROC > 0.85).|Diagnostic accuracy of predicting hospital discharge without ICU admission in COVID-19 contracted in-patients quantified as area under the receiver operator characteristics curve|Change of heart rate from baseline (hospitalization) to ICU admission|Change of heart rate variability from baseline (hospitalization) to ICU admission|Change of skin temperature from baseline (hospitalization) to ICU admission|Change of blood oxygen saturation from baseline (hospitalization) to ICU admission|Change of respiration rate from baseline (hospitalization) to ICU admission|Change of physical activity from baseline (hospitalization) to ICU admission|Change of stress level from baseline (hospitalization) to ICU admission|Change of sleep pattern from baseline (hospitalization) to ICU admission|Change of steps per day from baseline (hospitalization) to ICU admission|Change of systolic blood pressure from baseline (hospitalization) to ICU admission|Change of diastolic blood pressure from baseline (hospitalization) to ICU admission|Change of body temperature from baseline (hospitalization) to ICU admission|Change of oxygen partial pressure (pO2) from baseline (hospitalization) to ICU admission|Change of CO2 partial pressure (pCO2) from baseline (hospitalization) to ICU admission|Change of blood pH from baseline (hospitalization) to ICU admission|Change of bicarbonate from baseline (hospitalization) to ICU admission|Change of base excess from baseline (hospitalization) to ICU admission|Change of oxygen flow rate from baseline (hospitalization) to ICU admission","University Hospital Inselspital, Berne|ETH Zurich","All","18 Years to 120 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","WAVE","May 1, 2020","July 31, 2020","July 31, 2020","April 22, 2020",,"April 24, 2020","Emergency Department, University Hospital Bern, Inselspital, Bern, Switzerland",,"https://ClinicalTrials.gov/show/NCT04357834"
211,"NCT01774708","Predict Near Future Initiation of Bed Exit","BEDEXIT","Unknown status","No Results Available","Sleep","Device: Pressure sensitive pad","Bed Exit|Movement in bed","Atlanta VA Medical Center|National Institute on Aging (NIA)","All","18 Years and older   (Adult, Older Adult)",,"60","U.S. Fed|NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","1R21EB015943-01|0664699330000|R43AG042237-01","December 2012","March 2014","March 2014","January 24, 2013",,"January 7, 2014","Budd Terrace, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT01774708"
212,"NCT03676673","Deciphering the Autism Spectrum Disorder Beyond Genomics",,"Recruiting","No Results Available","Autism Spectrum Disorder","Other: Psychiatric diagnosis","ASD-associated transcriptome profiles","National Taiwan University Hospital","All","3 Years to 20 Years   (Child, Adult)",,"200","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","201801044RINC","August 1, 2018","December 2021","December 2021","September 19, 2018",,"September 19, 2018","National Taiwan Univeristy Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT03676673"
213,"NCT04113733","Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas",,"Enrolling by invitation","No Results Available","Crohn Disease","Other: Sample Collection","The change in cellular composition (i.e., percentage of cell types) between Crohn's disease and control patients as assessed by single-cell RNA sequencing analysis, RNA-fluorescence in situ hybridization, and multiplex immunofluorescence.","Vanderbilt University Medical Center|The Leona M. and Harry B. Helmsley Charitable Trust","All","18 Years and older   (Adult, Older Adult)",,"160","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","191738","December 17, 2019","December 2022","December 2022","October 3, 2019",,"December 23, 2019","Vanderbilt University Medical Center, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT04113733"
214,"NCT03550625","Computer Assisted Selection of Serrated Adenomas and Neoplastic Polyps - a New Clinical DRAft","CASSANDRA I","Unknown status","No Results Available","Polyps|Adenoma Colon|Automatic Judgement|Colonic Neoplasms","Diagnostic Test: Computer program","Assessment of the computer- made optical diagnosis of each colorectal polyp","Technische Universität München","All","18 Years to 99 Years   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","CASSANDRA I","July 15, 2018","December 15, 2018","May 15, 2019","June 8, 2018",,"June 8, 2018",,,"https://ClinicalTrials.gov/show/NCT03550625"
215,"NCT02697578","Artificial Intelligence: a New Alternative to Analyse CKD-MBD in Hemodialysis",,"Completed","No Results Available","Chronic Kidney Disease Mineral and Bone Disorder",,"Change from Baseline Fibroblast growth factor 23 (pg/ml) at 24 months","Maimónides Biomedical Research Institute of Córdoba","All","18 Years to 90 Years   (Adult, Older Adult)",,"197","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PI-0311-2014","February 1, 2016","December 19, 2018","December 19, 2018","March 3, 2016",,"December 21, 2018","Hospital Universitario Reina Sofía, Córdoba, Spain",,"https://ClinicalTrials.gov/show/NCT02697578"
216,"NCT04398563","Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use",,"Active, not recruiting","No Results Available","Heart Failure|Heart Failure With Preserved Ejection Fraction|Heart Failure With Reduced Ejection Fraction",,"Mortality|Readmission|Diagnostic work up according to guidelines|Treatment according to guidelines","University Hospital, Akershus|Novartis","All","18 Years and older   (Adult, Older Adult)",,"14998","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2019/833 (REK)","January 20, 2020","June 2021","December 2023","May 21, 2020",,"May 21, 2020","Akershus University Hospital, Lørenskog, Norway",,"https://ClinicalTrials.gov/show/NCT04398563"
217,"NCT04110756","ChangeGradients: Promoting Adolescent Health Behavior Change",,"Not yet recruiting","No Results Available","Alcohol Drinking|Self Efficacy|Adolescent Behavior|Risk-Taking|Cancer","Behavioral: ChangeGradients","Alcohol use|Self-efficacy: tool developed by Drs Elizabeth Ozer and Dr. Albert Bandura|Quality of Care: Adolescent Report of the Visit (AROV)","University of California, San Francisco|North Carolina State University","All","15 Years to 17 Years   (Child)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","19-28893","October 2020","March 2023","March 2023","October 1, 2019",,"March 25, 2020","University of California, San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT04110756"
218,"NCT04452058","CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC","TOP-RLC","Recruiting","No Results Available","Predictive Cancer Model|Lung Cancer|Preinvasive Adenocarcinoma","Other: Radiomic Algorithm","Pathological subtype|Objective Response Rate (ORR)|Progression-free survival (PFS)|Overall survival (OS)|Clinical Benefit Rate (CBR)","Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Guangdong Provincial People's Hospital","All","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","SYSEC-KY-KS-2019-107","August 1, 2019","December 1, 2021","December 30, 2022","June 30, 2020",,"June 30, 2020","Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China|Zhoushan Lung Cancer Institution, Zhoushan, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04452058"
219,"NCT04002258","Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment",,"Active, not recruiting","No Results Available","Schizophrenia|Antipyretics Toxicity|Prolactin Excess","Drug: Antipsychotic","prolactin level at first 1-month antipsychotic treatment|prolactin level at other time points","Shanghai Mental Health Center","All","14 Years and older   (Child, Adult, Older Adult)",,"10000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","CRC2018DSJ01-2","June 6, 2019","November 2020","December 2020","June 28, 2019",,"January 2, 2020","Shanghai Mental Health Center, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04002258"
220,"NCT03065829","Self-Management Behaviors of Caregivers of the Chronically Critically Ill","ASSIST","Completed","No Results Available","Critical Illness","Behavioral: ASSIST|Behavioral: Attention-Control","Repeated Measures|Change in Active Living Protocol (captured on wearable device)|Change in Daily Diary of Physical Activity (captured on wearable device)|Change in Perceived Stress Scale|Change in PROMIS-29 Scale|Change in Zarits Burden Interview|Change in Health Behaviors Questionnaire|Change in Heart Rate Variability (captured on wearable device)","Case Western Reserve University|National Institutes of Health (NIH)|National Institute of Nursing Research (NINR)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","19","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care","11-15-11|P30NR015326","February 2016","July 31, 2017","July 31, 2017","February 28, 2017",,"July 10, 2018","University Hospitals Case Medical Center, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03065829"
221,"NCT04376736","Home Visits for Patients at Risk for Appointment No-shows","SNAP HOME","Suspended","No Results Available","Utilization, Health Care|Engagement, Patient|No-Show Patients","Other: Home visit","Engagement|Healthcare utilization as assessed by number of hospitalizations","Johns Hopkins University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other","IRB00196142","September 1, 2019","July 1, 2021","July 1, 2022","May 6, 2020",,"May 6, 2020","Johns Hopkins Outpatient Center, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04376736"
222,"NCT04424030","International Consortium for Multimodality Phenotyping in Adults With Non-compaction","NONCOMPACT","Not yet recruiting","No Results Available","Non-Compaction Cardiomyopathy","Diagnostic Test: Echocardiography|Diagnostic Test: Magnetic resonance imaging (MRI)|Diagnostic Test: Computed tomography (CT)","Incidence of hard embolic adverse events|Incidence of hard arrhythmic adverse events|Incidence of hard heart failure related adverse events|Incidence of composite of hard adverse events|Incidence of all embolic adverse events|Incidence of all arrhythmic adverse events|Incidence of all heart failure related adverse events|Incidence of composite of adverse events","Stanford University|The Cleveland Clinic|University of Pennsylvania|Erasmus Medical Center|Seoul National University Hospital","All","18 Years and older   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","56001|SSU00099737","July 1, 2020","April 1, 2025","April 1, 2025","June 9, 2020",,"June 9, 2020",,,"https://ClinicalTrials.gov/show/NCT04424030"
223,"NCT02308306","Predictive Markers of the Effects of Opioid Therapy","ABILITY","Completed","No Results Available","Opioid Analgesic Treatment Response|Chronic Pain",,"Reduction of chronic pain assessed by 0-10 numerical rating scale (NRS) scores|Improvement of health-related quality of life assessed by QLQ-C30 scores|BPI worst pain in the past week|BPI least pain in the past week|BPI current pain in the past week|BPI pain severity in the past week|BPI pain interference score|Improvement score|Concomitant and rescue medication|Adverse events","University of Aarhus","All","18 Years and older   (Adult, Older Adult)",,"62","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ABILITY","October 2014","September 2015","September 2015","December 4, 2014",,"May 12, 2016","KU Leuven and the Leuven Centre for Algology & Pain Management, Leuven, Pellenberg, Belgium|Department of Rheumatology, Aarhus University Hospital, Aarhus C, Denmark|Friklinikken, Give, Denmark|Hospitalet Valdemar, Ringsted, Denmark|Ljubljana University Medical Centre, Department of Anaesthetics and Surgical Intensive Care, Ljubljana, Slovenia",,"https://ClinicalTrials.gov/show/NCT02308306"
224,"NCT03651700","Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia",,"Active, not recruiting","No Results Available","Aphasia","Device: Active TMS|Device: Sham TMS|Behavioral: CILT","Change in WAB-AQ|Change in PNT","H. Branch Coslett|National Institutes of Health (NIH)|National Institute on Deafness and Other Communication Disorders (NIDCD)|University of Pennsylvania","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","83","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","chbdfejh|R01DC016800","March 28, 2019","June 30, 2023","June 30, 2023","August 29, 2018",,"April 21, 2020","University of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03651700"
225,"NCT04174287","Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease",,"Recruiting","No Results Available","Alzheimer's Disease","Drug: F-18-AV45","Amyloid Distribution Among Normal, Prodromal AD and AD Dementia Subjects Measured by Standardized Uptake Value Ratio (SUVR) as Assessed by 18F-AV45 amyloid PET Scan.","Chang Gung Memorial Hospital","All","55 Years to 80 Years   (Adult, Older Adult)","Phase 2","300","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","201801833A0","March 28, 2019","March 27, 2023","September 27, 2023","November 22, 2019",,"November 22, 2019","Chang Gung Memorial Hospital,Linkou, Taoyuan City, Guishan Dist, Taiwan",,"https://ClinicalTrials.gov/show/NCT04174287"
226,"NCT01912118","The Medasense Study",,"Completed","No Results Available","Pain","Drug: Propofol|Drug: Remifentanil","Nociception level index (NoI)|Cardiovascular parameters|Movement|Depth of anesthesia","Leiden University Medical Center|Medasense Biometrics Ltd","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","96","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","NL43511.058.13","July 2013","June 2014","September 2014","July 30, 2013",,"April 6, 2015","Leiden University Medical Center, Leiden, Netherlands",,"https://ClinicalTrials.gov/show/NCT01912118"
227,"NCT03905226","Development of a Predictive Algorithm for the Risk of Rehospitalization of Patients With Heart Failure",,"Active, not recruiting","No Results Available","Heart Failure",,"Number of readmissions","Groupe Hospitalier Paris Saint Joseph","All","18 Years and older   (Adult, Older Adult)",,"1600","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","PREDIC","January 12, 2019","December 31, 2019","March 30, 2020","April 5, 2019",,"April 5, 2019","Groupe Hospitalier Paris Saint-Joseph, Paris, France",,"https://ClinicalTrials.gov/show/NCT03905226"
228,"NCT04030650","Study of Locomotor Expectations for Ascending/Descending Slope and Stairs in Patients With Limb Amputations","JCE","Recruiting","No Results Available","Lower Limb Amputation","Other: Functional analyses|Other: 3D analysis of walking and balance","The error rate of the algorithm","Centre Hospitalier Universitaire Dijon","All","18 Years and older   (Adult, Older Adult)",,"70","Other","Observational","Observational Model: Other|Time Perspective: Prospective","CASILLAS 2018-1","September 20, 2019","November 2021","November 2021","July 24, 2019",,"September 30, 2019","CHU Dijon Bourgogne, Dijon, France",,"https://ClinicalTrials.gov/show/NCT04030650"
229,"NCT04234360","Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation","eo-Drive","Not yet recruiting","No Results Available","COPD Exacerbation","Drug: 5 days of systemic corticotherapy (prednisone)|Drug: 5 days of placebo","Treatment failure|The speed of initial recovery: Time elapsed before showing signs of improvement|The speed of initial recovery: Time elapsed in acidosis/hypercapnia|The speed of initial recovery: Time elapsed before meeting pre-defined discharge criteria|Presence /absence of comorbidities or steroid side effects: glycemia|The occurrence of new or worsened diabetes/hyperglycemia|Body mass index|Hospital anxiety and depression scale (HAD)|The occurrence of any other potentially corticosteroid-induced comorbidities throughout the study|Episodes of pneumonia|Episodes of infection|Episodes of mild exacerbation.|Episodes of moderate exacerbation.|Episodes of severe exacerbation.|Forced expiratory volume in 1 second (litres)|Forced expiratory volume in 1 second (% predicted)|Forced vital capacity (litres)|Forced vital capacity (% predicted)|Residual volume (litres)|Residual volume (% predicted)|Total lung capacity (litres)|Total lung capacity (% predicted)|Oxygen needs (litres/min) during initial hospitalisation|Mode of pre-hospitalization living arrangements|Hospital discharge modality|Episodes of hospitalization|Episodes of emergency department use|Episodes of intensive care|Consults|The cumulative days alive and event-free|Mortality/survival|Medications|VAS scale for coughing|VAS scale for dyspnoea|VAS scale for sputum production|VAS scale for sleep perturbation|VAS scale for anxiety|The Breathlessness, Cough and Sputum Scale|The modified medical research council (mMRC) dyspnoea scale|The COPD assessment test|The Euroqol (EQ-5D-5L) questionnaire|The St George Respiratory Questionnaire|Six minute walking tests|The DIRECT questionnaire","University Hospital, Montpellier","All","40 Years to 85 Years   (Adult, Older Adult)","Phase 3","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","RECHMPL19_0069 UF 7771|2019-002724-33|LIC-18-18-0374","September 15, 2020","December 15, 2022","December 15, 2022","January 21, 2020",,"July 7, 2020","CHU Brest - Hôpital Caval Blanche, Brest, France|Centre hospitalier intercommunal de Créteil, Créteil, France|CHRU Lille, Lille, France|Hospice Civils de Lyon, Lyon, France|APHM - Hôpital Nord, Marseille, France|CHU Montpellier, Montpellier, France|CHU Nancy, Nancy, France|APHP - Hôpital BICHAT, Paris, France|APHP - Hôpital Cochin, Paris, France|APHP - Hôpital Universitaire Pitié-Salpétrière, Paris, France|CHU Bordeaux - Hôpital Haut Lévêque, Pessac, France|CHU Reims, Reims, France|CH Roubaix, Roubaix, France|CHRU Strasbourg, Strasbourg, France|Hôpital Larrey CHU Toulouse, Toulouse, France|Hôpital Nord Franche-Comté, Trévenans, France",,"https://ClinicalTrials.gov/show/NCT04234360"
230,"NCT03453554","Evaluating a Digital Memory Notebook App to Improve Functional Independence",,"Recruiting","No Results Available","Mild Cognitive Impairment","Other: Digital Notebook app|Other: Smart Home Prompting","Digital Memory Notebook Use|Quality of Life|Activities of Daily Living|Caregiver Burden|Coping self-efficacy|Cognitive functioning","Washington State University|United States Department of Defense","All","40 Years and older   (Adult, Older Adult)","Not Applicable","30","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","AZ150096","August 1, 2018","August 30, 2021","August 30, 2021","March 5, 2018",,"October 9, 2018","Washington State University - Pullman, Pullman, Washington, United States",,"https://ClinicalTrials.gov/show/NCT03453554"
231,"NCT04371289","Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up","CARDICoVRISK","Not yet recruiting","No Results Available","COVID-19|Cardiovascular Risk Factor",,"Predictive modeling of in-hospital outcome|Clinical, pathophysiological and molecular mechanisms|Short -Term Sequelae","Istituto Auxologico Italiano","All","18 Years and older   (Adult, Older Adult)",,"5500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CE_2020_03_26_02","April 2020","July 10, 2020","September 10, 2020","May 1, 2020",,"May 1, 2020","Istituto Auxologico Italiano, Milan, Italy",,"https://ClinicalTrials.gov/show/NCT04371289"
232,"NCT03808428","CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot",,"Recruiting","No Results Available","Stroke","Device: Ankle Group","Fugl-Meyer Assessment Lower Extremity (FMA-LE)|Functional Ambulation Classification (FAC)|Modified Ashworth Scale (MAS)|Berg Balance Scale (BBS)|Timed 10-Meter Walk Test (10MWT)|6 Minute Walk Test (6MWT)","Chinese University of Hong Kong|The Hong Kong Jockey Club Charities Trust","All","18 Years and older   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2018.493","February 1, 2019","December 31, 2021","December 31, 2021","January 17, 2019",,"January 17, 2019","Department of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03808428"
233,"NCT04206098","Chart Review of Patients With COPD, Using Electronic Medical Records and Artificial Intelligence","BigCOPData","Recruiting","No Results Available","Chronic Obstructive Pulmonary Disease","Other: Factors associated with Hospital admission for an Acute Exacerbation Chronic Obstructive Pulmonary Disease (AECOPD)","Number of factors associated with hospital admission of patients with AECOPD|Number of clinical characteristics of COPD hospitalized patients|Number of comorbidities of COPD patients hospitalized per sex|Number of patients with increased eosinophil blood counts|Number of patients with COPD hospitalized with elevated inflammatory parameters|Number of clinical phenotypes identified in COPD patients hospitalized|Number of COPD patients hospitalized do not follow treatment recommendations|Number of Risk on COPD patients hospitalized|Number of biologic biomarkers different to eosinophil count","Sociedad Española de Neumología y Cirugía Torácica|SAVANA|European Commission","All","35 Years to 99 Years   (Adult, Older Adult)",,"2500000","Other","Observational","Observational Model: Other|Time Perspective: Other","H2020","January 8, 2020","October 1, 2020","December 30, 2020","December 20, 2019",,"January 13, 2020","Kepler Universitäts Klinikum, Linz, Austria|Hospital Universitario de Guadalajara, Alcalá De Henares, Spain|Hospital Universitario Príncipe de Asturias, Alcalá De Henares, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Spain|Hospital Universitario Santiago de Compostela, Santiago De Compostela, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Arnau de Vilanova, Valencia, Spain|HUG, Geneva, Switzerland|Queen Elizabeth Hospital University, Birmingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04206098"
234,"NCT03968094","Early Detection of Respiratory Compromise to Prevent Harm of the Hospitalized Opioid Treated Patient",,"Enrolling by invitation","No Results Available","Pain",,"Opioid Induced Respiratory Depression","State University of New York at Buffalo","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","MOD00005932","June 1, 2019","September 2019","March 30, 2020","May 30, 2019",,"May 30, 2019","Buffalo General Medical Center, Buffalo, New York, United States",,"https://ClinicalTrials.gov/show/NCT03968094"
235,"NCT04240353","RECEIVER: Digital Service Model for Chronic Obstructive Pulmonary Disease (COPD)",,"Recruiting","No Results Available","Chronic Obstructive Pulmonary Disease","Other: COPD digital services","Successful engagement","NHS Greater Glasgow and Clyde|University of Glasgow","All","18 Years to 100 Years   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","INGN18RM173","August 1, 2018","July 31, 2021","July 31, 2021","January 27, 2020",,"January 27, 2020","Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04240353"
236,"NCT02580435","Deciphering the Role of the Gut Microbiota in Multiple Sclerosis",,"Not yet recruiting","No Results Available","Multiple Sclerosis",,"1. Change in expression of intestinal microbiome composition between MS patients and healthy controls.|Change in microbiome expression intestinal microbiome composition between MS patients phenotypes.","Sheba Medical Center|Weizmann Institute of Science","All","18 Years to 65 Years   (Adult, Older Adult)",,"520","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2356-15-SMC","December 2015","December 2020","December 2021","October 20, 2015",,"October 29, 2015",,,"https://ClinicalTrials.gov/show/NCT02580435"
237,"NCT03594760","PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer",,"Recruiting","No Results Available","Prostate Cancer","Diagnostic Test: 18F-DCFPyL IV injection","Overall survival|Progression free survival","Centre hospitalier de l'Université de Montréal (CHUM)","Male","18 Years and older   (Adult, Older Adult)","Phase 3","1000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","18.068","December 1, 2018","December 2023","December 2024","July 20, 2018",,"January 31, 2019","Centre Hospitalier de l'université de Montréal, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT03594760"
238,"NCT04462380","AiCR : Artificial Intelligence in Cardiac aRrest","AiCR","Recruiting","No Results Available","Cardio Respiratory Arrest",,"Prediction of mortality in the intensive care unit","Centre Hospitalier Universitaire de Nice|Institut National de Recherche en Informatique et en Automatique|AIINTENSE","All","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","20reamed01","February 1, 2020","December 31, 2020","December 31, 2020","July 8, 2020",,"July 8, 2020","Nice Hospital, Nice, France",,"https://ClinicalTrials.gov/show/NCT04462380"
239,"NCT03894514","Multi-variable Prediction Model of Total Knee Replacement Outcome",,"Not yet recruiting","No Results Available","Knee Osteoarthritis|Joint Disease|Total Knee Replacement|Arthroplasty Complications",,"Length of stay|Oxford knee Score (OKS)|International Physical Activity Questionnaires (IPAQ-short form)|Euro Quality of Life 5D questionnaire (EQ-5D)|Geriatric Depression Scale (GDS) short form|Visual Analogue Scale (VAS) of Pain|Expectations (Pain and Function)|Strength|Range of Motion|Timed Up & Go|Five times sit to stand test|One leg balance test","University of Valencia|Hospital Universitario La Fe|Hospital Clínico Universitario de Valencia","All","60 Years and older   (Adult, Older Adult)",,"150","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","LOS_ATR","May 1, 2019","May 2020","May 2020","March 28, 2019",,"March 28, 2019",,,"https://ClinicalTrials.gov/show/NCT03894514"
240,"NCT03208400","Virtual Reality Exposure in Spider Phobia",,"Completed","No Results Available","Specific Phobia|Cognitive-behavioral Therapy|Virtual Reality","Behavioral: virtual reality exposure","Spider Phobia Questionnaire (SPQ)|Behavioral Avoidance Text (BAT)|Clinical Global Impressions (CGI)","Julius-Maximilians University|University Hospital Muenster","All","18 Years and older   (Adult, Older Adult)","Not Applicable","338","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Spider_VR","September 1, 2017","May 31, 2019","February 10, 2020","July 5, 2017",,"February 11, 2020","Center of Mental Health, Dept. of Psychiatry, Psychosomatics, and Psychiatry, University Hospital of Wuerzburg, Wuerzburg, Bavaria, Germany|Dept. of Psychiatry, University Hospital Münster, Münster, North Rhine-Westphalia, Germany",,"https://ClinicalTrials.gov/show/NCT03208400"
241,"NCT03672279","Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder","CogCheck-MC","Not yet recruiting","No Results Available","Dementia Alzheimers|Dementia|Mild Cognitive Impairment|Dementia, Vascular|Dementia With Lewy Bodies|Cognition Disorders|Neurocognitive Disorders","Diagnostic Test: CogCheck","CogCheck|Mini-Mental State Examination (MMSE)|Montreal Cognitive Assessment (MoCA)|Consortium to Establish a Registry for Alzheimer's Disease - Neuropsychological Assessment Battery (CERAD-NAB)|Basel Verbal Learning Test (BVLT)|Geriatric Depression Scale (GDS)|Beck's Depression Inventory (BDI)","University Hospital, Basel, Switzerland","All","65 Years and older   (Older Adult)",,"150","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CogCheck-MC-Valid","July 1, 2020","December 31, 2024","December 31, 2024","September 14, 2018",,"September 26, 2019","Memory Clinic, University Center for Medicine of Aging, Felix Platter Hospital Basel, Basel, BS, Switzerland",,"https://ClinicalTrials.gov/show/NCT03672279"
242,"NCT03424681","Modafinil for the Treatment of Alcohol Use Disorders",,"Completed","Has Results","Alcohol Use Disorder","Drug: Modafinil|Other: Placebo","Time to Relapse|Drinks Per Drinking Day|Drinks Per Week|Percent Days Abstinent","The Mind Research Network","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","12","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","FP00002746","December 11, 2017","August 31, 2018","August 31, 2018","February 7, 2018","May 11, 2020","May 26, 2020","Mind Research Network, Albuquerque, New Mexico, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/81/NCT03424681/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03424681"
243,"NCT04457505","One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19",,"Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Severe Pneumonia|Respiratory Failure",,"One year mortality|Six month mortality","Consorcio Centro de Investigación Biomédica en Red, M.P.|Barcelona Supercomputing Center|Carlos III Health Institute","All","Child, Adult, Older Adult",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CIBERESUCICOVID","May 8, 2020","May 31, 2021","May 31, 2021","July 7, 2020",,"July 7, 2020","Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital General de Cataluña, Sant Cugat Del Vallès, Barcelona, Spain|Hospital Infanta Margarita de Cabra, Cabra, Córdoba, Spain|Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain|Hospital Son Llatzer, Palma De Mallorca, Mallorca, Spain|Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|Hospital Universitario Sant Joan d'Alacant, Alicante, Spain|Clínica Sagrada Família, Barcelona, Spain|Hospital Sagrat Cor, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Vall d'Hebron University Hospital, Barcelona, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital Burgos, Burgos, Spain|Hospital San Pedro de Alcantara, Cáceres, Spain|Hospital de León, León, Spain|Hospital Arnau de Vilanova Lleida, Lleida, Spain|Hospital Infanta Leonor de Madrid, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Complexo Hospitalario Universitario de Ourense, Ourense, Spain|Complejo Asistencial Universitario de Palencia, Palencia, Spain|Hospital Montecelo, Pontevedra, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitari Virgen de Valme, Sevilla, Spain|Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain|Hospital Clínic Universitari de València, Valencia, Spain|Hospital Universitari i Politècnic La Fe, Valencia, Spain|Hospital Universitario Valladolid, Valladolid, Spain|Hospital Nuestra Señora de Gracia, Zaragoza, Spain",,"https://ClinicalTrials.gov/show/NCT04457505"
244,"NCT04401319","rTMS and EEG in DOC Patients",,"Not yet recruiting","No Results Available","Disorder of Consciousness","Device: Sham Stimulation for Crossover Study|Device: DLPFC Stimulation for Crossover Study|Device: AG Stimulation for Crossover Study|Device: Sham Stimulation for Parallel Study|Device: DLPFC Stimulation for Parallel Study|Device: AG Stimulation for Parallel Study","Change from Baseline Coma Recovery Scale - Revised for Crossover Study|Change from Baseline Coma Recovery Scale - Revised for Parallel Study 1|Change from Baseline Coma Recovery Scale - Revised for Parallel Study 2|Change from Baseline Coma Recovery Scale - Revised for Parallel Study 3|Change from Baseline Resting-State EEG for Crossover Study 1|Change from Baseline Resting-State EEG for Crossover Study 2|Change from Baseline Resting-State EEG for Parallel Study 1|Change from Baseline Resting-State EEG for Parallel Study 2|Change from Baseline Resting-State EEG for Parallel Study 3","University of Liege|Therapiezentrum Burgau","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","B0201941888","November 2020","November 2022","January 2024","May 26, 2020",,"May 28, 2020","University Hospital of Liège, Liège, Belgium|Therapiezentrum Burgau, Burgau, Germany",,"https://ClinicalTrials.gov/show/NCT04401319"
245,"NCT04220242","Future of Colorectal Cancer Surgery","FOCCuS1","Recruiting","No Results Available","Colorectal Cancer|Surgery","Other: Video recordings with analysis thereafter applied|Other: Examination of microsections of tissue excised for the purposes of cancer resection|Other: Cancer organoid development and testing","Video recordings of Colorectal Cancer.|Analysis of video recordings|Biophysics visualisation software development|Biophysics model training|Validation of predictive accuracy biophysics-visualisation model|Coefficients of Variation|Microscopic Map of intratumoral fluorophore accumulation|Realtime delineation display of tumour area including margins","Mater Misericordiae University Hospital|Royal College of Surgeons, Ireland|IBM Research In Ireland","All","18 Years and older   (Adult, Older Adult)",,"250","Other","Observational","Observational Model: Cohort|Time Perspective: Other","DT 2018 0240","December 30, 2019","December 1, 2022","March 1, 2023","January 7, 2020",,"January 7, 2020","Mater Misericordiae University Hospital, Dublin, Other (Non U.s.), Ireland",,"https://ClinicalTrials.gov/show/NCT04220242"
246,"NCT01317628","Effects of Tobacco Smoke Exposure on Epigenetic Signatures and Immunotoxicological Reactions",,"Completed","No Results Available","The Study Focused on Reducing Tobacco Smoke Exposure for Child.","Behavioral: Tobacco smoke reduction trial intervention program","Change from Baseline in cotinine level at 3 months|Change from Baseline in smoking status at 3 months|Change from Baseline in DNA methylation at 3 months|Change from Baseline in immunological cytokine at 3 months|Change from Baseline in miRNA expression at 3 months|Change from Baseline in immunological function at 3 months","National Taiwan University Hospital","All","12 Years to 16 Years   (Child)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","201009040R","April 2011","June 2011","June 2011","March 17, 2011",,"October 29, 2013",,,"https://ClinicalTrials.gov/show/NCT01317628"
247,"NCT04459962","Covid-19 Breath Test",,"Recruiting","No Results Available","Covid-19 Infection","Diagnostic Test: Breath Test & Cheek Swab","To investigate/ examine the effectiveness of Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients with COVID-19 symptoms|-To profile the unique pattern of Volatile Organic Compounds (VOCs) found in the expired breath of COVID-19 patients using the NBT system (VOC analysis and ML).|To differentiate this unique profile from the patients that are found to be negative for COVID-19","Ancon Technologies Ltd","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","250","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2020ATL01","June 29, 2020","August 28, 2020","June 14, 2021","July 7, 2020",,"July 7, 2020","Ashford and St Peter's Hospitals NHS Foundation Trust, Chertsey, Surrey, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04459962"
248,"NCT04209166","A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features",,"Recruiting","No Results Available","Major Depressive Disorder","Drug: SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)|Drug: SSRIs/SNRIs+Mood Stabilizer|Drug: SSRIs/SNRIs+Quetiapine|Drug: Usual Treatment","remission of acute phase|switch rate","Shanghai Mental Health Center|Fourth Military Medical University|Guangzhou Psychiatric Hospital|Dalian Seventh People's Hospital|Wuhan Union Hospital, China|Shanghai Jiao Tong University School of Medicine","All","16 Years to 60 Years   (Child, Adult)","Not Applicable","780","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","CRC2018ZD05","August 12, 2019","October 31, 2022","October 31, 2022","December 23, 2019",,"December 23, 2019","Guangzhou Psychiatric Hospital, Guanzhou, Guangdong, China|Wuhan Mental Health Center, Wuhan, Hubei, China|Dalian Seventh People's Hospital, Dalian, Liaoning, China|Shanghai Mental Health Center, Shanghai, Shanghai, China|Fourth Military Medical University, Xian, Shanxi, China",,"https://ClinicalTrials.gov/show/NCT04209166"
249,"NCT03992521","Breast Cancer Liquid Biopsy Stratification","BALIBISTRA","Active, not recruiting","No Results Available","Breast Cancer","Genetic: Nucleosome positioning","Evaluating as proof-of-concept the ability to stratify patients solely based on a detailed plasma DNA analysis","Medical University of Graz","Female","18 Years to 99 Years   (Adult, Older Adult)",,"59","Other","Observational","Observational Model: Other|Time Perspective: Other","BreastctDNA01","October 1, 2018","October 2019","October 2022","June 20, 2019",,"June 20, 2019","Medical University of Graz, Graz, Austria",,"https://ClinicalTrials.gov/show/NCT03992521"
250,"NCT04441814","FOUND - Ancillary Study to Smile Protocol NCT03654105","FOUND","Enrolling by invitation","No Results Available","COVID 19|Inflammatory Status",,"Temporal variations in the frequency and morphology of SSNs according to the COVID-19 epidemic|Geographical variations in the frequency and morphology of SSNs according to the COVID-19 epidemic|Correlation between sub-solid lesions and individual risk|Correlation between sub-solid lesions and incidence of acute events","Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|University of Parma|University of Milan|University of Milano Bicocca","All","50 Years to 75 Years   (Adult, Older Adult)",,"960","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","INT 49/20","July 23, 2019","July 2021","July 2021","June 22, 2020",,"June 23, 2020","Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",,"https://ClinicalTrials.gov/show/NCT04441814"
251,"NCT01904942","Study of Hepatocellular Carcinoma in Cirrhotic Patients","CIRCE ProSpec","Completed","No Results Available","Hepatocellular Carcinoma",,"Proteomic investigations|Infrared spectroscopic investigations","Centre Hospitalier Universitaire Dijon","All","35 Years to 70 Years   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","DUCOROY PHRC K 2010","October 2008","June 2010",,"July 22, 2013",,"July 22, 2013",,,"https://ClinicalTrials.gov/show/NCT01904942"
252,"NCT03762902","Predicting Migraine Attacks Based on Environmental and Behavioral Changes as Detected From the Smartphone","Migraine","Terminated","No Results Available","Migraine Disorders|Headache Disorders|Headache Disorders, Primary|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases",,"Assessing Lifegraph's predictive ability of migraine attacks before subjects report they experience an attack.","Lifegraph Ltd.|Henry Ford Health System","All","18 Years to 75 Years   (Adult, Older Adult)",,"10","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","LifegraphMigrainePrediction","April 30, 2019","August 1, 2019","September 1, 2019","December 4, 2018",,"September 13, 2019","Henry Ford Health System Main Campus, Detroit, Michigan, United States|Henry Ford Health System, West Bloomfield, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03762902"
253,"NCT03972033","Neurobiological Processing of Emotions in Depression",,"Recruiting","No Results Available","Eye Movement Desensitization and Reprocessing|Cognitive Behavioral Therapy|Neurobiological Processing|Emotions|Functional Magnetic Resonance Imaging|High Definition Electroencefalography|Heart Rate Variability","Behavioral: EMDR|Behavioral: CBT","DSM-5 evaluation|changes in depressive symptoms|changes in cognitive component of depressive syndrome|changes in HD-EEG|changes in fMRI|changes in HRV|changes in anxiety symptmoms|changes in Loss-related and post-traumatic symptoms|changes in Quality of Life","University of Turin, Italy|EMDR Europe","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Screening","EMDRvsCBT","February 1, 2019","September 30, 2021","December 31, 2021","June 3, 2019",,"July 2, 2020","AOU Città della Salute e della Scienza di Torino, Torino, Italy",,"https://ClinicalTrials.gov/show/NCT03972033"
254,"NCT03826290","Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record",,"Recruiting","No Results Available","Diabetes Mellitus|Diabetes Mellitus, Type 2","Other: EHR-integrated diabetes dashboard","Per-patient change in Hemoglobin A1c (HbA1c) levels from beginning to end of evaluation period|Per-patient change in body mass index (BMI) from beginning to end of evaluation period|Cost of diabetes medications prescribed","University of Utah|Hitachi, Ltd.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","17000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","UUtah_00109162","January 9, 2019","January 2020","May 2020","February 1, 2019",,"February 1, 2019","University of Utah Health, Salt Lake City, Utah, United States",,"https://ClinicalTrials.gov/show/NCT03826290"
255,"NCT03666312","Enteric Microbiome and Liver Transplantation",,"Recruiting","No Results Available","Orthotopic Liver Transplantation",,"Early allograft dysfunction|Treated acute cellular rejection|Infectious complications|Length of stay (LOS) in the hospital after LT|Mortality|Biliary complications","Nicasio Mancini|Azienda Ospedaliera Città della Salute e della Scienza di Torino|Azienda Ospedaliero, Universitaria Pisana|IRCCS San Raffaele","All","18 Years and older   (Adult, Older Adult)",,"275","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ENT-LIVTRA","September 1, 2018","August 30, 2021","August 30, 2021","September 11, 2018",,"March 1, 2019","IRCCS San Raffaele, Milan, Italy|Azienda Ospedaliero, Universitaria Pisana, Pisa, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy",,"https://ClinicalTrials.gov/show/NCT03666312"
256,"NCT03217383","Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance Therapy",,"Active, not recruiting","No Results Available","Sleep Apnea|Sleep Apnea, Obstructive|Sleep Disordered Breathing","Device: MATRx plus","Sensitivity|Oral appliance compliance|Usability","Zephyr Sleep Technologies","All","21 Years to 80 Years   (Adult, Older Adult)","Not Applicable","61","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","ZCP201703","July 10, 2017","September 30, 2019","December 31, 2019","July 14, 2017",,"April 18, 2019","Zephyr Sleep Technologies, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT03217383"
257,"NCT04462913","Biometric Recognition and Rehabilitation Assessment of Lower Extremity Sports Injury Based on Gait Touch Information",,"Recruiting","No Results Available","Sport Injury|Osteoarthritis, Knee","Other: no intervention","walking speed|ground reaction force|knee flexion angle|the moment of knee extension in the gait cycle|The International Knee Documentation Committee (IKDC) score","Peking University Third Hospital","All","Child, Adult, Older Adult",,"550","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","OR001","July 28, 2017","December 1, 2022","December 30, 2022","July 8, 2020",,"July 8, 2020","Peking University Third Hospital, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04462913"
258,"NCT04393558","Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms",,"Recruiting","No Results Available","COVID-19|Healthy Control","Device: ADAM Sensor","Body temperature|Cough Frequency|Respiratory frequency|Heart Rate Instantaneous heart rate every 15 minutes.","Shirley Ryan AbilityLab","All","18 Years to 95 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","STU00212522","April 20, 2020","December 31, 2022","December 31, 2022","May 19, 2020",,"May 21, 2020","Shirley Ryan AbilityLab, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT04393558"
259,"NCT04228094","Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD",,"Recruiting","No Results Available","Attention Deficit-hyperactivity Disorder","Other: TDApp1: an eHealth intervention","Treatment recommended/prescribed|Patient/parent satisfaction with the participation in the health decision-making process|Patient/parent satisfaction with TDApp1|ADHD symptom severity|Adverse events|Patient/parent satisfaction with the treatment prescribed|Physical activity","Universitat de Girona","All","6 Years to 65 Years   (Child, Adult, Older Adult)",,"55","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","tdapp1","March 25, 2020","December 2020","March 2021","January 14, 2020",,"March 25, 2020","Institut d'Assitència Sanitària, Girona, Catalonia, Spain",,"https://ClinicalTrials.gov/show/NCT04228094"
260,"NCT03625271","The Canadian Armed Forces PEER Study","PEERCanada","Recruiting","No Results Available","Depression|Non-psychotic Diagnosis as Co-morbidity","Device: The PEER Report","Quick Inventory of Depressive Symptomatology - Self Report 16 Item Questionnaire|CHRT-7SR:|PCL-M/C - if applicable:|Patient-recorded CGI-I (Clinical Global Impressions-Improvement)|Physician-recorded CGI-I (Clinical Global Impressions-Improvement)|CGI-S (Clinical Global Impressions - Severity) - Physician|HAM-D (Hamilton Rating Scale for Depression):","CNS Response|University of Ottawa|Canadian Forces Health Services Centre Ottawa","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","150","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","CNS013","June 16, 2016","July 1, 2019","December 1, 2019","August 10, 2018",,"July 10, 2019","The Royal Mental Health Center, Ottawa, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03625271"
261,"NCT04362982","Αn Information System for Symptom Diagnosis and Improvement of Attention Deficit Hyperactivity Disorder (ADHD360)","ADHD360","Recruiting","No Results Available","Attention Deficit Hyperactivity Disorder","Other: ADHD360 platform: An intervention intergrating a serious game along with a mobile application for daily behavioral monitoring.","Explore whether the game analytics could discriminate the ADHD from non-ADHD users of the ADHD360 platform.|Explore whether the monitoring data could discriminate the ADHD from non-ADHD users of the ADHD360 platform.|Explore whether the game analytics along with the monitoring data could discriminate the ADHD from non-ADHD users of the ADHD360 platform.|Investigate the impact of ADHD360 platfrom as intervention on general intelligence index|Change in attention|Change in the frequency of ADHD symptoms","Aristotle University Of Thessaloniki","All","7 Years to 16 Years   (Child)","Not Applicable","20","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","5162.18.12.2019","April 1, 2020","April 30, 2021","April 30, 2021","April 27, 2020",,"April 27, 2020","Laboratory of Medical Physics, AUTH, Thessaloniki, Greece",,"https://ClinicalTrials.gov/show/NCT04362982"
262,"NCT04172025","Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens",,"Recruiting","No Results Available","Multiresistant Bacterial Pathogens|Virulent Bacterial Pathogens","Diagnostic Test: Analysis of Bacterial Genome","Identification of transmission clusters based on genetic similarity.|Detection of Genotypic Resistance","University Hospital, Basel, Switzerland|Swiss National Science Foundation","All","Child, Adult, Older Adult",,"10000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2019-01291; qu19Egli5","September 30, 2019","December 31, 2024","December 31, 2024","November 21, 2019",,"December 9, 2019","Institute of Microbiology CHUV, Lausanne, Vaud, Switzerland|Service of Hospital Preventive Medicine CHUV, Lausanne, Vaud, Switzerland|Clinical Bacteriology and Mycology, Basel, Switzerland|Institute of Veterinary Bacteriology, Bern, Switzerland|Bacteriology Laboratory, Universität Geneva, Geneva, Switzerland|Institute for Foodsafety and -hygiene, VetSuisse, Zürich, Switzerland",,"https://ClinicalTrials.gov/show/NCT04172025"
263,"NCT03552497","The Potential of Radiomics to Differentiate Between Malignant and Benign Bosniak 3 Renal Cysts.","BIII","Active, not recruiting","No Results Available","Renal Cyst Complex","Diagnostic Test: Radiomics","malignancy classifier","Maastricht University|University of California, San Francisco|Stanford University|Erasmus Medical Center|Memorial Sloan Kettering Cancer Center|University of Sao Paulo General Hospital|University Hospital, Aachen","All","Child, Adult, Older Adult",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","BIIIP_18","August 7, 2018","December 1, 2020","January 31, 2021","June 12, 2018",,"April 6, 2020","Maastricht University Medical Center, Maastricht, Limburg, Netherlands",,"https://ClinicalTrials.gov/show/NCT03552497"
264,"NCT03268031","Artificial Intelligence-assissted Glaucoma Evaluation","AGE","Recruiting","No Results Available","Artificial Intelligence|Glaucoma","Diagnostic Test: Visual field and OCT tests","Accuracy of diagnosis by artificial intelligence algorithm|Sensitivity of diagnosis by artificial intelligence algorithm|Specificity of diagnosis by artificial intelligence algorithm","Sun Yat-sen University|Chinese Academy of Sciences","All","Child, Adult, Older Adult",,"5000","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","ProjectAGE","August 15, 2017","June 1, 2020","January 1, 2021","August 31, 2017",,"September 25, 2019","Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03268031"
265,"NCT03643692","Adaptive, Real-time, Intelligent System to Enhance Self-care of Chronic Disease","ARISES","Completed","No Results Available","Diabetes Mellitus, Type 1","Device: ARISES","Usability Questionnaire","Imperial College London","All","18 Years and older   (Adult, Older Adult)","Not Applicable","12","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","18HH4410","February 26, 2019","July 1, 2019","July 1, 2019","August 23, 2018",,"October 10, 2019","Imperial College Clinical Research Facility, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03643692"
266,"NCT01465087","Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples",,"Completed","No Results Available","Multiple Sclerosis","Other: NA-NOSE artificial olfactory system","Volatile organic compounds in the exhaled breath|Markers in exhaled breath","Carmel Medical Center|Technion, Israel Institute of Technology","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","314","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CMC-11-0083-CTIL|Nano-MS-2011","December 2011","February 2014","January 2015","November 4, 2011",,"June 28, 2016","Multiple Sclerosis Clinic, Carmel Medical Center, Haifa, Israel",,"https://ClinicalTrials.gov/show/NCT01465087"
267,"NCT01206023","Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples","MS-NANOSE","Completed","No Results Available","Multiple Sclerosis","Other: NA-NOSE artificial olfactory system","Successful discrimination between healthy and MS","Carmel Medical Center|Technion, Israel Institute of Technology","All","18 Years to 60 Years   (Adult)",,"71","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","Nano-MS-10","November 2010","November 2011","November 2012","September 21, 2010",,"February 23, 2017","MS Clinic, Carmel Medical Center, Haifa, Israel|MS Clinic, Carmel Medical Center, Haifa, Israel",,"https://ClinicalTrials.gov/show/NCT01206023"
268,"NCT03904667","Application of Watson for Oncology in Hepatocellular Carcinoma Surgery",,"Active, not recruiting","No Results Available","Liver Resection","Other: Watson on oncology surgery decision evaluation","Operative outcomes|Postoperative survival","Zhujiang Hospital","All","18 Years to 80 Years   (Adult, Older Adult)",,"150","Other","Observational","Observational Model: Cohort|Time Perspective: Other","20170101","January 1, 2017","December 31, 2021","December 31, 2021","April 5, 2019",,"April 5, 2019","Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03904667"
269,"NCT03739177","Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients",,"Recruiting","No Results Available","Bladder Cancer","Diagnostic Test: Onco4D Biodynamic Chemotherapy Selection Assay","Objective pathological response measured at the time of cystectomy.","Animated Dynamics, Inc.","All","18 Years and older   (Adult, Older Adult)",,"150","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","002","June 22, 2017","June 30, 2020","June 30, 2020","November 13, 2018",,"January 13, 2020","Animated Dynamics, Inc., Indianapolis, Indiana, United States","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/77/NCT03739177/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT03739177"
270,"NCT03164863","Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients",,"Recruiting","No Results Available","Breast Cancer","Diagnostic Test: Onco4D Biodynamic Chemotherapy Selection Assay","Objective pathological response measured at the time of surgery.","Animated Dynamics, Inc.","All","18 Years and older   (Adult, Older Adult)",,"150","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","001-B","March 6, 2017","December 31, 2020","December 31, 2020","May 24, 2017",,"January 13, 2020","Animated Dynamics, Inc., Indianapolis, Indiana, United States",,"https://ClinicalTrials.gov/show/NCT03164863"
271,"NCT03611361","Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients","WISCR","Recruiting","No Results Available","Amputation Wound|Peripheral Arterial Disease","Device: SpectralMD DeepView Wound Imaging System 2.0","Standardized amputation healing assessment","SpectralMD|Baylor Research Institute","All","18 Years and older   (Adult, Older Adult)",,"250","Industry|Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","CP-16-002","November 18, 2015","July 2022","August 2022","August 2, 2018",,"October 3, 2019","Dr. Dennis Gable, Plano, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03611361"
272,"NCT04087564","The Impact of Music on Nociceptive Processing",,"Recruiting","No Results Available","Pain, Acute|Pain, Chronic|Anxiety|Anxiety Disorders|Catastrophization|Healthy","Other: music intervention","Modulation of Pressure Pain Threshold/Tolerance|Modulation of Temporal Summation with Repeated Pinpricks|Modulation of Temporal Summation with Pressure Cuff|Modulation of Heat Pain Threshold and Tolerance|Modulation of Heat Offset Analgesia|Modulation of Conditioned Pain Modulation|Modulation of Anxiety","Brigham and Women's Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","210","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2019P000824","June 13, 2019","June 1, 2021","July 1, 2022","September 12, 2019",,"October 3, 2019","Brigham and Women's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04087564"
273,"NCT04324333","Modelling Missteps to Improve Fall Risk Assessment.",,"Recruiting","No Results Available","Fall Patients","Behavioral: Digital wearable system","Physical Activity|Community ambulation|The frequency of falling|Changes in endurance|Improve in motor function","Tel-Aviv Sourasky Medical Center|Owlytics Healthcare","All","65 Years to 90 Years   (Older Adult)","Not Applicable","200","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","TASMC-18-NG-0646-CTIL","September 9, 2019","December 31, 2024","December 31, 2024","March 27, 2020",,"March 31, 2020","The Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT04324333"
274,"NCT04357977","A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device",,"Not yet recruiting","No Results Available","Coronavirus|COVID","Diagnostic Test: RBA-2","Covid +","Kaligia Biosciences, LLC|University of South Florida","All","18 Years and older   (Adult, Older Adult)",,"300","Industry|Other","Observational","Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional","KBS005","April 2020","August 2020","December 2020","April 22, 2020",,"April 22, 2020","Tampa General Hospital, Tampa, Florida, United States|University of South Florida, Tampa, Florida, United States|AdventHealth Tampa, Tampa, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04357977"
275,"NCT03787433","Assisted Rehabilitation Care During Post-stroke mANaGement: fEasibiLity Assessment","ARCANGEL","Completed","No Results Available","Stroke","Device: ARC - Assisted Rehabilitation Care","Number of patients successfully completing the study|Ratio between the total number of subjects refusing to participate before training and the total number of subjects screened|Ratio between the total number of subjects refusing to participate after training and the total number of subjects screened|Number of training sessions|Overall training period duration|Assisted Rehabilitation Care (ARC) questionnaire score|Assisted Rehabilitation Care (ARC) questionnaire change|ARC global satisfaction score|Modified version of Adult Carer Quality of Life Questionnaire (AC-QoL) total score|Device-related adverse effects|Modified Rankin Score change (N.Ireland)|Barthel Index change (Italy)|Euro Quality of Life - 5 Dimension (EQ-5D) Health Questionnaire summary index|Euro Quality of Life - 5 Dimension (EQ-5D) Health Questionnaire summary index change|Signs of Depression Scale (SODS, N.Ireland)|Zung Self-Rating Depression Scale (SDS, Italy)|Resource consumption","Camlin Ltd|Northern Health and Social Care Trust|Azienda Sanitaria Locale 3, Torino","All","18 Years and older   (Adult, Older Adult)",,"41","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ARCANGEL","November 23, 2018","June 12, 2020","June 12, 2020","December 26, 2018",,"June 16, 2020","Azienda Sanitaria Locale 3, Torino, Pinerolo, Italy|Northern Health and Social Care Trust, Antrim, Northern Ireland, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03787433"
276,"NCT03746392","Project to Improve Communication About Serious Illness - Pilot Study","PICSI-P","Active, not recruiting","No Results Available","Malignant Neoplasm|Leukemia, Lymphocytic, Chronic, B-Cell|Lung Disease Chronic|Congestive Heart Failure|Liver Failures, Chronic|Renal Insufficiency, Chronic|Dementia|Diabetes Complications|Peripheral Vascular Disease|Frail Elderly","Behavioral: Jumpstart Intervention","Documentation of goals of care","University of Washington","All","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","STUDY00004821","July 1, 2018","June 30, 2020","June 30, 2020","November 19, 2018",,"April 24, 2020","Harborview Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT03746392"
277,"NCT04305938","A Human Clinical Study to Collect Calibration and Performance Data for the RBA-1 and KBS-1",,"Not yet recruiting","No Results Available","Calibration and Validation of Analyte Testing System","Diagnostic Test: Minimally invasive and non-invasive blood analyte measurement","Analyte validation","Kaligia Biosciences, LLC","All","18 Years and older   (Adult, Older Adult)",,"1000","Industry","Observational","Observational Model: Case-Only|Time Perspective: Prospective","KBS004","April 1, 2020","December 31, 2020","December 31, 2020","March 12, 2020",,"March 12, 2020","Tampa General Hospital, Tampa, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04305938"
278,"NCT03193528","A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer",,"Recruiting","No Results Available","Bladder Cancer",,"To examine the sensitivity and specificity of the multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples to reference standard of cystoscopy in a cohort of 450 participants presenting with gross hematuria.|To compare the sensitivity and specificity of the multiplex ELISA assay to VUC and NMP22® BladderChek to reference standard of cystoscopy in this cohort.|To develop a BCa risk calculator from this cohort using cutting edge machine learning techniques (e.g., random forest) incorporating biomarker data and clinical data.","Charles Rosser|Fred Hutchinson Cancer Research Center|University of Texas|Cedars-Sinai Medical Center","All","18 Years and older   (Adult, Older Adult)",,"450","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Rosser-2015-7","December 30, 2016","December 30, 2021","December 30, 2022","June 20, 2017",,"March 31, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States|UT Southwestern Medical Center at Dallas, Dallas, Texas, United States|Department of Urology, Nara Medical University, Nara, Japan",,"https://ClinicalTrials.gov/show/NCT03193528"
279,"NCT03694145","Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images",,"Recruiting","No Results Available","Diabetic Retinopathy|Diabetic Macular Edema","Other: In-Person Eye Examination","Proportion of patients accurately diagnosed with retinopathy","Charles Drew University of Medicine and Science|National Library of Medicine (NLM)|Los Angeles County Department of Public Health|University of California, Los Angeles","All","18 Years and older   (Adult, Older Adult)",,"500","Other|NIH","Observational","Observational Model: Other|Time Perspective: Prospective","1218589-3|R01LM012309","October 25, 2018","September 2020","September 2020","October 3, 2018",,"December 9, 2019","Los Angeles Department of Public Health, Los Angeles, California, United States|University of California - Los Angeles, Los Angeles, California, United States|Charles R. Drew University of Medicine and Science, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT03694145"
280,"NCT03692247","The Impact of Music Therapy on Nociceptive Processing",,"Completed","No Results Available","Pain|Chronic Pain","Other: Smartphone-based Music Intervention","Changes in Pain Sensitivity in the Presence of Music","Brigham and Women's Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","2017P002872","June 7, 2018","July 18, 2018","July 18, 2018","October 2, 2018",,"January 30, 2019","Brigham and Women's Hospital, Brookline, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03692247"
281,"NCT04460638","SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling","CoviDiagMS","Not yet recruiting","No Results Available","SARS-CoV 2","Biological: Saliva collection|Other: Clinical assessment","Development of a test based on the MALDI-TOF profiling method to detect individuals infected with SARS-CoV2 from saliva sample.|Rate of correct classification by the test (MALDI-TOF MS profiling) from saliva sample|Rate of correct classification by RT-PCR from saliva sample|Identification of proteins specific to the SARS-CoV2 infection|Presence of a positive anti-SARS-CoV2 antibody response|Correlation between the identified protein markers and the clinical course of the participants.","Direction Centrale du Service de Santé des Armées","All","18 Years and older   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2020-COVID19-15","August 2020","August 2022","August 2022","July 7, 2020",,"July 7, 2020",,,"https://ClinicalTrials.gov/show/NCT04460638"
282,"NCT04226027","Dynamically Tailored Behavioral Interventions in Diabetes",,"Recruiting","No Results Available","Type 2 Diabetes","Behavioral: T2.coach","Change in HbA1c value|DPSI Score|SCA-I Score|DSES Score|PAID Score","Columbia University|Clinical Directors Network|University of Colorado, Denver|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","280","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","AAAS5528|R01DK113189","January 17, 2020","September 30, 2022","September 30, 2022","January 13, 2020",,"February 17, 2020","Clinical Directors Network, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04226027"
283,"NCT04283864","Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease",,"Not yet recruiting","No Results Available","Crohn Disease",,"Personalised nutrition Algorithm based on microbiome.","Weizmann Institute of Science|The Leona M. and Harry B. Helmsley Charitable Trust","All","6 Years to 18 Years   (Child, Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","0722-19 -RMC","July 1, 2020","October 2020","October 2020","February 25, 2020",,"May 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04283864"
284,"NCT03872102","Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging",,"Suspended","No Results Available","Parkinson Disease|Multiple System Atrophy|Progressive Supranuclear Palsy",,"Imaging biomarker of progression rate|Imaging biomarker that discriminates different neurodegenerative diseases|Change from baseline in MDS-UPDRS score|Change from baseline in Uniﬁed Multiple System Atrophy Rating Scale (UMSARS) score|Change from baseline in Progressive Supranuclear Palsy Rating Scale (PSPRS) score|Change from baseline in Parkinson disease questionnaire|Change from baseline in Schwab and England Activities of Daily Living Scale","University of Texas Southwestern Medical Center","All","Child, Adult, Older Adult",,"90","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Bioinformatics Study","March 28, 2019","August 2022","October 2022","March 13, 2019",,"April 6, 2020","UT Southwestern Medical Center, Dallas, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03872102"
285,"NCT02843529","Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)","AltoidaML","Completed","No Results Available","Alzheimer Disease|Mild Cognitive Impairment|Memory Disorders|Cognitive Impairment|Dementia|Presymptomatic Disease","Other: Altoida: neuropsychological, MRI, EEG and CSF biomarkers","Change in sensitivity , specificity and accuracy of Altoida models|Change from Baseline in Clinical Measure 1|Change from Baseline in Clinical Measure 2|Change from Baseline in Clinical Measure 3|Change from Baseline in Clinical Measure 4|Change from Baseline in Clinical Measure 5|Change from Baseline in Clinical Measure 6|Change from Baseline in Clinical Measure 7|Change from Baseline in Cognitive Measure|Secondary resting state EEG endpoints|Secondary resting state auditory oddball ERP endpoints|Total Abeta 1-42 (Aβ42) amyloid deposition|Change of brain amyloid deposition|Change of CSF biomarkers tau and ptau181 values|MRI (Optional)|Changes in Driving breaking force|Changes in Driving acceleration velocity|Changes in Driving direction|Changes in driving violations","Altoida|Greek Alzheimer's Association and Related Disorders|University of Roma La Sapienza|IRCCS Centro San Giovanni di Dio Fatebenefratelli|Neuromed IRCCS|Scripps Health|Global Brain Health Institute (GBHI)|Takeda Pharmaceuticals International, Inc.|Research Center on Computational Biomarkers (RCCBM)|BiHELab - Bioinformatics and Human Electrophysiology Lab|Fundacion Clinic per a la Recerca Biomédica|University of Dublin, Trinity College|University of Barcelona|EIT Health|Klinik Hirslanden, Zurich|Center for BrainHealth - The University of Texas at Dallas","All","55 Years to 90 Years   (Adult, Older Adult)","Not Applicable","548","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Diagnostic","altoidaML01","October 17, 2016","February 18, 2020","February 21, 2020","July 26, 2016",,"May 27, 2020",,,"https://ClinicalTrials.gov/show/NCT02843529"
286,"NCT03911297","DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome","DAISy-PCOS","Recruiting","No Results Available","Polycystic Ovary Syndrome","Other: Women with polycystic ovary syndrome","Metabolic risk|Dissect the severity and pattern of androgen excess in development of metabolic disease|Eligibility for other PCOS-related studies","University of Birmingham|University Hospital Birmingham NHS Foundation Trust|Birmingham Women's and Children's NHS Foundation Trust|University Hospital of Wales|University Hospitals Coventry and Warwickshire NHS Trust|Royal Infirmary of Edinburgh|The Leeds Teaching Hospitals NHS Trust|St Mary's NHS Trust|Barts & The London NHS Trust","Female","18 Years to 70 Years   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","RG 18-033|WT209492/Z/17/Z","August 14, 2019","June 1, 2021","April 1, 2024","April 11, 2019",,"October 2, 2019","Wellcome Trust Clinical Research Facility, Birmingham, West Midlands, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03911297"
287,"NCT03054142","China Collaborative Study on Epidemiology of Acute Kidney Injury",,"Recruiting","No Results Available","Acute Kidney Injury","Other: no intervention","Incidence of AKI|Recognition rate of AKI|Proportion of nephrology referral|In-hospital mortality|Longer ICU stay|Higher medical cost","XinLing Liang|Guangdong Provincial People's Hospital","All","Child, Adult, Older Adult",,"1000000","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","CCS-AKI RF2011-2016","January 2017","December 1, 2021","January 1, 2022","February 15, 2017",,"June 23, 2020","Nephrology Dept,Guangdong General Hospital, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03054142"
288,"NCT04458168","Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living",,"Not yet recruiting","No Results Available","Ovarian Cancer","Behavioral: Use of Purposeful app","Feasibility assessed by enrollment rate|Feasibility assessed by percentage of days of app use|Feasibility assessed by trajectory of usage on a percent of days used on both a weekly and monthly time scale.|Acceptability assessed by percentage of patients who find the Purposeful app to be acceptable|Change in life purpose from baseline|Change in quality of life assessed using Functional Assessment of Cancer Therapy-Ovarian (FACT-O) Trial Outcome Index (TOI) (FACT-O TOI)|Change in quality of life assessed using Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)","University of Michigan Rogel Cancer Center|Rogel Cancer Center Cancer Control and Population Sciences O-SURE initiative","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","UMCC 2018.153|HUM00140226","September 2020","April 2023","April 2023","July 7, 2020",,"July 7, 2020","University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT04458168"
289,"NCT02329795","Image-derived Prediction of Response to Chemo-radiation in Glioblastoma","IDEPREG","Terminated","No Results Available","Glioblastoma","Radiation: Radiotherapy|Drug: Temozolomide","Sensitivity and specificity of predicted response|DICE-similarity coefficient and percentage overlap of 64Cu-ATSM and contrast-enhanced T1-weighted MRI|Correlation (volume and maximum values) between lactate and hypoxia","Rigshospitalet, Denmark","All","18 Years and older   (Adult, Older Adult)",,"16","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","192/13","October 2014","October 2016","October 2016","January 1, 2015",,"October 12, 2017","Department of Oncology, Section for Radiotherapy, Rigshospitalet, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT02329795"
290,"NCT04454450","Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer",,"Recruiting","No Results Available","Ovarian Cancer|High Grade Ovarian Serous","Diagnostic Test: PET/MRI|Diagnostic Test: Contrast enhanced CT","Comparison between radiologist tumor segmentation","Memorial Sloan Kettering Cancer Center","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","20-212","June 22, 2020","June 2022","June 2022","July 1, 2020",,"July 1, 2020","Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04454450"
291,"NCT04349787","Improving Optical Diagnosis of Colorectal Polyps Using CADx and BASIC.",,"Completed","No Results Available","Colorectal Cancer|Colorectal Polyp","Other: Computer-aided diagnosis (CADx)|Other: BLI Adenoma Serrated International Classification (BASIC)","Diagnostic accuracy of CADx versus endoscopists|Diagnostic accuracy of BASIC versus intuition|Diagnostic metrics of CADx|AUC of CADx|Diagnostic metrics of endoscopists|Diagnostic metrics of endoscopists for high confidence diagnosis|Interobserver agreement|Computation time of CADx","Maastricht University Medical Center|Catharina Ziekenhuis Eindhoven|Eindhoven University of Technology","All","18 Years and older   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","METC 2019-1231","November 26, 2019","March 8, 2020","March 8, 2020","April 16, 2020",,"April 16, 2020","Maastricht University Medical Center, Maastricht, Limburg, Netherlands",,"https://ClinicalTrials.gov/show/NCT04349787"
292,"NCT03994341","NEC Thermography Infrared Imaging Study",,"Recruiting","No Results Available","Necrotizing Enterocolitis","Diagnostic Test: A FLIR Thermovision a320M thermal IR camera","Region of interest inclusion|Accurate classification of heat distribution maps as NEC versus Normal","Ottawa Hospital Research Institute|Carleton Unniversity","All","26 Weeks to 42 Weeks   (Child)",,"15","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","NEC-01","August 13, 2019","June 1, 2021","June 1, 2022","June 21, 2019",,"September 6, 2019","Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03994341"
293,"NCT04012281","International Post PCI FFR Registry",,"Completed","No Results Available","Coronary Disease","Device: Percutaneous coronary intervention","Discrimination index of prediction model for target-vessel failure|Independent predictors for target vessel failure","Seoul National University Hospital|The First Affiliated Hospital with Nanjing Medical University|Tsuchiura Kyodo General Hospital|Keimyung University Dongsan Medical Center|Ulsan University Hospital|Busan Veterans General Hospital|Samsung Medical Center|Sejong General Hospital|Tokyo Medical University|Gifu Heart Center|Japanese Red Cross Kyoto Daini Hospital|Inje University","All","18 Years to 100 Years   (Adult, Older Adult)",,"2228","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","1906-152-1044","August 17, 2010","February 11, 2019","March 28, 2019","July 9, 2019",,"July 16, 2019",,,"https://ClinicalTrials.gov/show/NCT04012281"
294,"NCT03336411","A Personalized Diet Study to Reduce Glycemic Exposure",,"Recruiting","No Results Available","Pre-diabetes|Overweight and Obesity","Behavioral: mHealth|Behavioral: Personalized mHealth","Body weight, percent change|Body Composition|Metabolic Adaptation|Weight regain","NYU Langone Health|American Heart Association|Weizmann Institute of Science","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","17-00741","December 12, 2017","October 2020","May 2021","November 8, 2017",,"May 29, 2020","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03336411"
295,"NCT03517306","PET/CT Based Radiomics for Lung Cancer (PERL)",,"Recruiting","No Results Available","Lung Cancer","Other: No Interventions","Creation of a FDG PET/CT based radiomic score for survival|Validation of a FDG PET/CT based radiomic score for survival","Second Affiliated Hospital of Wenzhou Medical University|Beijing Chao Yang Hospital|General Hospital of Ningxia Medical University|Soochow University|First Affiliated Hospital of Wenzhou Medical University","All","18 Years and older   (Adult, Older Adult)",,"1500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","SAHoWMU-CR2018-05-223","May 1, 2018","May 31, 2019","September 28, 2019","May 7, 2018",,"April 4, 2019","Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT03517306"
296,"NCT01119703","Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2)",,"Completed","Has Results","Vaccine Response Impaired","Biological: Tetanus & Diphtheria booster vaccine (Td)|Biological: TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine]|Biological: Dukoral® Traveler's Diarrhea Vaccine (WC/rBS)","Antibody Titer Responses to Hepatitis B Virus Surface Antigen (HBV sAg) Vaccine, Measured and Predicted Based on Pre-vaccination Biomarkers in Healthy, Elderly Participants.|Antibody Titer Responses to Tetanus Booster Vaccine, Measured and Predicted Based on Pre-vaccination Biomarkers in Healthy, Elderly Participants.|Antibody Titer Responses to Reduced Diphtheria Toxin Vaccine, Measured and Predicted Based on Pre-vaccination Biomarkers in Healthy, Elderly Participants.|Antibody Titer Responses to Oral Cholera Vaccine (WC/rBS), Measured and Predicted Based on Pre-vaccination Biomarkers in Healthy, Elderly Participants.|Post-vaccination Antibody Titer Responses to Different Vaccines in Healthy, Elderly, Participants.|Antibody Titer Responses to Hepatitis B Virus Surface Antigen (HBV sAg) Vaccine, Measured and Predicted Based on Early Post-vaccination Biomarkers in Healthy, Elderly Participants.|Antibody Titer Responses to Tetanus Booster Vaccine, Measured and Predicted Based on Early Post-vaccination Biomarkers in Healthy, Elderly Participants.|Antibody Titer Responses to Reduced Diphtheria Toxin Vaccine, Measured and Predicted Based on Early Post-vaccination Biomarkers in Healthy, Elderly Participants.|Antibody Titer Responses to Oral Cholera Vaccine (WC/rBS), Measured and Predicted Based on Early Post-vaccination Biomarkers in Healthy, Elderly Participants.","Merck Sharp & Dohme Corp.","All","25 Years and older   (Adult, Older Adult)",,"174","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","0000-131|MK-0000-131","July 2010","November 2011","November 2011","May 7, 2010","November 22, 2012","December 29, 2015",,,"https://ClinicalTrials.gov/show/NCT01119703"
297,"NCT03366558","Identification of Motor Symptoms Related to Parkinson's Disease Using Motion Tracking Sensors at Home","KÄVELI","Unknown status","No Results Available","Parkinson Disease","Diagnostic Test: UPDRS questionnaires|Diagnostic Test: 20-step walking test","Accuracy of the classification of data from movement sensors in relation to the detected motor symptoms|Accuracy of the detection of the time when the Parkinson medicine was taken","Satakunta Central Hospital|Tampere University of Technology","All","30 Years and older   (Adult, Older Adult)",,"150","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","5137/31/2016","March 27, 2018","December 31, 2018","December 31, 2018","December 8, 2017",,"April 19, 2018","Satakunta Central Hospital, Unit of Neurology, Pori, Finland",,"https://ClinicalTrials.gov/show/NCT03366558"
298,"NCT03560661","Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS)","SPEECH-ALS","Completed","No Results Available","Amyotrophic Lateral Sclerosis|Primary Lateral Sclerosis|Kennedy's Disease",,"Number of patients in each patterns of dysarthria|Functional scale with the Norris score|Functional scale with the ALS functional rating scale-R (ALS FRS-R)|Severity of the dysarthria|Clinical examination","Assistance Publique - Hôpitaux de Paris|Centre National de la Recherche Scientifique, France","All","18 Years and older   (Adult, Older Adult)",,"71","Other","Observational","Observational Model: Other|Time Perspective: Prospective","NI17040J|2017-A03151-52","July 5, 2018","December 23, 2019","December 23, 2019","June 18, 2018",,"January 29, 2020","APHP - Hôpital Pitié-Salpêtriere, Paris, France",,"https://ClinicalTrials.gov/show/NCT03560661"
299,"NCT03379532","BCI-controlled NMES in Subacute Stroke",,"Recruiting","No Results Available","Stroke","Device: BCI-NMES|Device: Sham-NMES","Change in Upper Limb Fugl-Meyer Score, after treatment|Change in motor evoked potential amplitude of the paretic arm|Change in fractional anisotropy (FA) of the cortico-spinal tract as determined from diffusion tensor imaging|Change in electroencephalography functional connectivity","University Hospital, Geneva|Ecole Polytechnique Fédérale de Lausanne|Clinique Romande de Readaptation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","CRSII5-170985B","January 26, 2018","December 31, 2020","December 31, 2020","December 20, 2017",,"July 25, 2019","Division of Neurorehabilitation, University Hospital of Geneva, Geneva, GE, Switzerland|Clinique Romande de Readaptation, Sion, Switzerland",,"https://ClinicalTrials.gov/show/NCT03379532"
300,"NCT04039178","Efficacy of EMF BCI Based Device on Acute Stroke",,"Recruiting","No Results Available","Acute Stroke","Device: BQ|Device: Sham","Fugle Meyer (FM)|ARAT|BBT|TMT|NIHSS|Promis 10|MoCA|mRs|MRI-DTI|brain recovery biomarkers","BrainQ Technologies Ltd.","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","50","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","BQ3","September 4, 2018","April 2020","June 2020","July 31, 2019",,"July 31, 2019","BLK super specialty hospital, New Delhi, India",,"https://ClinicalTrials.gov/show/NCT04039178"
301,"NCT03559582","Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)",,"Enrolling by invitation","No Results Available","Tuberculosis",,"Measure area under the concentration curve (AUC) to anti-tuberculosis (TB) medications relative to TB treatment outcome in severe TB syndromes|Collect stool in patients undergoing pharmacokinetic testing to measure the environmental enteropathy index|Collect stool in patients undergoing pharmacokinetic testing to measure the quantitative burden and species distribution of enteric pathogens by the enteric TAC assay- 35 bacterial, viral, parasitic species)","University of Virginia|National Institute of Allergy and Infectious Diseases (NIAID)|Scientific Center for Family Health and Human Reproduction Problems, Russia|Kilimanjaro Christian Medical Centre, Tanzania|Haydom Lutheran Hospital|Mbarara University of Science and Technology|International Centre for Diarrhoeal Disease Research, Bangladesh|University of Florida","All","Child, Adult, Older Adult",,"713","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","18452|U01AI115594","April 28, 2016","September 2019","December 2019","June 18, 2018",,"June 13, 2019",,,"https://ClinicalTrials.gov/show/NCT03559582"
302,"NCT03174574","Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.","TCOG","Recruiting","No Results Available","Pancreas Cancer|Melanoma",,"Genomic and risk factor differences among family members who share identical predisposing CDKN2A gene mutations, with different phenotypes; will discover patterns of tumorigenesis, tissue specificity, gene-gene, and gene-environment interactions.","Mayo Clinic|National Cancer Institute (NCI)","All","18 Years and older   (Adult, Older Adult)",,"500","Other|NIH","Observational","Observational Model: Family-Based|Time Perspective: Prospective","16-005414|R01CA208517","August 17, 2016","June 30, 2021","July 31, 2021","June 2, 2017",,"September 24, 2019","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03174574"
303,"NCT03193515","A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer",,"Recruiting","No Results Available","Bladder Cancer",,"Sensitivity and specificity of multiplex ELISA assay will be confirmed by cystoscopy.|Sensitivity and specificity of multiplex ELISA assay will be compared to VUC and NMP22 BladderCheck.","Charles Rosser|Fred Hutchinson Cancer Research Center|University of Texas|Cedars-Sinai Medical Center","All","18 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Rosser-2015-6","December 30, 2016","December 30, 2021","December 30, 2022","June 20, 2017",,"March 31, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States|UT Southwestern Medical Center at Dallas, Dallas, Texas, United States|Kyoto University Graduate School of Medicine, Kyoto, Japan",,"https://ClinicalTrials.gov/show/NCT03193515"
304,"NCT04440553","A Mobile App to Increase Physical Activity in Students",,"Completed","No Results Available","Mobile Health|Physical Activity|Exercise|Mood|Machine Learning","Behavioral: Uniform random message delivery|Behavioral: Reinforcement learning message delivery","Steps (measured by phone pedometer)|Depression scores|Anxiety scores|Behavioral Activation","University of California, Berkeley","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","103","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","2019-04-12118","September 12, 2019","December 10, 2019","December 20, 2019","June 19, 2020",,"June 24, 2020","Caroline Figueroa, Berkeley, California, United States",,"https://ClinicalTrials.gov/show/NCT04440553"
305,"NCT04132362","Benefits of Personalised Music in Dementia - a Feasibility Study",,"Recruiting","No Results Available","Dementia","Behavioral: Personalised music listening","Median time (in hours) required to generate personalised music playlists for participants living with dementia assessed using activity logs recorded by researchers, carers and/or relatives/friends.|Acceptability by participants of the delivery method(s) of personalised playlists in care homes, assessed through qualitative methods such as feedback from participants (people living with dementia, their relatives/friends and their carers).|Extent of correlation between measures of emotional responses of people living with dementia to personalised music listening (using facial expression change algorithm) with direct observation by researchers, documented in activity logs.","Music for my Mind","All","Child, Adult, Older Adult",,"140","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","MFMM265263","November 28, 2019","December 31, 2021","December 31, 2021","October 18, 2019",,"February 19, 2020","Willow Court, Harpenden, Hertfordshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04132362"
306,"NCT04357236","18F-FDG PET Imaging Analysis of Antiepileptic Drug Response in BECTS",,"Completed","No Results Available","Benign Epilepsy With Centrotemporal Spikes",,"The 'area under curve' (AUC ) of our model in classification performance","Second Affiliated Hospital, School of Medicine, Zhejiang University","All","6 Years to 18 Years   (Child, Adult)",,"55","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2019-437","June 1, 2019","March 30, 2020","April 20, 2020","April 22, 2020",,"April 22, 2020","Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04357236"
307,"NCT02810093","Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis","SENOMETRY","Unknown status","No Results Available","Breast Cancer","Other: retrospective medical records analyze","Validate the reliability of a computer-based, automatic information retrieval method specific to medical records from breast cancer multidisciplinary meetings|Breast cancer recurrence rate after some therapeutic procedures","University Hospital, Strasbourg, France|Quantmetry","Female","18 Years and older   (Adult, Older Adult)",,"10000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","6373","May 2016","November 2016","December 2016","June 22, 2016",,"June 22, 2016","University Strasbourg Hospital, Strasbourg, France",,"https://ClinicalTrials.gov/show/NCT02810093"
308,"NCT03209102","Emotional Regulation and Impulsivity Among Adolescents With Borderline Personality Disorder","ADOLIMIS","Not yet recruiting","No Results Available","Borderline Personality Disorder|Adolescent Development","Other: Clinical assessment|Behavioral: Stress elicitation experiment|Other: Structural and Functional MRI|Biological: salivary collections of amylase and cortisol","Comparison between subjective and objective acute stress experience in BPD Adolescents vs Healthy controls|Investigating the neural correlates and modulation of motivation and impulsivity using structural and task-based fMRI","Institut National de la Santé Et de la Recherche Médicale, France","All","13 Years to 18 Years   (Child, Adult)","Phase 2","66","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","C16-58","July 2017","September 2019","September 2020","July 6, 2017",,"July 6, 2017",,,"https://ClinicalTrials.gov/show/NCT03209102"
309,"NCT03112928","Phantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLP",,"Recruiting","No Results Available","Phantom Limb Pain","Device: Phantom Motor Execution|Device: Phantom Motor Imagery","Pain Rating Index registered at the beginning (1st session) and at the end of the treatment (15th session).|Pain Disability Index registered at the beginning (1st session) and the end of the treatment (15th session).","Integrum|Chalmers University of Technology|Sahlgrenska University Hospital, Sweden|Örebro University, Sweden|Bräcke Diakoni, Sweden|University Rehabilitation Institute, Republic of Slovenia|University Hospital, Ghent|University Medical Center Groningen|University of New Brunswick|National University of Ireland, Galway, Ireland|Ruhr University of Bochum","All","18 Years and older   (Adult, Older Adult)","Not Applicable","66","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","007733","May 8, 2017","April 2020","April 2020","April 13, 2017",,"August 7, 2019","Rehabilitation Centre Ghent University Hospital, Ghent, East Flanders, Belgium|Institue of Biomedical Engineering, University of New Brunswick, Fredericton, New Brunswick, Canada|School of Psychology, National University of Ireland, Galway, Connacht, Ireland|University of Groningen, University Medical Center Groningen, Department of Rehabilitation Medicine, Groningen, Netherlands|University Rehabilitation Institute, Ljubljana, Slovenia|Ortopedteknik, Region Örebro län, Örebro, Närke, Sweden|Bräcke Diakoni, Stockholm, Uppland, Sweden|Gåskolan, Ortopedtekniska avdelningen, Göteborg, Västergötland, Sweden",,"https://ClinicalTrials.gov/show/NCT03112928"
310,"NCT03745118","Development of a Practical, Minimally Invasive Seizure Gauge",,"Enrolling by invitation","No Results Available","Epilepsy","Device: EpiTel EpiLog|Device: Byte Flies Sensor Dots|Device: Empatica E4|Device: Biovotion Everion|Device: GeneActiv","Assessment of Physiological Signals Measurable with Wearable Sensors|Pattern Analysis","Mayo Clinic","All","7 Years and older   (Child, Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","18-008357","November 19, 2018","December 1, 2020","December 2020","November 19, 2018",,"January 21, 2020","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03745118"
311,"NCT01505478","Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule",,"Withdrawn","No Results Available","Sepsis",,"28 day in-hospital mortality|ICU Admission","Beth Israel Deaconess Medical Center|New York University|United States Department of Defense","All","18 Years and older   (Adult, Older Adult)",,"0","Other|U.S. Fed","Observational","Observational Model: Cohort|Time Perspective: Prospective","2011P000356","July 2012",,,"January 6, 2012",,"April 5, 2017","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01505478"
312,"NCT03629743","Correlate of Surface Electroencephalogram (EEG) With Implanted EEG Recordings (ECOG)",,"Recruiting","No Results Available","Anesthesia","Device: EEG|Device: ECOG","Electrocardiogram (EEG) change before, during, and after anesthesia.|Electrocardiogram (EEG) change during any changes in conciousness.|Electrocardiogram (EEG) change during any seizures.","Stanford University","All","18 Years and older   (Adult, Older Adult)",,"20","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","45987","November 11, 2019","December 1, 2020","December 1, 2020","August 14, 2018",,"November 19, 2019","Stanford University, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT03629743"
313,"NCT04061434","ECG Algorithms for CRT Response Evaluation","OVERCOME","Recruiting","No Results Available","ECG Monitoring",,"Number of correctly assessed ECG signals by the automatic recognition of resynchronization in CRT-mediated therapy.|Correctly recognized ECG signals after adding each cycle of 20 new ECG recordings from patients with electrical heart function disturbances.|Number of registered ECG signals from patients holding a CIED.","Medical University of Warsaw|The National Centre for Research and Development","All","18 Years to 100 Years   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","OVERCOME","March 1, 2019","June 1, 2020","June 1, 2020","August 19, 2019",,"August 19, 2019","1st Department of Cariology of Medcial University of Warsaw, Warsaw, Mazowieckie, Poland",,"https://ClinicalTrials.gov/show/NCT04061434"
314,"NCT04005183","Renal Cell Carcinoma Microenvironment Discovery Project","REMEDY","Recruiting","No Results Available","Renal Cell Carcinoma",,"Molecular profiling of various cell populations within tumour by using single cell RNA-CITEseq.|Determination of the radiological and pathological features associated with the derived tumor microenvironment molecular data","University Health Network, Toronto|Celsus Therapeutics PLC","All","18 Years and older   (Adult, Older Adult)",,"300","Other|Industry","Observational","Observational Model: Other|Time Perspective: Prospective","17-5204","May 6, 2019","May 1, 2030","July 1, 2030","July 2, 2019",,"July 2, 2019","University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04005183"
315,"NCT04438967","Brain Health in the Time of COVID-19",,"Recruiting","No Results Available","Brain Health",,"Test the hypothesis that COVID-19 infection will lead to increased risk of neurological impairment|Determine cognitive and behavioral functional patterns that predict susceptibility to neurological impairment due to COVID-19","Miro Health|Johns Hopkins University|University of Pittsburgh","All","18 Years and older   (Adult, Older Adult)",,"10000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","MIRO_001_2020","June 16, 2020","December 31, 2020","December 31, 2020","June 19, 2020",,"July 7, 2020","Miro Health, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT04438967"
316,"NCT04273672","Speech, Linguistic and Acoustic Markers in Parkinson's Disease","SLAM-PD","Recruiting","No Results Available","Parkinson Disease|Cognitive Impairment, Mild|Speech","Diagnostic Test: Cognitive Battery|Behavioral: Voice, Speech and Language Analysis|Behavioral: Questionnaires and Clinical Assessments|Genetic: DNA Analysis","We will develop a regression model using speech acoustic parameters to classify PD participants by cognitive status (mild cognitive impairment [MCI] vs. normal cognition)|We will measure the difference in number and duration of within-utterance pauses, and pauses before verbs in PD participants with and without mild cognitive impairment|We will measure syntax processing efficiency score (percentage correctly understood sentences/processing time) in controls, and in PD with and without MCI","University of Massachusetts, Worcester|Sonde Health, Inc.|Massachusetts Institute of Technology/Lincoln Labs|Boston University|VA Puget Sound Health Care System","All","18 Years and older   (Adult, Older Adult)",,"150","Other|U.S. Fed","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","H00011523","January 13, 2020","February 2022","August 2022","February 18, 2020",,"February 18, 2020","UMass Medical School/UMass Memorial Medical Center, Worcester, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04273672"
317,"NCT03212534","Inpatient Mortality Prediction Algorithm Clinical Trial (IMPACT)","IMPACT","Unknown status","No Results Available","Decompensation, Heart|Decompensation; Heart, Congestive|Death","Other: Patient mortality prediction","In-hospital mortality|Hospital length of stay","Dascena|University of California, San Francisco","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1024","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","17-22319","July 2017","October 2017","October 2017","July 11, 2017",,"July 11, 2017","UCSF Moffit-Long Hospital, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT03212534"
318,"NCT04021069","Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer",,"Active, not recruiting","No Results Available","Breast Cancer|Invasive Ductal Breast Carcinoma|Invasive Lobular Breast Carcinoma","Diagnostic Test: Radiomic, pathomic, and clinical markers","Pathologic complete response (pCR)|Time to local breast recurrence|Time to distant metastasis (months)|Time to death","Sunnybrook Health Sciences Centre","All","18 Years and older   (Adult, Older Adult)",,"800","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","270-2018","August 30, 2018","December 30, 2019","August 30, 2024","July 16, 2019",,"July 16, 2019","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04021069"
319,"NCT03921242","Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease",,"Recruiting","No Results Available","Diabetes Mellitus, Type 2|Renal Insufficiency, Chronic","Drug: Metformin|Drug: Sulfonylurea|Drug: DPP-4 inhibitor|Drug: SGLT2 inhibitor|Drug: GLP1 receptor agonist","Incidence of Severe Hypoglycemia Assessed from EMR|Difference in Glycosylated Hemoglobin (HbA1c) level (mmol/mol)|Heterogeneity of Treatment Effect Via Pre-specified Sub-Group Analyses|Incidence of acidosis, hospitalization for hyperglycemia, acute myocardial infarction, stroke, heart failure hospitalization, and heart failure emergency room visits|Difference in Body-Mass Index Assessed From EMR (BMI) (kg/m2)|Difference in Laboratory-Measured eGFR (mL/min)","Weill Medical College of Cornell University|Patient-Centered Outcomes Research Institute","All","18 Years and older   (Adult, Older Adult)",,"16000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","1809019555","August 1, 2019","March 1, 2021","March 1, 2021","April 19, 2019",,"September 26, 2019","University of North Carolina, Chapel Hill, North Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT03921242"
320,"NCT04186975","Computerized Antepartum Monitoring Using Non-invasive Fetal Ecg for High Risk Pregnancy",,"Not yet recruiting","No Results Available","Cardiotocography","Device: Non-Invasive fetal ECG|Device: Fetal heart rate monitor","Identification of abnormal fetal heart rate from NI-FECG|Computerized NI-FECG for the prediction of abnormal FHR traces|Comparison between computerized CTG and NI-FECG|Develop a portable NI-FECG monitor for remote fetal monitoring.","Rambam Health Care Campus|Technion, Israel Institute of Technology","Female","18 Years to 50 Years   (Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","0529-19-RMB","December 1, 2019","December 1, 2023","December 1, 2023","December 5, 2019",,"December 5, 2019",,,"https://ClinicalTrials.gov/show/NCT04186975"
321,"NCT01775826","Validating Machine -Learned Classifiers of Sedentary Behavior and Physical Activity","iWatch","Completed","No Results Available","Physical Activity|Sedentary Lifestyle","Other: Measurement","physical activity behavior classification using study sensors (accelerometers, Sensecam and GPS)","University of California, San Diego","All","6 Years to 85 Years   (Child, Adult, Older Adult)","Not Applicable","225","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1R01CA164993-01A1","March 2013","April 2016","April 2016","January 25, 2013",,"August 20, 2019","UCSD, La Jolla, California, United States",,"https://ClinicalTrials.gov/show/NCT01775826"
322,"NCT03882671","Development of a Minimally Invasive Seizure Gauge",,"Enrolling by invitation","No Results Available","Epilepsy","Device: EpiTel Epilog|Device: Empatica E4|Device: GENEActiv","Multimodal Assessment of Physiological Signals During Seizure Events Measurable with Wearable Sensors|Wearable Sensors Comfort Assessment|Seizure Detection and Prediction using Multimodal Physiological Data","Seer Medical Pty Ltd","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HREC042_18","January 1, 2019","December 1, 2020","December 1, 2020","March 20, 2019",,"March 20, 2019","Seer Medical, Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT03882671"
323,"NCT04306939","Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study","GREAT1","Recruiting","No Results Available","Chronic Pancreatitis|Inflammatory Bowel Diseases|Hepatitis|NASH - Nonalcoholic Steatohepatitis|Acute Pancreatitis|Rheumatoid Arthritis|Diabetes Mellitus|Dyslipidemias|Multiple Sclerosis|Irritable Bowel Syndrome|Chronic Pain|Chronic Disease|Chronic Kidney Diseases|Crohn Disease|Celiac Disease|Biliary Cirrhosis|Bile Acid Synthesis Defect|Gastritis|Cholecystitis|Cholelithiases|IPMN|Cyst Pancreas|Cystic Fibrosis|Pancreatic Exocrine Insufficiency|Diarrhea Chronic|Constipation - Functional|Constipation Chronic Idiopathic","Other: venipuncture|Behavioral: Questionnaires|Other: Additional Sample Collections","Define the molecular disorders contributing to clinicopathological disease definitions for common complex disorders|Define risk factors for disease progression, severity, complications and poor quality of life.|Common disease mechanisms and repurposing of medications.|Pain profile|Patient Reported Global Health Assessment","University of Pittsburgh","All","12 Years and older   (Child, Adult, Older Adult)",,"120000","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","STUDY19020035","November 1, 2014","December 1, 2025","December 1, 2025","March 13, 2020",,"April 3, 2020","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04306939"
324,"NCT02991105","Epidemiology of Cancer After Solid Organ Transplantation - EpCOT Study","EpCOT","Not yet recruiting","No Results Available","Malignancy",,"Cancer-related mortality after solid organ transplantation|Risk for cancer after solid organ transplantation|Associated morbidity after developing cancer after solid organ transplantation|Risk prediction for cancer after solid organ transplantation","University Hospital Birmingham NHS Foundation Trust","All","Child, Adult, Older Adult",,"85410","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","EpCOT","August 2020","February 2023","February 2023","December 13, 2016",,"June 12, 2020","University Hospitals Birmingham NHS Foundation Trust, Birmingham, West Midlands, United Kingdom|University of Birmingham, Birmingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02991105"
325,"NCT03896529","Neurobiological Mechanisms of Aging and Stress on Prospective Navigation",,"Recruiting","No Results Available","Aging|Anxiety|Memory Impairment","Behavioral: Anticipatory psychological stress","Behavioral probability of taking a shortcut between control and treatment groups|fMRI activation level between control and treatment groups|Neural memory representation reactivation between control and treatment groups|Relationship between fMRI activity level and behavioral probability of taking a shortcut.|2. Salivary cortisol (stress hormone) response difference between stress and control participant groups.","Georgia Institute of Technology","All","65 Years to 80 Years   (Older Adult)","Not Applicable","85","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","H18233","September 24, 2019","March 31, 2021","March 31, 2021","April 1, 2019",,"April 24, 2020","Center for Advance Brain Imaging, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT03896529"
326,"NCT03785028","Analysis of Electrocorticographic Signals",,"Recruiting","No Results Available","Epilepsy","Behavioral: working memory and attention","Experiment 1.b. Prioritization cue-related changes in the neural representation of stimuli|Experiment 1.b. Prioritization cue-related changes in phase-amplitude coupling|Experiment 3.b. Covert spatial attention-related changes in phase-amplitude coupling","University of Wisconsin, Madison","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015-0282","July 19, 2019","December 2023","December 2023","December 24, 2018",,"August 5, 2019","University of Wisconsin, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03785028"
327,"NCT03797339","Multi-omics Study of Clinical Endpoints in CHD","OmiDETCHD","Recruiting","No Results Available","Coronary Heart Disease","Other: risk factors of adverse cardiovascular events|Other: multi-omics target discovery|Other: validation|Other: Predictive mathematical models","Death|MACE|Bleeding|Statin-induced myopathy (SIM)|CI-AKI","Guangdong Provincial People's Hospital|RenJi Hospital|West China Hospital|Xiangya Hospital of Central South University|First Affiliated Hospital, Sun Yat-Sen University","All","18 Years to 80 Years   (Adult, Older Adult)",,"4000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2017YFC0909301","July 1, 2017","December 31, 2019","December 31, 2020","January 9, 2019",,"February 12, 2019","Guangdong General Hospital, Guangzhou, Guangdong, China|The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|XiangYa Hospital Central South University, Changsha, Hunan, China|Renji Hospital Affiliated to Shanghai Jiaotong University, Shanghai, Shanghai, China|West China Hospital, Sichuan University, Chengdu, Sichuan, China",,"https://ClinicalTrials.gov/show/NCT03797339"
328,"NCT02641145","Molecular Imaging of Primary Amyloid Cardiomyopathy","MICA","Recruiting","No Results Available","Amyloidosis, Primary|Cardiomyopathy","Radiation: F-18 florbetapir/C-11 acetate PET|Device: MRI|Radiation: N-13 ammonia PET","Change in F-18 florbetapir myocardial retention index from baseline to 6 months and 12 months|Change in Serum oxidative stress markers from baseline to 6 months and 12 months|Change in Myocardial oxidative metabolism markers from baseline to 6 months|Change in Magnetic resonance imaging markers from baseline to 6 months and 12 months|Change in Myocardial energy efficiency from baseline to 6 months|Light Chain Toxicity|Understand the role of gut microbiota and heavy metals in the pathogenesis of AL Amyloidosis","Brigham and Women's Hospital|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)|American Heart Association","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","125","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2015P002477|1R01HL130563-01A1","April 1, 2016","March 30, 2020","April 2020","December 29, 2015",,"August 2, 2019","Brigham and Womens' Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02641145"
329,"NCT01140724","Personalizing Perioperative Analgesia in Children",,"Active, not recruiting","No Results Available","Postoperative Pain",,"Look at polymorphisms in genes that regulate pain perception, opioid transport and opioid receptor signaling to see if there is a higher susceptibility to pain and morphine requirement.|Evaluate relationship of pupil reaction and response to 5% carbon dioxide to adverse effects of morphine","Indiana University|Children's Hospital Medical Center, Cincinnati|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","6 Years to 15 Years   (Child)",,"1200","Other|NIH","Observational","Observational Model: Other|Time Perspective: Prospective","1707325115|7R01HD089458-02","April 2008","April 2020","April 2021","June 9, 2010",,"May 23, 2019","Riley Hospital for Children, Indianapolis, Indiana, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT01140724"
330,"NCT03979573","Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate Cancer","PROMM-AS","Recruiting","No Results Available","Prostate Cancer","Diagnostic Test: Multiparametric MRI|Diagnostic Test: Radiomics|Diagnostic Test: MR-guided Biopsy|Diagnostic Test: Molecular Markers","Reduction of the discontinuation of Active Surveillance (AS)|Value of MRI (ADC) regarding aggressiveness|Detectionrates of targeted (FUS-GB) versus systematic (TRUS-GB) biopsies|Correlation of clinical parameters with Gleason score progression or MRI quantified progression|Patient compliance to recommended MRI-based observation|Evaluation of Resolve DWI","Heinrich-Heine University, Duesseldorf","Male","Child, Adult, Older Adult","Not Applicable","90","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","5941R","October 1, 2017","September 30, 2020","September 30, 2021","June 7, 2019",,"June 7, 2019","University Düsseldorf, Medical Faculty, Dusseldorf, NRW, Germany",,"https://ClinicalTrials.gov/show/NCT03979573"
331,"NCT04358536","Classification of COVID-19 Infection in Posteroanterior Chest X-rays",,"Completed","No Results Available","COVID-19","Device: CovX","Identification of COVID-19","Dascena","All","18 Years and older   (Adult, Older Adult)",,"230","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","04202002","April 1, 2020","April 17, 2020","April 17, 2020","April 24, 2020",,"April 24, 2020","Dascena, Oakland, California, United States",,"https://ClinicalTrials.gov/show/NCT04358536"
332,"NCT02556567","Exploring the Effects of Sleep Patterns and Physical Activity on Asthma in Adolescents With Wrist-worn Smart Devices",,"Completed","No Results Available","Asthma","Other: Fitbit® Charge Heart Rate (HR) wristband","Asthma Symptoms , Sleep Patterns and Physical Activity|Risk of Increasing Asthma Symptoms","Arkansas Children's Hospital Research Institute|University of Arkansas|University of Florida","All","14 Years to 17 Years   (Child)","Not Applicable","23","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","204310","August 2015","June 2016","December 2016","September 22, 2015",,"June 28, 2018","Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States",,"https://ClinicalTrials.gov/show/NCT02556567"
333,"NCT03530098","Validation of an Artificial Intelligence-based Algorithm for Skeletal Age Assessment",,"Completed","No Results Available","Bone Age","Device: BoneAgeModel","Paired Difference of Skeletal Age Estimate|Time Saved","Stanford University","All","1 Year to 18 Years   (Child, Adult)","Not Applicable","1903","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRB #44764","July 12, 2018","October 1, 2019","November 1, 2019","May 21, 2018",,"February 12, 2020","Stanford University, Stanford, California, United States|Yale New Haven Hospital, New Haven, Connecticut, United States|Boston Children's Hospital, Boston, Massachusetts, United States|New York University, New York, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03530098"
334,"NCT04015895","Implementation of a Tool to Identify Social Weaknesses in the Cancer Care Pathway","iDEFCO","Recruiting","No Results Available","Cancer","Other: DEFCO tool","Population reach|Tool adaptation by professionals|Change from 6 months PACIC questionnaire result at 12 months|Evaluation of effectiveness in real life by PPE|Change from baseline FACT-G questionnaire result at 12 months|Change from baseline HAD questionnaire result at 12 months|Evaluation of practices effectiveness by using the tool|Evaluation of effectiveness of practices by Personalized Care Project|Evaluation of effectiveness of practices by identification of support systems|Evaluation of effectiveness of practices by patient's satisfaction: questionnaire|Evaluation of effectiveness of practices by caregiver's satisfaction offering the tool: questionnaire|Maintenance and institutionalization|Change from baseline interview with professional at 12 months","Centre Hospitalier Universitaire de Saint Etienne|Ligue contre le cancer, France","All","18 Years and older   (Adult, Older Adult)",,"850","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","18CH176|2018-A03310-55","December 4, 2019","September 2020","September 2021","July 11, 2019",,"January 9, 2020","Centre Jean Perrin, Clermont-Ferrand, France|Hospices Civils de Lyon, Lyon, France|Chu Saint-Etienne, Saint-Étienne, France|Hôpital Privé de la Loire, Saint-Étienne, France",,"https://ClinicalTrials.gov/show/NCT04015895"
335,"NCT04004559","MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)","RBC-02","Recruiting","No Results Available","Invasive Breast Cancer|Neoadjuvant Chemotherapy|Radiomics|Axillary Lymph Node|Prognosis","Other: No interventions","Disease free survival (DFS)|pathological complete response (pCR)|Pathological axillary lymph node status|Overall survival (OS)|Breast cancer specific motality (BCSM)|Recurrence free survival (RFS)","Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Sun Yat-sen University|Tungwah Hospital of Sun Yat-Sen University","Female","18 Years to 75 Years   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","SYSEC-KY-KS-2019-055-001","May 28, 2019","October 30, 2020","May 30, 2025","July 2, 2019",,"June 29, 2020","Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China|Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China|Sun Yat-Sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04004559"
336,"NCT04300270","Validation of a Novel Smartphone-based Method for Heart Rhythm Monitoring in the Home Environment",,"Recruiting","No Results Available","Atrial Fibrillation|Atrial Flutter|Arrhythmia","Device: Smartphone PPG recordings|Device: Smartphone ECG","Performance of the novel smartphone-based photoplethysmographic method for heart rhythm diagnostics and discrimination of atrial fibrillation from normal heart rhythm.|Independent predictors for recurrence of atrial fibrillation within 30 days of treatment with direct current cardioversion.|Predictors for recurrence of atrial fibrillation within 30 days of treatment with direct current cardioversion using deep learning and machine learning techniques.|Participant compliance for recording heart rhythm with the novel smartphone-based method twice daily for 30 days.|Correlation between patient self-reported symptoms and recorded heart rhythm.|Proportion of same day cancellations for planned treatment of atrial fibrillation with cardioversion for patients using the novel smartphone-based photoplethysmographic method for heart rhythm monitoring prior to the treatment compared to no monitoring.","Karolinska Institutet|Danderyd Hospital","All","18 Years and older   (Adult, Older Adult)",,"480","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SmartBeats","November 27, 2018","June 2020","December 2021","March 9, 2020",,"March 9, 2020","Danderyd University Hospital, Stockholm, Sweden",,"https://ClinicalTrials.gov/show/NCT04300270"
337,"NCT04200326","Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled Asthma","TWINKLE","Completed","No Results Available","Severe Uncontrolled Asthma",,"Sentiment score|Emotion confidence score|Key phrase extraction|Message analysis|PEF|FEV1|FEV1/FVC|ACQ-6 Score|SGRQ Score|daily UMotif measure","AstraZeneca","All","18 Years to 75 Years   (Adult, Older Adult)",,"5","Industry","Observational","Observational Model: Other|Time Perspective: Prospective","D3250R00061","December 20, 2019","April 9, 2020","April 9, 2020","December 16, 2019",,"April 22, 2020","Research Site, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04200326"
338,"NCT03826407","Development of a Point of Care System for Automated Coma Prognosis",,"Recruiting","No Results Available","Coma, Traumatic|Coma",,"Change in multiple electrophysiological measures across specified time points during coma|Correlation between behavioral and electrophysiological measures after coma emergence|Sensitivity and specificity changes in prognostic capabilities of electrophysiological measures|Coma etiology|Age in months","McMaster University|Canadian Institutes of Health Research (CIHR)|Natural Sciences and Engineering Research Council, Canada|Hamilton Health Sciences Corporation|Brain Vision Solutions Inc.|McGill University","All","18 Years and older   (Adult, Older Adult)",,"70","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ComaML2018|CPG158287|CHRP 523461-18","January 2019","December 31, 2020","March 31, 2021","February 1, 2019",,"February 1, 2019","McMaster University / Hamilton Health Sciences, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03826407"
339,"NCT04086849","Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers",,"Recruiting","No Results Available","Head and Neck Neoplasm|Squamous Cell Carcinoma of Head and Neck","Diagnostic Test: Radiomic, pathomic, and clinical markers","Time to locoregional recurrence|Time to distant metastasis|Time to death","Sunnybrook Health Sciences Centre","All","18 Years and older   (Adult, Older Adult)",,"450","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","087-2019","July 30, 2019","December 30, 2024","June 30, 2025","September 12, 2019",,"September 13, 2019","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04086849"
340,"NCT03674255","Echocardiography: Value and Accuracy at REst and STress","EVAREST","Enrolling by invitation","No Results Available","Coronary Artery Disease|Ischaemic Heart Disease|Angina Pectoris",,"Assessment of Prognostically Significant CAD|Examination of Medical Records|Quantification of Extracellular Vesicles (obtained from blood samples) by Flow Cytometry|Assessment of Time to Diagnosis|Analysis of Potential Cost Savings Through the Use of Novel Biomarkers By the Reduction in Unnecessary Procedures|Investigation into the use of stress echocardiography as a clinical procedure in the UK.","University of Oxford|Oxford University Hospitals NHS Trust|Royal United Hospital Bath NHS Trust|Tameside Hospital NHS Foundation Trust|Royal Berkshire NHS Foundation Trust|East Lancashire Hospitals NHS Trust|Bradford Teaching Hospitals NHS Foundation Trust|Calderdale and Huddersfield NHS Foundation Trust|Great Western Hospital NHS Foundation Trust|Mid Essex Hospital NHS Trust|Buckinghamshire Healthcare NHS Trust|Wrightington, Wigan and Leigh NHS Foundation Trust|Chelsea and Westminster Hospital NHS Foundation Trust|Milton Keynes University Hospital NHS Foundation Trust|University Hospitals Bristol NHS Foundation Trust|North Middlesex University Hospital|Northumbria Healthcare NHS Foundation Trust|London North West Healthcare NHS Trust|St George's University Hospitals NHS Foundation Trust|Ultromics Ltd|National Institute for Health Research, United Kingdom|King's College Hospital NHS Trust|Guy's and St Thomas' NHS Foundation Trust|Poole Hospital NHS Foundation Trust|Blackpool Teaching Hospitals NHS Foundation Trust|Mid Yorkshire Hospitals NHS Trust|Northampton General Hospital NHS Trust|North West Anglia NHS Foundation Trust|Yeovil District Hospital NHS Foundation Trust|East Suffolk and North Essex NHS Foundation Trust|Nottingham University Hospitals NHS Trust|Hampshire Hospitals NHS Foundation Trust|Lantheus Medical Imaging","All","18 Years and older   (Adult, Older Adult)",,"23000","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","18100","March 2015","March 2020","January 2032","September 17, 2018",,"March 10, 2020",,,"https://ClinicalTrials.gov/show/NCT03674255"
341,"NCT04424121","CCTA, CACS and ECG Stress Testing in Patients With Suspected CAD: Precision Phenotyping and Financial Evaluation","DATASET","Not yet recruiting","No Results Available","Stable Angina|Coronary Artery Disease|Atherosclerosis|Coronary Artery Calcification","Diagnostic Test: CCTA","Major Adverse Cardiac Events (MACE)|Chest-pain rehospitalization|Frequency of angina [Seattle Angina Questionnaire (SAQ)]|Generic health status [Medical Outcomes Study 12-Item Short Form (SF-12)]","Aristotle University Of Thessaloniki|Lefkos Stavros The Athens Clinic|Affidea Kozani Cardiac Imaging Center|National and Kapodistrian University of Athens","All","18 Years and older   (Adult, Older Adult)","Not Applicable","900","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","DATASET PRECISE_01062020_03448","January 1, 2021","June 30, 2023","December 31, 2023","June 9, 2020",,"June 9, 2020","Lefkos Stavros The Athens Clinic, Athens, Greece|National and Kapodistrian University of Athens, School of Medicine, Athens, Greece|Affidea Kozani Cardiac Imaging Center, Kozáni, Greece|Aristotle University of Thessaloniki, School of Medicine, Thessaloníki, Greece",,"https://ClinicalTrials.gov/show/NCT04424121"
342,"NCT04369053","Prevention of Colorectal Cancer Through Multiomics Blood Testing","PREEMPT CRC","Recruiting","No Results Available","Colon Cancer|Rectal Cancer|Colon Neoplasm|Colon Diseases|Colon Lesion|Colon Polyp|Colorectal Cancer|Polyp|Adenoma|Rectal Diseases|Gastrointestinal Tract Cancers","Diagnostic Test: Freenome test","Sensitivity for CRC of the Freenome test|Specificity of the Freenome test","Freenome, Inc.","All","45 Years to 85 Years   (Adult, Older Adult)",,"14000","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","FRNM-004","May 20, 2020","July 30, 2021","July 30, 2021","April 30, 2020",,"July 8, 2020","IACT Health, Columbus, Georgia, United States|Quincy Medical Group, Quincy, Illinois, United States|American Health Network of Indiana, LLC, Muncie, Indiana, United States",,"https://ClinicalTrials.gov/show/NCT04369053"
343,"NCT03525054","Semantic and Syntactic Computerized Analysis of Free Speech","ASESID","Recruiting","No Results Available","Psychotic Disorders|Psychosis|Schizophrenia and Related Disorders|Schizophrenia Prodromal|Diagnosis, Psychiatric",,"Transition to schizophrenia|Identification of patients at ""ultra high risk "" for developing schizophrenia","University Hospital, Brest","All","15 Years to 30 Years   (Child, Adult)",,"150","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ASESID (29BRC17.0198)","May 18, 2018","May 18, 2022","May 18, 2022","May 15, 2018",,"July 2, 2018","CHRU de Brest, Brest, France|CH de SAINT ANNE, Paris, France",,"https://ClinicalTrials.gov/show/NCT03525054"
344,"NCT03569176","Examining the Efficacy of a Mobile Therapy for Children With Autism Spectrum Disorder",,"Completed","No Results Available","Autism Spectrum Disorder","Device: Autism Glass","Change in socialization subscale scores of the Vineland Adaptive Behavior Scales, 2nd Edition (VABS-II) from baseline to week 6.|Change in Parent Rated Social Responsiveness Scale 2 (SRS-2) from baseline to week 6|Change in NEPSY-II, Affect Recognition subscale scores from baseline to week 6|Change in Emotion Guessing Game (EGG) scores from baseline to week 6|Change in ASD symptoms as measured by Brief Observation of Social Communication Change (BOSCC) from baseline to week 6|Change in adaptive social and personal skills as measured by Vineland Adaptive Behavior Scales, 2nd edition (VABS-II) Full Scale from baseline to week 6.|Change in child's emotional, behavioral, and social problems from Baseline (week 0) to Week 6 as measured by Child Behavior Checklist (CBCL).","Dennis Paul Wall|Stanford University","All","6 Years to 12 Years   (Child)","Not Applicable","74","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IRB-34059","November 1, 2016","April 11, 2018","April 15, 2018","June 26, 2018",,"July 17, 2018",,,"https://ClinicalTrials.gov/show/NCT03569176"
345,"NCT03419520","GENYAL Study to Childhood Obesity Prevention",,"Completed","No Results Available","Childhood Onset Obesity","Behavioral: Nutritional counseling","Changes in the percentage of children with a diagnosis of obesity|Changes in energy intake|Changes in body fat mass percentage|Physical activity|Genetic predisposition to develop obesity","IMDEA Food","All","6 Years to 7 Years   (Child)","Not Applicable","221","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","IMD PI0024","February 15, 2017","March 30, 2017","March 30, 2017","February 5, 2018",,"August 13, 2019","IMDEA-Food, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT03419520"
346,"NCT04193085","Wearable Technology to Assess Gait Function in SMA and DMD",,"Recruiting","No Results Available","Spinal Muscular Atrophy Type 3|Duchenne Muscular Dystrophy",,"Validation of Instrumented Insoles: Six Minute Walk Test|Validation of Instrumented Insoles: 10 Meter Walk/Run|Validation of Instrumented Insoles: Time Up and Go Test (TUG)|Validation of Instrumented Insoles: Straight Line Walking|Validation of Instrumented Insoles: Circle Walking|Muscle Strength Testing with Hand-held Dynamometry (HHD)|Free-living Testing of Instrumented Insoles","Columbia University|Muscular Dystrophy Association|Stevens Institute of Technology","All","5 Years and older   (Child, Adult, Older Adult)",,"39","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","AAAS5641","November 25, 2019","December 31, 2020","December 31, 2020","December 10, 2019",,"December 11, 2019","Columbia University Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04193085"
347,"NCT00435097","Computer Assisted Early Detection of Liver Metastases From fMRI Maps",,"Unknown status","No Results Available","Metastatic Colorectal Cancer",,,"Hadassah Medical Organization","All","20 Years and older   (Adult, Older Adult)",,,"Other","Observational","Observational Model: Defined Population|Primary Purpose: Screening|Time Perspective: Longitudinal|Time Perspective: Prospective","colmri-HMO-CTIL",,,,"February 14, 2007",,"February 14, 2007","Hadassah Medical Organization, Jerusalem, Israel|Hebrew University, Jerusalem, Israel",,"https://ClinicalTrials.gov/show/NCT00435097"
348,"NCT04235127","The Catalonia Suicide Risk Code Epidemiology Study: an Epidemiological Study of Suicide Attempts in Catalonia, Spain","CSRC-Epi","Active, not recruiting","No Results Available","Suicide, Attempted|Suicide|Suicide and Self-harm","Other: sociodemographic variables, somatic conditions, mental disorders, treatment and drug use","Number of catalan residents with suicide attempt (incidence)|Number of Catalan residents committing suicide (incidence)","Hospital del Mar Research Institute (IMIM)|Catalan Agency for Health Information, Assessment and Quality|National Centre for Suicide Research and Prevention, Norway|Harvard Medical School","All","10 Years and older   (Child, Adult, Older Adult)",,"186000","Other","Observational","Observational Model: Case-Control|Time Perspective: Other","CSRC-EPI (2017/7431/I)","June 2014","December 2019",,"January 21, 2020",,"January 28, 2020",,,"https://ClinicalTrials.gov/show/NCT04235127"
349,"NCT03422770","Ultrasonic Markers for Myocardial Fibrosis and Prognosis in Aortic Stenosis",,"Recruiting","No Results Available","Aortic Valve Stenosis|Myocardial Fibrosis","Diagnostic Test: Echocardiography|Diagnostic Test: MRI|Diagnostic Test: Blood test|Diagnostic Test: ECG and Holter-ECG|Diagnostic Test: 6 min walking test","Cardiovascular morbidity and mortality|All cause mortality|Time of first re-hospitalisation|Cardiac systolic function|Cardiac diastolic function","Norwegian University of Science and Technology|St. Olavs Hospital|Oslo University Hospital","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","2017/1068","January 9, 2018","January 2021","January 2021","February 6, 2018",,"February 20, 2020","Department of Circulation and Medical Imaging, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT03422770"
350,"NCT04420793","Voice Changes During ECT","VAPRE","Recruiting","No Results Available","Unipolar Depression|Bipolar Depression|Bipolar Disorder, Manic","Other: Questionnaire","Acoustic feature: zero crossing rate|Acoustic feature: energy and entropy|Acoustic feature: spectral centroid, spectral spread, spectral entropy, spectral flux, spectral rolloff|Acoustic feature: Mel-Frequency Cepstral Coefficients, Chroma Vectors, and Chroma Deviation|Linguistic features: question ratio, filler ratio, number ratio, type token ratio|Linguistic features: verb frequency, noun frequency, pronoun frequency, adverb frequency, adjective frequency, particle frequency, conjunction frequency, pronoun frequency|Linguistic features: standardized word entropy|Linguistic features: Brunets index|Linguistic features: Honores statistic|Linguistic features: rate of speech|Meta-features: fatigue|Meta-features: audio quality|Meta-features: sentiment|Meta-features: stress|Meta-features: gender|Meta-features: accent|Meta-features: length|Meta-features: age|Comparing the voice feature(s) with greatest statistically significant change to Patient Health Questionnaire (PHQ)-9 scores|Acoustic Feature Specific Changes within and across sessions|Linguistic Feature Specific Changes within and across sessions|Meta-Feature Specific Changes within and across sessions|Acoustic Feature Specific Changes between sessions|Linguistic Feature Specific Changes between sessions|Meta-Feature Specific Changes between sessions|Patient Chart Review Data: Age|Patient Chart Review Data: inpatient/outpatient status|Patient Chart Review Data: gender|Patient Chart Review Data: race|Patient Chart Review Data: Psychiatric diagnosis for ECT|Patient Chart Review Data: PHQ-9 score at each session|Patient Chart Review Data: Psychiatric hospitalizations|Patient Chart Review Data: Past Psychiatric Medication Trials|Patient Chart Review Data: Current Psychiatric Medication Trials|Patient Chart Review Data: Classes of Current Psychiatric Medications|Patient Chart Review Data: Suicidal Ideation at ECT consult|Patient Chart Review Data: Past Suicide Attempts|Patient Chart Review Data: Psychiatric Review of Systems|Patient Chart Review Data: Family Psychiatric History|Patient Chart Review Data: Number of non-psychiatric medical diagnoses|Patient Chart Review Data: Past non-psychiatric medication trials|Patient Chart Review Data: Current non-psychiatric Medications|Patient Chart Review Data: Tobacco use history|Patient Chart Review Data: Tobacco use pack year|Patient Chart Review Data: Prior ECT treatment|Patient Chart Review Data: total # of prior ECT treatments for response in the past|Patient Chart Review Data: Prior transcranial magnetic stimulation (TMS) treatment|Patient Chart Review Data: Prior response to ECT or TMS|Patient Chart Review Data against voice features|Generating ROC curves: stress|Generating ROC curves: fatigue|Generating ROC curves: sentiment","Medical University of South Carolina","All","18 Years to 89 Years   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","00089198","November 7, 2019","June 30, 2021","June 30, 2021","June 9, 2020",,"June 9, 2020","Medical University of South Carolina, Charleston, South Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04420793"
351,"NCT03342716","Resolution of Organ Injury in Acute Pancreatitis - RESORP","RESORP","Active, not recruiting","No Results Available","Pancreatitis, Acute",,"Annual incidence of new-onset type 3c diabetes mellitis in patients with AP|Nested cohort only - difference in the 3 month to 36 month change in pancreatic fibrosis index between participants with AP with MODS and those with AP without MODS|Specific gene and promoter sequence variation between participants with AP and AP-MODS|miRNA signatures of disease severity and resolution|Metabolomic profiling of AP resolution.|Incidence of premature cellular senescence as a pathological consequence of AP-MODS.|Alteration in immune cell subset phenotype as a long-term response to AP-MODS|Cardiorespiratory dysfunction as a legacy of endothelial injury during AP-MODS","University of Edinburgh|Medical Research Council","All","16 Years and older   (Child, Adult, Older Adult)",,"229","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","v11 23 Sept 2019|MR/P008887/1","November 27, 2017","May 2023","May 2023","November 17, 2017",,"June 11, 2020","Royal Infirmary of Edinburgh, Edinburgh, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03342716"
352,"NCT04400253","South Asians Active Together (SAATH) Study",,"Not yet recruiting","No Results Available","Physical Inactivity|South Asian","Behavioral: SAATH Intervention","Averaged daily minutes spent in moderate- and vigorous-intensity physical activity measured by ActiGraph accelerometers|Averaged daily minutes spent in walking or running behavior measured by ActiGraph accelerometers|Averaged daily hours spent in sedentary behaviors measured by ActiGraph accelerometers|Systolic and diastolic blood pressure (mmHg) measured by a sphygmomanometer|Self-efficacy score measured by the Exercise Confidence Survey|Self-efficacy score measured by Dishman's Barriers to Self-Efficacy questionnaire","Northwestern University|Skokie Health Department|Skokie Park District|University of Illinois at Chicago|Metropolitan Asian Family Services|University of Chicago|Ann & Robert H Lurie Children's Hospital of Chicago","Female","11 Years and older   (Child, Adult, Older Adult)","Not Applicable","320","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","STU00211374:","September 1, 2020","July 31, 2024","July 31, 2024","May 22, 2020",,"June 9, 2020",,,"https://ClinicalTrials.gov/show/NCT04400253"
353,"NCT04376853","CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch","CoronaWatch","Recruiting","No Results Available","COVID-19","Device: Apple Watch Series 5","Biomarker|Protective factors|SmartWatch compliance|Arrhythmias|QT time changes|Longitudinal risk models","University Hospital Heidelberg|The German Heart Foundation|Klaus Tschira Stiftung|Freunde und Förderer der Kardiologie Heidelberg","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CoronaWatch","April 15, 2020","June 2020","July 2020","May 6, 2020",,"May 6, 2020","Department III of Internal Medicine, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany",,"https://ClinicalTrials.gov/show/NCT04376853"
354,"NCT04182126","HS#2017-3512, Adaptive Interventions for Optimizing Malaria Control: A Cluster-Randomized SMART Trial",,"Recruiting","No Results Available","LLIN, PBO LLIN, IRS, Larviciding","Other: Regular long-lasting insecticidal nets|Other: LLIN plus Piperonyl butoxide-treated LLIN|Other: Long-lasting microbial larvicide|Other: Indoor residual spraying with micro-encapsulated pirimiphos-methyl","Annual clinical malaria incidence rate|Malaria infection prevalence|Malaria vector density|Malaria transmission intensity","University of California, Irvine","All","6 Months and older   (Child, Adult, Older Adult)","Not Applicable","122872","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","U19AI129326-03S1","December 1, 2019","March 31, 2024","March 31, 2024","December 2, 2019",,"March 5, 2020","Program in Public Health, Irvine, California, United States|Tom-Mboya University College, Maseno University, Homa Bay, Homa Bay County, Kenya",,"https://ClinicalTrials.gov/show/NCT04182126"
355,"NCT03800329","Remote Monitoring to Improve Physician Monitoring, Patient Satisfaction, and Predict Readmissions Following Surgery",,"Enrolling by invitation","No Results Available","Remote Monitoring","Device: Snap40 Monitor|Other: No Monitor","Physician satisfaction in the use of remote monitoring technology.|Patient satisfaction in the use of remote monitoring technology.","Mayo Clinic|Snap40 Ltd.","All","40 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","17-008249","March 7, 2018","March 2020","March 2020","January 11, 2019",,"March 13, 2020","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03800329"
356,"NCT04229446","Music Based Caregiving in Patients With Pain and Dementia",,"Recruiting","No Results Available","Pain|Dementia|Music|Activity, Motor|Quality of Life","Behavioral: Music based caregiving","Pain occurence|The total daily physical activity|Stage of dementia disease|Neuropsychiatric symptoms|Depression|Level of quality of life: QUALID-scale|Aids of daily living","Oslo University Hospital|Helse Midt-Norge|St. Olavs Hospital|University of Oslo|University of Bergen|Norwegian Centre for Ageing and Health","All","Child, Adult, Older Adult","Not Applicable","240","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","2018/2519","August 5, 2019","August 5, 2020","December 31, 2022","January 18, 2020",,"January 18, 2020","Oslo University Hospital, Oslo, Norway|St. Olavs hospital Trondheim University Hospital, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT04229446"
357,"NCT03948620","Macrolide in Pregnancy and Adverse Child Outcomes",,"Completed","No Results Available","Infection","Drug: Macrolides|Drug: Penicillins","Number of major malformation overall|Number of cardiovascular malformation|Number of nervous system malformation|Number of gastrointestinal system malformation|Number of genital malformation|Number of urinary malformation|Rate of cerebral palsy|Rate of epilepsy|Rate of attention-deficit/hyperactivity disorder (ADHD)|Rate of autism spectrum disorder (ASD)","Institute of Child Health","All","up to 14 Years   (Child)",,"726274","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","Heng1","January 1, 1990","June 30, 2016","June 30, 2016","May 14, 2019",,"May 15, 2019",,"""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/20/NCT03948620/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03948620"
358,"NCT03773562","Imaging the Migraine Brain Pre- and Post-Erenumab",,"Recruiting","No Results Available","Migraine","Drug: Erenumab","Changes in Pain-Induced Brain Activations|Changes in Brain Functional Connectivity (temporal correlations in BOLD signal fluctuations)|Accuracy of Predicting Treatment Response|Early Changes in Pain-Induced Brain Activations|Early Changes in Brain Functional Connectivity (temporal correlations in BOLD signal fluctuations)|Changes in Brain Perfusion|Changes in Brain Regional Volumes|Changes in Brain Cortical Thickness|Changes in Brain White Matter Tract Integrity","Mayo Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18-001497","March 25, 2019","September 3, 2020","December 2, 2020","December 12, 2018",,"April 14, 2020","Mayo Clinic in Arizona, Scottsdale, Arizona, United States",,"https://ClinicalTrials.gov/show/NCT03773562"
359,"NCT03623828","Treating Severe Brain-injured Patients With Apomorphine",,"Recruiting","No Results Available","Disorder of Consciousness","Drug: Apomorphine Hydrochloride 50Mg/10mL Prefilled Syringe","Change from baseline in Coma Recovery Scale - Revised (CRS-R)|Nociception Coma Scale - Revised (NCS-R)|resting-state EEG|EEG with auditory paradigms|PET|fMRI|Circadian rythmycity using body movements|Circadian rythmycity using body temperature variations|Number of sleep cycles using night EEG|Glasgow Outcome Scale - Extended (GOS-E)|Phone-adapted CRS-R","University of Liege|Université Catholique de Louvain","All","18 Years to 55 Years   (Adult)","Phase 2","6","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2017/81a","October 3, 2018","December 2022","August 2023","August 9, 2018",,"January 10, 2020","Neurological Hospital Center William Lennox, Ottignies, Brabant Wallon, Belgium|University Hospital of Liège, Liège, Belgium",,"https://ClinicalTrials.gov/show/NCT03623828"
360,"NCT03787134","Oscillatory Contributions to Working Memory and Attention",,"Recruiting","No Results Available","Young Adults","Behavioral: working memory and attention","Experiment 1.a. Behavioral accuracy|Experiment 1.a. Reaction time|Experiment 1.a. Changes in multivariate pattern classification of electroencephalography data in response to prioritization cues and in response to pulses of transcranial magnetic stimulation.|Experiment 1.a. Spatially distributed phase coupling extraction-identified components of the transcranial magnetic stimulation-evoked electroencephalography signal|Experiment 2.a. The amplitude of multivariate inverted encoding model-reconstructions of stimulus location, derived from the transcranial magnetic stimulation-evoked response|Experiment 2.a. Spatially distributed phase coupling extraction-identified components of the transcranial magnetic stimulation-evoked electroencephalography signal|Experiment 2.a. Correlation of the amplitude of multivariate inverted encoding model-reconstructions of the location of the unattended memory item with alpha band power.|Experiment 2.a. Correlation of the amplitude of multivariate inverted encoding model-reconstructions of the location of the unattended memory item with beta-band power|Experiment 3.a. Power in the alpha band of the EEG as a function of retinotopic location|Experiment 3.a. Frequency in the alpha band of the EEG as a function of retinotopic location|Experiment 3.a. Spatially distributed phase coupling extraction-identified components of the electroencephalography signal from signals corresponding to the attended location|Experiment 4.a. Behavioral accuracy assessed as mean percentage correct responses.|Experiment 4.a. Reaction time assess as latency to press response button after onset of critical stimulus.|Experiment 4.a. Power in the alpha band of the EEG as a function of retinotopic location|Experiment 4.a. Frequency in the alpha band of the EEG as a function of retinotopic location|Experiment 4.a. Spatially distributed phase coupling extraction-identified alpha-band components of the electroencephalography signal from signals corresponding to the attended location|Experiment 5. The amplitude of the ""contralateral delay activity"" (CDA) slow component of the EEG during the time period from 1000-1600 milliseconds after stimulus array onset.|Experiment 5. Multivariate inverted encoding modeling of the EEG signal to determine whether or not stimulus information is carried in this signal.|Experiment 6. Multivariate inverted encoding modeling of the EEG signal to determine whether or not contextual information is carried in this signal","University of Wisconsin, Madison|National Institute of Mental Health (NIMH)","All","18 Years to 35 Years   (Adult)","Not Applicable","269","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2016-0500|A538900|SMPH\PSYCHIATRY\PSYCHIATRY|2R01MH095984-06|2R01MH064498-10","March 1, 2019","December 2023","December 2023","December 26, 2018",,"April 6, 2020","University of Wisconsin - Madison, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03787134"
361,"NCT02784197","cPSTA System CADLAD Study","CADLAD","Completed","No Results Available","Coronary Artery Disease","Device: Phase Signal Recorder","Machine-learned algorithm","Analytics For Life","All","21 Years and older   (Adult, Older Adult)","Not Applicable","2622","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","BSA-CD-001","May 2016","December 2017","May 2018","May 27, 2016",,"June 12, 2019",,,"https://ClinicalTrials.gov/show/NCT02784197"
362,"NCT04121403","Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)","NOR-MS","Recruiting","No Results Available","Relapsing Multiple Sclerosis|Multiple Sclerosis","Biological: Rituximab|Drug: Cladribine","Number of new or enlarging cerebral MRI T2 lesions|T2 lesions after 48 weeks|Annual clinical relapse rate (ARR)|Relapse-free patients|Disability progression|Change in disability","Oslo University Hospital|University of Oslo|Göteborg University|Sykehuset Ostfold|Sykehuset Telemark|Vestre Viken Hospital Trust|Sorlandet Hospital HF|Helse Stavanger HF|Sykehuset Innlandet HF|Sykehuset i Vestfold HF|Helse Forde|University Hospital of North Norway","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 3","264","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","11383","October 16, 2019","July 2023","December 2023","October 9, 2019",,"May 28, 2020","Department of Neurology - Drammen, Vestre Viken HF, Drammen, Buskerud, Norway|Department of Neurology - Lillehammer, SI Lillehammer, Lillehammer, Oppland, Norway|Department of Neurology, Stavanger universitetssykehus, Stavanger, Rogaland, Norway|Department of Neurology - Førde, Helse Førde HF, Førde, Sogn Og Fjordane, Norway|Department of Neurology - Skien, Sykehuset Telemark, Skien, Telemark, Norway|Department of Neurology - Tromsø, University Hospital of North Norway, Tromsø, Troms, Norway|Department of Neurology - Kristiansand, Sørlandet sykehus HF, Kristiansand, Vest-Agder, Norway|Department of Neurology - Tønsberg, Sykehuset i Vestfold HF, Tønsberg, Vestfold, Norway|Department of Neurology, Oslo University Hospital, Oslo, Norway|Department of Neurology - Kalnes, Sykehuset Østfold HF, Sarpsborg, Østfold, Norway",,"https://ClinicalTrials.gov/show/NCT04121403"
363,"NCT02641496","Cognitive Behavioral Therapy to Increase CPAP Adherence in Veterans With PTSD",,"Recruiting","No Results Available","Obstructive Sleep Apnea|PTSD|Posttraumatic Stress Disorder","Behavioral: CBT-OSA|Behavioral: Sleep Education","Time in hours of ""mask-on"" CPAP usage per night|Functional Outcomes of Sleep Questionnaire (FOSQ)|California Verbal Learning Test, Second Edition (CVLT-II)|PTSD Checklist for DSM-5 (PCL-5)","VA Office of Research and Development","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","144","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","D1799-R","January 1, 2017","December 31, 2020","December 31, 2021","December 29, 2015",,"June 29, 2020","VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT02641496"
364,"NCT00885131","Effect of Reward on Learning in Motor Cortex",,"Completed","No Results Available","Healthy",,"The outcome measures will be (a) graded changes in blood oxygen level-dependent (BOLD) in response to motor learning and reward and (b) variations in GABA concentration in response to motor learning and reward.|The secondary outcome measures will be variations in response time in the behavioral performance of a learning task.","National Institute of Neurological Disorders and Stroke (NINDS)|United States Department of Defense|National Institutes of Health Clinical Center (CC)|Center for Neuroscience and Regenerative Medicine (CNRM)","All","18 Years to 50 Years   (Adult)",,"64","NIH|U.S. Fed","Observational","Time Perspective: Prospective","090124|09-N-0124","April 15, 2009",,"January 22, 2013","April 21, 2009",,"December 9, 2019","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00885131"
365,"NCT03564457","20K Distributed Learning Challenge",,"Completed","No Results Available","Non Small Cell Lung Cancer","Other: No interventions will take place (observational)","Overall survival","Maastricht Radiation Oncology|Radboud University|The Netherlands Cancer Institute|Manchester Academic Health Science Centre|Catholic University of the Sacred Heart|Fudan University|Velindre Cancer Center|University of Michigan|Cardiff University","All","Child, Adult, Older Adult",,"20000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","20K Distributed Learning","July 1, 2018","October 1, 2018","October 1, 2018","June 20, 2018",,"March 8, 2019","MAASTRO clinic, Maastricht, Netherlands",,"https://ClinicalTrials.gov/show/NCT03564457"
366,"NCT02839733","Dopamine and Motor Learning in Cerebral Palsy",,"Recruiting","No Results Available","Cerebral Palsy",,"Learning (specific measures vary by task)|Genetic testing (for dopamine and activity-related genes)","National Institutes of Health Clinical Center (CC)","All","5 Years to 25 Years   (Child, Adult)",,"120","NIH","Observational","Observational Model: Case-Control|Time Perspective: Prospective","160149|16-CC-0149","June 21, 2017","May 22, 2025","May 22, 2025","July 21, 2016",,"June 2, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02839733"
367,"NCT02498964","Use of High Fidelity Simulation in Cardiac-specific Anesthesia Scenarios for Resident Education and Assessment",,"Unknown status","No Results Available","Resident Education and Assessment of Difficult and High Acuity Scenarios That Focus on Cardiac Anesthesia","Other: Teaching,education,feedback and practice sessions to help improve as needed","Use of NASA Task Load Index Scale in the Evaluation of Neuro-Cognitive Workload during Cardiac Anesthesia Based Simulation Scenarios","Sujatha Bhandary|Ohio State University","All","Child, Adult, Older Adult",,"14","Other","Observational","Observational Model: Other|Time Perspective: Prospective","Buck-IRB 2015B0264","July 2015","April 2018","July 2018","July 15, 2015",,"April 5, 2017",,,"https://ClinicalTrials.gov/show/NCT02498964"
368,"NCT02130089","Can Dietitians Reduce Interdialytic Weight Gain in at Risk Hemodialysis Patients Through Tailored Education on Dietary Sodium and Fluid Intake?",,"Completed","No Results Available","End Stage Renal Disease Requiring Hemodialysis","Behavioral: Intensive Tailored Education","Average Percent Interdialytic Weight Gain|Thirst Intensity|Sodium and Fluid Knowledge","Academy of Nutrition and Dietetics","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","13-186","April 2014","November 2015","November 2015","May 5, 2014",,"January 27, 2016","Auckland Board of Health, Auckland, New Zealand",,"https://ClinicalTrials.gov/show/NCT02130089"
369,"NCT03851497","Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer",,"Recruiting","No Results Available","Breast Cancer",,"Benign or malignant lesions as determined by pathology","Peking Union Medical College Hospital|Peking University Third Hospital|Beijing Hospital|Beijing Chao Yang Hospital|Beijing Zhongguancun Hospital|Peking University Aerospace Centre Hospital|Beijing Anzhen Community Health Service Center|First Hospital of Tsinghua University|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|The First Affiliated Hospital of Zhengzhou University|Henan Provincial People's Hospital|Third Affiliated Hospital of Zhengzhou University|Xinxiang Central Hospital|Henan Cancer Hospital|First Hospital of China Medical University|Shengjing Hospital|Liaoning Cancer Hospital & Institute|West China Hospital|Sichuan Provincial People's Hospital|Yan'an Hospital of Kunming City|Xi'an Central Hospital|Ningxia Medical University|First Hospital of Shijiazhuang City|Chengde Central Hospital|Qinghai Province Cancer Hospital|Gansu Cancer Hospital|Shanghai Zhongshan Hospital|Ruijin Hospital|The Affiliated Hospital of Qingdao University|Qingdao Central Hospital|Shandong Jining No.1 People's Hospital|Linyi Tumour Hospital|The First Affiliated Hospital of Shanxi Medical University|The Second Affiliated Hospital of Harbin Medical University|Second Hospital of Jilin University|The Second Hospital of the West Coast New Area of Qingdao|Fudan University|Tongji Hospital|The First Affiliated Hospital with Nanjing Medical University|Peking University Shougang Hospital|Gansu Jiugang Hospital","Female","18 Years and older   (Adult, Older Adult)",,"2244","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","S-detect 2019","January 1, 2019","January 1, 2021","January 1, 2021","February 22, 2019",,"March 10, 2020","Peking Union Medical College Hospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT03851497"
370,"NCT03978910","Rendering of a Local 1g Environment for Enhanced Motor Learning in Altered Gravity","Sim1g","Recruiting","No Results Available","Healthy","Other: measurements of the accuracy of the reaching movements","accuracy of the reaching movements","University Hospital, Caen","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","18","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","18-210","April 1, 2019","May 30, 2020","May 30, 2021","June 7, 2019",,"June 7, 2019","Caen Univerity Hospital, Caen, France",,"https://ClinicalTrials.gov/show/NCT03978910"
371,"NCT03389932","Explore Transplant @Home Within Kaiser Permanente Southern California",,"Active, not recruiting","No Results Available","End Stage Renal Disease","Behavioral: Patient-Guided","Deceased Donor Kidney Transplant (DDKT) and Living Donor Kidney Transplant (DDKT) Knowledge|Decisional Balance|Informed Decision-Making","University of California, Los Angeles|Kaiser Permanente","All","18 Years and older   (Adult, Older Adult)","Not Applicable","977","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","R39OT29879","July 11, 2018","May 31, 2020","August 31, 2020","January 4, 2018",,"October 2, 2019","Kaiser Permanente Research and Evaluation, Pasadena, California, United States",,"https://ClinicalTrials.gov/show/NCT03389932"
372,"NCT02114450","Human-Machine System for the H2 Lower Limb Exoskeleton","H2-NeuroExo","Unknown status","No Results Available","Stroke|Hemiparesis","Behavioral: Robot-assisted training with the H2 lower limb powered exoskeleton|Behavioral: Supervised motor practice","Change from baseline in Fugl-Meyer Assessment - Lower Extremity Motor Function|Change from baseline in Functional Gait Assessment|Change from baseline in Lower limb joint kinematics during walking|Change in cortical dynamics measured by Electroencephalography (EEG)|Change in robotic measure of performance measured by the H2|Change from baseline in Berg Balance Scale score|Change from baseline in distance walked during the 6-minute walk test|Change from baseline in Timed Up and Go Test score","University of Houston|The University of Texas Health Science Center, Houston|TIRR Memorial Hermann","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","14107|HSC-MS-14-0129","March 2014","December 2017","July 2018","April 15, 2014",,"February 2, 2016","TIRR Memorial Hermann Hospital, Houston, Texas, United States|University of Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02114450"
373,"NCT04302298","The Role of Virtual Reality in Orthopaedic Surgery Education",,"Completed","No Results Available","Virtual Reality|Surgical Training","Device: Virtual Reality","Completion Rate|Number of Steps Performed Correctly - Accuracy|Time of Completion","University of Illinois at Chicago","All","20 Years to 27 Years   (Adult)","Not Applicable","27","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","2019-0335","August 20, 2019","September 25, 2019","November 18, 2019","March 10, 2020",,"March 10, 2020","University of Illinois at Chicago College of Medicine, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT04302298"
374,"NCT03583827","Motor Learning of Stroke Patients in Virtual Environments",,"Recruiting","No Results Available","Stroke|Stroke Sequelae","Other: Virtual reality|Other: Conventional physical therapy","Change the angle of movement|Change the EEG power of alpha and beta waves|Change the Absolute error","Universidade Federal do Rio Grande do Norte|Conselho Nacional de Desenvolvimento Científico e Tecnológico","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","475182/2012-0","February 10, 2014","November 20, 2019","February 1, 2020","July 11, 2018",,"December 3, 2019","Department of Physical Therapy-Federal University of Rio Grande do Norte, Natal, RN, Brazil",,"https://ClinicalTrials.gov/show/NCT03583827"
